<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Chem (Los Angeles)</journal-id><journal-id journal-id-type="iso-abbrev">Med Chem (Los Angeles)</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Medicinal chemistry</journal-title></journal-title-group><issn pub-type="epub">2161-0444</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6137267</article-id><article-id pub-id-type="pmcid-ver">PMC6137267.1</article-id><article-id pub-id-type="pmcaid">6137267</article-id><article-id pub-id-type="pmcaiid">6137267</article-id><article-id pub-id-type="manuscript-id">NIHMS965876</article-id><article-id pub-id-type="pmid">30221034</article-id><article-id pub-id-type="doi">10.4172/2161-0444.1000495</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS965876</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA965876</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>1-Aminobenzotriazole: A Mechanism-Based Cytochrome P450 Inhibitor and Probe of Cytochrome P450 Biology</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>de Montellano</surname><given-names initials="PRO">Paul R Ortiz</given-names></name><xref rid="CR1" ref-type="corresp">*</xref></contrib><aff id="A1">Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143, USA</aff></contrib-group><author-notes><corresp id="CR1"><label>*</label><bold>Corresponding author:</bold> Paul R Ortiz de Montellano, Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143, USA, Tel: 4154762903; <email>ortiz@cgl.ucsf.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>31</day><month>3</month><year>2018</year></pub-date><pub-date pub-type="ppub"><year>2018</year></pub-date><volume>8</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">320559</issue-id><elocation-id>038</elocation-id><pub-history><event event-type="nihms-submitted"><date><day>30</day><month>08</month><year>2018</year></date></event><event event-type="pmc-release"><date><day>14</day><month>09</month><year>2018</year></date></event><event event-type="pmc-live"><date><day>14</day><month>09</month><year>2018</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-04-30 15:25:35.493"><day>30</day><month>04</month><year>2025</year></date></event></pub-history><permissions><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-965876.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.omicsonline.org/open-access/1aminobenzotriazole-a-mechanismbased-cytochrome-p450-inhibitor-and-probe-of-cytochrome-p450-biology-2161-0444-1000495-100211.html"/><abstract id="ABS1"><p id="P1">1-Aminobenzotriazole (1-ABT) is a pan-specific, mechanism-based inactivator of the xenobiotic metabolizing forms of cytochrome P450 in animals, plants, insects, and microorganisms. It has been widely used to investigate the biological roles of cytochrome P450 enzymes, their participation in the metabolism of both endobiotics and xenobiotics, and their contributions to the metabolism-dependent toxicity of drugs and chemicals. This review is a comprehensive evaluation of the chemistry, discovery, and use of 1-aminobenzotriazole in these contexts from its introduction in 1981 to the present.</p></abstract><kwd-group><kwd>Cytochrome P450</kwd><kwd>Mechanism-based inhibition</kwd><kwd>Heme adducts</kwd><kwd>1-Aminobenzotriazole</kwd><kwd>Benzyne</kwd><kwd>Arachidonic acid oxidation</kwd><kwd>Estradiol</kwd><kwd>Xenobiotics</kwd><kwd>Drug metabolism</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="S1"><title>Introduction</title><p id="P2">The inhibition of cytochrome P450 enzymes to study their roles in the metabolism of endogenous compounds and xenobiotics, and for potential practical purposes, began as soon as this class of enzymes was recognized in the early 1960s [<xref rid="R1" ref-type="bibr">1</xref>]. Initially, the most commonly used inhibitors were SKF-525A, which inhibits multiple isoforms [<xref rid="R2" ref-type="bibr">2</xref>], and metyrapone, which inhibits what became known as the CYP2B class of P450 enzymes, but was primarily utilized as an inhibitor of P450 enzymes in the steroid biosynthetic pathway [<xref rid="R3" ref-type="bibr">3</xref>]. With increasing understanding of the native complement of cytochrome P450 enzymes in humans and other species, particularly the understanding provided by genomic data, the search for cytochrome P450 inhibitors diverged into two tracks.</p><p id="P3">One direction for this search was the identification of inhibitors that are isoform specific, or as close to that as possible, as these can be used to probe the biology and/or exploit the inhibition of individual cytochrome P450 enzymes. These inhibitors could be competitive, non-competitive, quasi-irreversible, or mechanism-based [<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr">5</xref>]. On the other hand, agents have also been sought that are pan-specific, i.e., that broadly inhibit the complement of cytochrome P450 enzymes involved in drug metabolism, while minimally perturbing the P450 enzymes involved in biosynthetic processes. These agents include SKF-525A and ketoconazole [<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref>], but this review focuses on 1-aminobenzotriazole (1-ABT), a widely employed mechanism-based inhibitor. Comparisons of 1-ABT and SKF-525A in investigations of drug metabolism by cytochrome P450 enzymes delineate the advantages of 1-ABT. For example, SKF-525A disrupts autophagy in primary rat hepatocytes, whereas 1-ABT and several other P450 inhibitors do not [<xref rid="R8" ref-type="bibr">8</xref>]. In another study, SKF-525A and ketoconazole were shown to inhibit CCKinduced [(Ca<sup>2+</sup>)]<sup>-</sup>induced oscillations in rat pancreatic acinar cells, whereas 1-ABT did not [<xref rid="R9" ref-type="bibr">9</xref>].</p><p id="P4">The currently available reviews on cytochrome P450 inhibition take a horizontal perspective that surveys the breadth of the field (e.g., [<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref>]). This review pursues a vertical, comprehensive analysis of the relevant chemistry, biochemistry, and biology associated with 1-aminobenzotriazole.</p></sec><sec id="S2"><title>Chemistry of 1-Aminobenzotriazole (1-ABT)</title><p id="P5">1-Aminobenzotriazole, abbreviated as 1-ABT, was first prepared in 1960 [<xref rid="R12" ref-type="bibr">12</xref>], but a more practical synthesis was subsequently described by Campbell and Rees [<xref rid="R13" ref-type="bibr">13</xref>]. These authors also demonstrated that oxidation of 1-ABT by lead tetra-acetate resulted in the release of nitrogen gas and the essentially quantitative formation of benzyne, as established by its dimerization and trapping by other substrates. For example, it reacts with tetraphenylcyclopentadienone to give 1,2,3,4-tetraphenylnapthalene after loss of CO from the initial adduct (<xref rid="F1" ref-type="fig">Figure 1</xref>) [<xref rid="R14" ref-type="bibr">14</xref>]. As Campbell and Rees also showed that the oxidation of 1-ABT by other chemical agents gave similar results [<xref rid="R15" ref-type="bibr">15</xref>].</p></sec><sec id="S3"><title>Discovery of 1-ABT as a Cytochrome P450 Inactivating Agent</title><p id="P6">In view of the chemistry of 1-ABT, its biological oxidation by cytochrome P450 enzymes was examined to determine if this would produce benzyne within a biological environment. In effect, incubation of rat liver microsomes with 1-ABT in the presence of the cofactor NADPH led to rapid loss of the cytochrome P450 chromophore and the accumulation of a novel porphyrin [<xref rid="R16" ref-type="bibr">16</xref>]. Cytochrome P450 inactivation requires NADPH and is inhibited by CO, features which implicate an autocatalytic process. Glutathione does not prevent cytochrome P450 loss, which suggests that this is a mechanism-based process in which benzyne generated within the enzyme active site reacts with the heme before diffusing away from the active site cavity [<xref rid="R16" ref-type="bibr">16</xref>]. Exposure of isolated perfused rabbit lungs or microsomes from such lungs showed that 1-ABT caused loss of both specific P450 content and the ethoxyresorufin O-deethylation and benzphetamine N-demethylase activities [<xref rid="R17" ref-type="bibr">17</xref>]. These losses were detectable at concentrations of 1-ABT above 10 &#956;M, with maximum losses occurring at concentrations above 1 mM. At the higher concentrations of 1-ABT, the losses of P450 and benzphetamine N-demethylase activity were similar. Furthermore, covalent binding of radiolabeled 1-ABT to lung microsomes (0.3 nmol/mg protein) was similar to the spectroscopically measured loss of cytochrome P450 (0.3 nmol/mg protein) [<xref rid="R17" ref-type="bibr">17</xref>], suggesting a stoichiometric process. 1-ABT also inhibited the metabolism of resorufin ethers in the livers and skin of mice [<xref rid="R18" ref-type="bibr">18</xref>] and of ethoxycoumarin by rat liver slices, isolated hepatocytes, and hepatic microsomes [<xref rid="R19" ref-type="bibr">19</xref>].</p><p id="P7">Based on its UV-visible spectrum, resistance to forming a zinc complex, and mass spectrometric molecular ion, the accumulated porphyrin was tentatively identified as protoporphyrin IX with a benzene group forming a bridge between two nitrogen atoms of the porphyrin (<xref rid="F2" ref-type="fig">Figure 2</xref>) [<xref rid="R20" ref-type="bibr">20</xref>]. NMR analysis of the modified porphyrin isolated from rats treated <italic toggle="yes">in vivo</italic> with 1-ABT unambiguously confirmed this structure. In addition, a second minor fluorescent product was isolated that was identified as N-phenylprotoporphyrin IX, in which a phenyl group is attached to only one of the nitrogens of the porphyrin. It was estimated that less than 12 molecules of 1-ABT were consumed per molecule of P450 inactivated.</p><p id="P8">The oxidation of 1-ABT by P450 enzymes could be envisaged to proceed via either (path a) initial N-hydroxylation followed by dehydration and then fragmentation, or (path b) sequential hydrogen abstractions from the exocyclic nitrogen followed by fragmentation (<xref rid="F3" ref-type="fig">Figure 3</xref>). Relevant experimental data is scarce, but DFT computational studies favor the two hydrogen abstraction model (path b) of <xref rid="F3" ref-type="fig">Figure 3</xref> [<xref rid="R21" ref-type="bibr">21</xref>]. However, as will be discussed in a later section on derivatives of 1-ABT, N-monoalkyl 1-aminobenzotriazoles also inactivate cytochrome P450 [<xref rid="R22" ref-type="bibr">22</xref>]. It is possible that these agents act by a different mechanism than 1-ABT itself, but if not, it would suggest that, at least in some instances, sequential removal of two hydrogens is not required for benzyne generation.</p></sec><sec id="S4"><title>Metabolism and Pharmacokinetics of 1-ABT</title><p id="P9">The major metabolite observed in the plasma of male rats after oral administration of <sup>14</sup>C-labeled 1-ABT was the N-acetyl derivative, but the N-glucuronides of 1-ABT and of benzotriazole were also found in the urine (<xref rid="F4" ref-type="fig">Figure 4</xref>) [<xref rid="R23" ref-type="bibr">23</xref>]. N-acetylation of 1-ABT by human N-acetyltransferases NAT1 and NAT2 has been confirmed by <italic toggle="yes">in vitro</italic> incubations in studies, which also demonstrated that 1-ABT is a time-independent inhibitor of the N-acetyltransferases in rat liver [<xref rid="R24" ref-type="bibr">24</xref>]. In contrast, 1-ABT was not found to be a measurable inhibitor of rat liver glucuronosyl transferases or sulfotransferases, as judged by its failure to inhibit the action of these enzymes on acetaminophen and 7-hydroxycoumarin, respectively. The absence of glucuronosyl transferase inhibition in rats was independently reported [<xref rid="R25" ref-type="bibr">25</xref>].</p><p id="P10">Although the benzotriazole glucuronide (<xref rid="F4" ref-type="fig">Figure 4</xref>) was detected in the urine of rats, benzotriazole was not observed in the serum or urine [<xref rid="R23" ref-type="bibr">23</xref>]. However, benzotriazole itself was reported as the primary detectable metabolite in incubations of <sup>14</sup>C-labeled 1-ABT with guinea pig hepatic or pulmonary microsomes [<xref rid="R26" ref-type="bibr">26</xref>]. The authors postulated a plausible mechanism in which hydroxylation of the exocyclic nitrogen is followed by elimination of HNO to give benzotriazole (<xref rid="F5" ref-type="fig">Figure 5</xref>).</p><p id="P11">Oral administration of <sup>14</sup>C-labeled 1-ABT to male rats showed that the compound is absorbed slowly, 50% of the radioactivity remaining in the stomach 6 h after dosing, with maximum plasma and tissue concentrations observed at 24 h [<xref rid="R23" ref-type="bibr">23</xref>]. Of the initial dose, 71% was excreted in the urine and 12% in the feces over a period of 72 h. Measurement of radioactivity in the various tissues showed that the highest tissue-to-plasma ratios were in the liver, adrenals, and kidneys, with half-lives of elimination from these tissues of ~24, 16, and 24 h, respectively. The plasma half-life was ~9 h.</p><p id="P12">Comparison of the effect of oral and intravenous 1-ABT on the bioavailability of midazolam in rats revealed that bioavailability was much lower with oral administration, which led to the conclusion that 1-ABT inactivated intestinal P450 enzymes, which are responsible for most of midazolam metabolism [<xref rid="R27" ref-type="bibr">27</xref>]. This led to the proposal that 1-ABT can be used to evaluate gut versus liver clearance of drugs. Using metoprolol as a probe, the AUC was found to increase 16- and 6.5-times when 1-ABT was co-administered orally and intravenously, respectively [<xref rid="R28" ref-type="bibr">28</xref>]. This difference was interpreted as being due to a delay in the absorption of 1-ABT. However, a different study concluded from the fact that concentration-time curves were linear and proportional to the dose that 1-ABT is rapidly absorbed into the systemic circulation in rats and has a t<sub>1/2</sub> of 8&#8211;13 h [<xref rid="R29" ref-type="bibr">29</xref>]. It has also been reported that 1-ABT delays gastric emptying in rats and can alter systemic exposure and T<sub>max</sub> of coadministered agents [<xref rid="R30" ref-type="bibr">30</xref>]. The observation that 50 mg/kg of 1-ABT inhibited antipyrine clearance by 88% when given shortly before the antipyrine, but only by 29% when given 24 h before, suggested that the duration of 1-ABT was relatively short [<xref rid="R31" ref-type="bibr">31</xref>]. However, The pharmacokinetic profiles of oral doses of 1-ABT ranging from 5 to 200 mg/kg, determined in rats, dogs, and monkeys, showed that a single dose of 50 mg/kg in rats and 20 mg/kg in dogs and monkeys produced high plasma concentrations that were sustained over 24 hours [<xref rid="R32" ref-type="bibr">32</xref>]. This resulted in inhibition of the plasma clearance of antipyrine by 88% in rats, 96% in dogs, and 83% in monkeys. Using a serial sampling method after administration of 50, 100, and 150 mg/kg oral doses to mice and guinea pigs revealed that the plasma 1-ABT concentrations were maintained at levels of 5&#8211;100 &#956;M for at least 12 hours in both species [<xref rid="R33" ref-type="bibr">33</xref>]. <italic toggle="yes">In vitro</italic> studies indicated that the K<sub>i</sub> values for 1-ABT as a mechanism-based inactivator were 45.6 and 193 &#956;M in mice and guinea pigs, respectively, with the corresponding k<sub>inact</sub> values of 0.089 and 0.075 min<sup>-1</sup>. Administration of 1-ABT 2 hours before intravenous antipyrine decreased plasma antipyrine clearance by approximately 95% in mice and 84&#8211;95% in guinea pigs at all the doses of 1-ABT examined [<xref rid="R33" ref-type="bibr">33</xref>]. Osmotic pumps can be used to maintain maximum blood concentrations of 1-ABT for at least 6 days [<xref rid="R31" ref-type="bibr">31</xref>]. Indeed, ALZET osmotic pumps were able to maintain the 1-ABT plasma concentration above 4.1 mg/ml over 336 hours without overt toxicity [<xref rid="R34" ref-type="bibr">34</xref>]. A convenient LC/MS/MS assay for the quantitation of 1-ABT in pharmacokinetic studies has been reported [<xref rid="R35" ref-type="bibr">35</xref>]. On the other hand, a test of the residual effects of 1-ABT and quinidine on drug disposition in rats after a 7-day washout period suggested that this period suffices to return to the original pharmacokinetics observed with naive rats [<xref rid="R36" ref-type="bibr">36</xref>].</p></sec><sec id="S5"><title>Specificity of 1-ABT</title><sec id="S6"><title>Cytochrome P450</title><p id="P13">Early work showed that the cytochrome P450 enzymes induced in rat liver by phenobarbital and 3-methylcholanthrene were similarly inactivated by 1-ABT [<xref rid="R37" ref-type="bibr">37</xref>]. Furthermore, similar amounts of N,N&#8217;-aryl bridged porphyrin adducts were obtained from male and female rat livers after treatment with 1-ABT [<xref rid="R38" ref-type="bibr">38</xref>]. Other early studies supported the conclusion that 1-ABT was a relatively non-selective inactivating agent for cytochrome P450 enzymes. It inactivated the liver, lung, and kidney P450 enzymes of uninduced, phenobarbital pretreated, and &#946;-naphthoflavone-pretreated guinea pigs [<xref rid="R39" ref-type="bibr">39</xref>], the rat liver and lung enzymes before and after pretreatment with &#946;-naphthoflavone [<xref rid="R40" ref-type="bibr">40</xref>], and recombinant human P450 enzymes in microsomes from baculovirus infected insect cells [<xref rid="R7" ref-type="bibr">7</xref>]. The use of isoform selective probe substrates indicated that pooled human liver microsomes incubated with 1 mM 1-ABT for 30 min resulted in complete inactivation of CYP2A6 and CYP3A4, but retention of a residual activity of up to 20% with CYP1A2, &#8722;2B6, &#8722;2C8, &#8722;2C9, &#8722;2C19, and &#8722;2D6 [<xref rid="R41" ref-type="bibr">41</xref>]. In this study, CYP2C9 was particularly resistant, with 60% of the activity remaining. A separate study indicated that 1-ABT caused a concentration dependent inhibition of CYP1A2, &#8722;2B6, &#8722;2C9, &#8722;2C19, &#8722;2D6, and &#8722;3A4 [<xref rid="R32" ref-type="bibr">32</xref>]. A later study showed, however, that addition of (S)-warfarin together with 1-ABT resulted in potent inactivation of CPY2C9, presumably because 1-ABT is displaced from the (S)-warfarin binding site to one more favorable for its oxidation [<xref rid="R42" ref-type="bibr">42</xref>]. In accord with catalysis-dependent inactivation, inhibition of baculovirus-expressed P450 enzymes is less differentiated from those of ketoconazole and SKF-525A in the absence of preincubation under turnover conditions [<xref rid="R6" ref-type="bibr">6</xref>].</p><p id="P14">The inactivation of CYP2E1 by 1-ABT has been extensively investigated. An early study demonstrated that 1-ABT caused loss of CPY2E1 activity but not loss of the protein, whereas CCl<sub>4</sub> caused loss of both the activity and the protein [<xref rid="R43" ref-type="bibr">43</xref>]. The modification of CYP2E1 by 1-ABT thus does not trigger rapid degradation of the P450 protein, in contrast to modification by CCl<sub>4</sub>. The inactivation of CYP2E1 by 1-ABT has been used to establish the role of this enzyme in the metabolism of acrylamide [<xref rid="R44" ref-type="bibr">44</xref>], methacrylonitrile [<xref rid="R45" ref-type="bibr">45</xref>], 1,3-butadiene [<xref rid="R46" ref-type="bibr">46</xref>], urethane [<xref rid="R47" ref-type="bibr">47</xref>], and chlorzoxazone [<xref rid="R48" ref-type="bibr">48</xref>].</p><p id="P15">CYP4A11, a human fatty acid &#969;-hydroxylase, is inactivated by 1-ABT, but interestingly, its L131F mutant is not [<xref rid="R49" ref-type="bibr">49</xref>]. In the case of CYP4A1, the homologous rat enzyme, the wild-type enzyme and its E320A mutant are not inactivated by 1-ABT, but the D323E and E320A/D323E mutants are inactivated [<xref rid="R50" ref-type="bibr">50</xref>]. Suppression of inactivation of CYP4A11 by the L131F mutation, and enabling of inactivation of CYPA1 by a D323A mutation, are ascribed to alterations in steric interference to the productive binding of 1-ABT. These results are reminiscent of the finding that occupying the (<italic toggle="yes">S</italic>)-warfarin site of CYP2C9 enables its much more effective inactivation by 1-ABT [<xref rid="R42" ref-type="bibr">42</xref>].</p><p id="P16">The cytochrome P450 enzymes involved in sterol biosynthetic pathways appear to be resistant to the action of 1-ABT. In incubations with guinea pig adrenal microsomes it did not inhibit the 11-, 17&#945;- or 21-sterol hydroxylases [<xref rid="R51" ref-type="bibr">51</xref>,<xref rid="R52" ref-type="bibr">52</xref>]. However, 1-ABT did inhibit the activities of these enzymes when administered <italic toggle="yes">in vivo</italic> to rats or guinea pigs [<xref rid="R53" ref-type="bibr">53</xref>&#8211;<xref rid="R55" ref-type="bibr">55</xref>]. It was postulated that an extra-adrenal metabolite of 1-ABT was responsible for the <italic toggle="yes">in vivo</italic> inactivation of the adrenal enzymes despite their resistance to inactivation <italic toggle="yes">in vitro</italic>. Inactivation of CYP51 has been cited [<xref rid="R56" ref-type="bibr">56</xref>], but no evidence for this is available in the published literature.</p><p id="P17">It is important to note that cytochrome P450 reductase, the electron donor partner of most cytochrome P450 enzymes, is not inactivated in rats by incubation with 1-ABT in the presence of NADPH [<xref rid="R57" ref-type="bibr">57</xref>]. Similarly, 1-ABT does not inhibit cytochrome b<sub>5</sub>, which is an alternative electron donor for some P450 enzymes [<xref rid="R25" ref-type="bibr">25</xref>]. Comparable results were obtained in studies of P450 inactivation in a plant enzyme system [<xref rid="R58" ref-type="bibr">58</xref>]. The loss of P450 activities is thus due to inactivation of the hemoproteins themselves rather than their electron donor partners.</p><p id="P18">Species differences in susceptibility to inactivation of P450 metabolism have been reported. The oxidation of ketamine by human and canine liver microsomes was markedly inhibited, but little inhibition was seen with equine microsomes [<xref rid="R59" ref-type="bibr">59</xref>].</p><p id="P19">1-ABT has been used to inactivate cytochrome P450 enzymes in non-mammalian species, including plants, insects, fungi, and bacteria. This aspect of 1-ABT specificity is addressed in the section that describes inactivation in these species.</p></sec><sec id="S7"><title>Proteins other than cytochrome P450</title><p id="P20">The interactions of proteins other than the cytochrome P450 enzymes with 1-ABT has been examined to provide a context for any physiological observations that may be made when this agent is used to inactivate P450 enzymes in intact cells, tissues, or animals. Inhibition of oxidative enzymes other than the cytochromes P450, for example, would complicate specific attribution of a physiological consequence to inactivation of cytochrome P450 enzymes. The flavin monooxygenase (FMO) family of enzymes is of concern in this regard, as their oxidative activities towards heteroatomic substrates resemble those of the P450 enzymes. However, a number of studies have established that 1-ABT is neither a substrate nor an inhibitor of the FMO enzymes. Thus, 1-ABT has no effect on lung or liver FMO enzymes [<xref rid="R17" ref-type="bibr">17</xref>,<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R60" ref-type="bibr">60</xref>,<xref rid="R61" ref-type="bibr">61</xref>]. One consequence of this is that 1-ABT has been used to determine the relative roles of FMO and P450 enzymes in the oxidative metabolism of xenobiotics (<xref rid="T1" ref-type="table">Table 1</xref>).</p><p id="P21">1-ABT is reported to not be an inhibitor of horseradish peroxidase, as it does not inhibit the oxidation of o-anisidine by this enzyme [<xref rid="R68" ref-type="bibr">68</xref>], but measurements of the binding of benzo[a]pyrene to serum bovine albumin in the presence of horseradish peroxidase and H<sub>2</sub>O<sub>2</sub> suggested that this process is inhibited by 1-ABT [<xref rid="R69" ref-type="bibr">69</xref>]. Based on indirect evidence, the inference has been made that 1-ABT interacts with hemoglobin [<xref rid="R70" ref-type="bibr">70</xref>]. However, clear and convincing evidence that 1-ABT actually inhibits horseradish peroxidase or interacts with hemoglobin is not available. In contrast, chloroperoxidase, a cytochrome P450-like enzyme with a thiolate iron ligand clearly oxidizes 1-ABT to phenol and is inactivated in the process [<xref rid="R20" ref-type="bibr">20</xref>].</p><p id="P22">1-ABT is a substrate for N-acetyltransferases and inhibits these enzymes [<xref rid="R71" ref-type="bibr">71</xref>]. 1-ABT is also reportedly a non-competitive inhibitor of mouse, rat, and human monoamine oxidases with K<sub>i</sub> values of 7.87. 8.61, and 65.2 &#956;M, respectively, when measured <italic toggle="yes">in vitro</italic> with S9 liver fractions [<xref rid="R56" ref-type="bibr">56</xref>]. It does not, however, inhibit aldehyde oxidase [<xref rid="R72" ref-type="bibr">72</xref>], &#945;,&#946;-ketone reductase [<xref rid="R73" ref-type="bibr">73</xref>], or 3&#946;-hydroxysteroid dehydrogenase [<xref rid="R53" ref-type="bibr">53</xref>]. Although the glucuronide of 1-ABT has been observed in rat urine [<xref rid="R23" ref-type="bibr">23</xref>], 1-ABT has no inhibitory activity against the rat glucuronosyl transferases and sulfotransferases [<xref rid="R24" ref-type="bibr">24</xref>] and little if any against the human glucuronosyl transferases [<xref rid="R74" ref-type="bibr">74</xref>]. Indeed, in rat hepatocytes, treatment with 1-ABT increased the formation of the 1-<italic toggle="yes">O</italic>-acyl glucuronides of gemfibrozil, tolmetin, mefenamic acid, and diclofenac, and the <italic toggle="yes">S</italic>-acyl glutathione conjugates of mefenamic acid and diclofenac [<xref rid="R75" ref-type="bibr">75</xref>]. 1-ABT also does not significantly alter the glutathione transferase activities or glutathione levels in rat liver or kidney [<xref rid="R25" ref-type="bibr">25</xref>].</p><p id="P23">Studies with sandwich-cultured human hepatocytes indicate that 1-ABT does not alter the hepatic transport of rosuvastatin, atorvastatin, or midazolam [<xref rid="R71" ref-type="bibr">71</xref>]. Work published in a poster supported the inference that 1-ABT does not interfere with transporters, as concentrations of 1-ABT up to 1 mM did not inhibit the MDR1, Bcrp1, and MRP2 transporters [<xref rid="R76" ref-type="bibr">76</xref>]. In another study, the <italic toggle="yes">in vivo</italic> clearance of GNE1, an inhibitor of the p21-activated kinase PAK1, was lower than predicted [<xref rid="R77" ref-type="bibr">77</xref>]. The use of transporter knockout rats with and without 1-ABT administration indicated that the clearance of this agent is determined by uptake transporters rather by metabolism. These results indicate that 1-ABT does not interfere with transporters. However, 1-ABT can interact with transporter inhibitors by inhibiting the metabolism of drugs whose concentration is elevated due to transporter inhibition. As a case in point, the toxicity of nefazodone, which inhibits bile acid transport, is due to the unmetabolized drug. The toxicity of this drug is potentiated by 1-ABT, which prevents metabolism of nefazodone [<xref rid="R78" ref-type="bibr">78</xref>]. Similarly, inhibition of the bile acid export pump, which results in accumulation of bile acids in hepatocytes, can be potentiated by inhibition of the metabolism of pump inhibitors by 1-ABT [<xref rid="R79" ref-type="bibr">79</xref>].</p></sec></sec><sec id="S8"><title>Induction of Cytochrome P450 Enzymes</title><p id="P24">In an early study, administration of 1-ABT to rats was not found to induce the mRNA or P450 protein levels for what were then known as cytochromes P450b and P450e, nor did 1-ABT prevent the elevation of P450 mRNA levels caused by co-administration of phenobarbital or 3-methylcholanthrene [<xref rid="R80" ref-type="bibr">80</xref>]. However, two decades later 1-ABT was found to upregulate the expression of CYP2B6 and CYP3A4 mRNA in a concentration dependent manner in freshly isolated human hepatocytes. Indirect data suggested that 1-ABT is a CAR, but not PXR activator [<xref rid="R81" ref-type="bibr">81</xref>]. In another study with primary cultured rat hepatocytes, 1-ABT was found to indirectly increase CYP2B mRNA levels, possibly by inhibiting the initial step in the conversion of monocarboxylic to dicarboxylic fatty acids, thereby decreasing peroxisomal &#946;-oxidation and increasing intracellular fatty acid levels [<xref rid="R82" ref-type="bibr">82</xref>].</p></sec><sec id="S9"><title>Toxicity of 1-ABT</title><p id="P25">1-ABT has been reported to have no readily observable toxicity when administered to houseflies [<xref rid="R83" ref-type="bibr">83</xref>], wheat seedlings [<xref rid="R84" ref-type="bibr">84</xref>], beagle dogs [<xref rid="R85" ref-type="bibr">85</xref>], rats [<xref rid="R85" ref-type="bibr">85</xref>,<xref rid="R86" ref-type="bibr">86</xref>], or mice [<xref rid="R86" ref-type="bibr">86</xref>]. Furthermore, administration of 1-ABT to mice via an ALZET osmotic pump for 16 days caused no overt toxicity [<xref rid="R34" ref-type="bibr">34</xref>]. The results of a more detailed 13-week toxicological and pathologic evaluation of the effects of 1-ABT generally agree with this conclusion [<xref rid="R87" ref-type="bibr">87</xref>]. This study showed that in male Sprague-Dawley rats hepatic P450 levels and resorufin dealkylation activity were reduced to less than 30% of control values without obvious signs of toxicity such as changes in body weight, food consumption, or clinical appearance. Hemoglobin, hematocrit, and erythrocyte counts decreased slightly, whereas mean corpuscular hemoglobin concentration, mean corpuscular volume, red cell distribution width, and mean corpuscular hemoglobin were slightly increased. Some accumulation of lipids was suggested by an increase in liver weight, centrilobular hypertrophy, and intracytoplasmic vacuolization. Thyroid stimulating hormone was slightly elevated and triiodothyronine and thyroxin were slightly decreased. Adrenal weight was increased and hypertrophy of the zona fascicularis of the adrenal gland was observed. Some increase in kidney weight was also noted. It is likely that the changes observed are secondary to the persistent decrease in cytochrome P450 activities. The authors concluded that the effects of daily 1-ABT administration &#8220;over a 13 week period were well-tolerated under controlled laboratory conditions&#8221;.</p><p id="P26">Moorthy et al. reported that administration of 1-ABT to rats, followed by exposure for 24-. 28-, or 60-hours to &gt;95% oxygen caused the 1-ABT-treated animals to die between 48 and 60 hours, whereas no control rats exposed to similar hyperoxic conditions died at up to 60 hours of exposure [<xref rid="R88" ref-type="bibr">88</xref>]. 1-ABT thus potentiated hyperoxic lung injury.</p></sec><sec id="S10"><title>Analogues of 1-ABT</title><p id="P27">A number of analogues of 1-ABT have been examined to explore the range of structures compatible with mechanism-based inactivation of P450 enzymes. Efforts to alter the core 1-ABT structure have yielded mixed results. Compounds <bold>3</bold> and <bold>4</bold> (<xref rid="F6" ref-type="fig">Figure 6</xref>) cause catalysisdependent loss of the P450 content in microsomal incubations, but do not appear to result in the formation of a covalent heme adduct, while compound <bold>2</bold> causes NADPH-independent conversion of the P450 to a P420 chromophore [<xref rid="R20" ref-type="bibr">20</xref>].</p><p id="P28">Modifications of the aromatic hydrocarbon ring and of the exocyclic amino group, however, are tolerated. Thus, replacement of the benzene ring of 1-ABT by a naphthyl ring as in compound <bold>7</bold> (<xref rid="T2" ref-type="table">Table 2</xref>) yields an analogue that interacts with cytochrome P450 in much the same way as 1-ABT [<xref rid="R20" ref-type="bibr">20</xref>], causing both catalysis-dependent loss of the P450 chromophore and accumulation of a hepatic pigment. Although the structure of the pigment was not established, it had properties very similar to those of the N,N&#8217;-bridged porphyrin adduct obtained with 1-ABT (<xref rid="F2" ref-type="fig">Figure 2</xref>).</p><p id="P29">The N-mono- and N,N-diacetyl derivatives of 1-ABT, compounds <bold>8</bold> and <bold>9</bold>, cause NADPH-dependent loss of P450 content and the formation <italic toggle="yes">in vivo</italic> of a porphyrin pigment analogous to that obtained with 1-ABT. The same is observed with the N-methyl, N-acetyl derivative <bold>10</bold>, N-methyl analogue <bold>11</bold>, and the N-butyl derivative <bold>12</bold> [<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R22" ref-type="bibr">22</xref>]. A porphyrin pigment was formed <italic toggle="yes">in vivo</italic> with these agents, but its identity was not determined. Compounds <bold>13</bold>-<bold>15</bold> represent the introduction of even larger substituents on the exocyclic nitrogen. These agents, which are more lipophilic and are generally active at lower concentrations than 1-ABT, cause catalysis-dependent loss of both P450 content and catalytic activities. In the case of the N-benzyl derivative <bold>13</bold>, it has been explicitly demonstrated that a hepatic pigment similar to that formed with 1-ABT is formed in phenobarbital-pretreated rats [<xref rid="R20" ref-type="bibr">20</xref>]. This indicates that inactivation by the N-benzyl derivative, as with 1-ABT itself, involves formation of a benzyne that adds to the P450 heme group. Although it is conceivable that the N-benzyl compound is first oxidized to 1-ABT, which then is the actual inactivating agent, it is more likely that benzyne formation is directly initiated from the N-benzyl derivative by electron abstraction from the nitrogen.</p><p id="P30">Compound <bold>5</bold> (<xref rid="F6" ref-type="fig">Figure 6</xref>), a putative possible intermediate in the inactivation mechanism of 1-ABT (<xref rid="F5" ref-type="fig">Figure 5</xref>), does not cause detectable P450 loss [<xref rid="R20" ref-type="bibr">20</xref>]. This indicates that this N-hydroxyl compound is not an intermediate in the action of 1-ABT. The N-nitro compound <bold>6</bold> could not be properly evaluated because it is a powerful electron acceptor that interferes with the P450 assay and, upon administration to rats <italic toggle="yes">in vivo,</italic> causes asphyxia [<xref rid="R20" ref-type="bibr">20</xref>].</p><p id="P31">Analysis of the effects of compounds <bold>13</bold>-<bold>15</bold> suggests that, in addition to heme adduct formation, there are alternative, isoformdependent inhibitory mechanisms. Thus, incubation of these agents with liver microsomes from untreated, phenobarbital-induced, or &#946;-naphthoflavone-induced guinea pigs led to the observation of a complex with an absorption maximum at approximately 455 nm [<xref rid="R90" ref-type="bibr">90</xref>]. This corresponds to the formation of a metabolite-intermediate (MI) complex comparable to that formed with other amines, an inference consistent with the fact that the complex was disrupted by addition of 50 &#956;M potassium ferricyanide or, in the case of <bold>14</bold> and <bold>15</bold>, by sedimentation and resuspension. The formation of this complex was highest with the microsomes from phenobarbital-induced guinea pigs, and was attenuated in the presence of 1 mM glutathione. Interestingly, formation of this complex was not observed with pulmonary microsomes from guinea pigs or rabbits. Formation of the MI complex is therefore only observed with some P450 enzymes in some tissues. Further work suggested that mechanism-based inactivation was favored by CYP1A1 and CYP2B, and reversible inhibition by CYP1A2 [<xref rid="R91" ref-type="bibr">91</xref>]. The nature of this complex was not further characterized, but it was postulated that it might result from formation of an alkyl nitroso species according to the scheme in <xref rid="F7" ref-type="fig">Figure 7</xref>. Coordination of the electron pair in the nitrogen of the nitroso group to the heme iron would then explain the MI complex. In any case, this process is ancillary and independent from that associated with the direct action of 1-ABT.</p><p id="P32">Rat CYP2B1 is completely inactivated <italic toggle="yes">in vitro</italic> by incubation of liver microsomes with 1 &#956;M N-benzyl compound <bold>13</bold>. Benzaldehyde, benzotriazole, 1-ABT, and an unknown metabolite of <bold>13</bold> tentatively assigned to a &#8220;dimer&#8221; of the inhibitor were isolated from these incubations [<xref rid="R92" ref-type="bibr">92</xref>]. However, the Gly478Ala mutant of CYP2B1 was not inactivated and only produced the &#8220;dimeric&#8221; metabolite. Modeling studies suggested that the Gly478Ala mutation prevented oxidation of the 1-amino group, favoring instead oxidation of the 7-benzyl carbon and preventing formation of the inactivating metabolite. Mechanistic studies of CYP2B1 inactivated by the N-benzyl derivative of 1-ABT indicated that the inactivated enzyme was reduced more slowly by NADPH-cytochrome P450 reductase [<xref rid="R93" ref-type="bibr">93</xref>]. The data also indicated that differences existed in the extent to which the metabolism of several compounds was inhibited. N-benzyl 1-ABT also inhibited the 7-ethoxyresorufin O-deethylase and 7-methoxyresorufin O-demethylase activities by 88 and 71%, respectively, in microsomes from &#946;-naphthoflavone-induced guinea pig heart [<xref rid="R94" ref-type="bibr">94</xref>]. These activities were attributed to CYP1A1.</p><p id="P33">Both enantiomers of N-(&#945;-methylbenzyl)-1-aminobenzotriazole [<xref rid="R14" ref-type="bibr">14</xref>] inactivated guinea pig hepatic CYP2B and CYP1A enzymes, with small differences in enantiospecificity [<xref rid="R95" ref-type="bibr">95</xref>].</p><p id="P34">Inactivation of guinea pig lung and liver CYP1A1, CYP2B4, and CYP4B1 by the N-benzyl and N-(&#945;-methylbenzyl) analogues <bold>13</bold> and <bold>14</bold> has been compared by measuring changes in the oxidation of 7-ethoxyresorufin (CYP1A1), 7-pentoxyresorufin (CYP2B4) and 4-aminobiphenyl N-hydroxylation (CYP4B1) [<xref rid="R96" ref-type="bibr">96</xref>]. In uninduced and phenobarbital induced guinea pigs the order of inactivation was 2B1&gt;1A1&gt;&gt;4B1. However, in &#946;-naphthoflavone induced animals, the &#945;-methyl compound inhibited lung CYP2B4, whereas even at concentrations 100-fold higher, it did not inhibit CYP4B1 and CYP1A1. The &#945;-methyl compound was also much more active <italic toggle="yes">in vivo</italic> in inactivation of lung CYP2B4 than of the liver enzymes. In contrast, 1-ABT exhibited little isoform or tissue specificity. The authors postulated that the lung specificity of the N-substituted compounds <bold>13</bold> and <bold>14</bold> reflected selective absorption by the lipophilic aromatic amine uptake system of the lung. In these studies, inhibition by compounds <bold>13</bold> and <bold>14</bold> was not paralleled by comparable losses in P450 content, whereas with 1-ABT the activity and P450 losses were comparable. This indicates that the inhibition caused by the substituted 1-ABT analogues included mechanisms other than heme alkylation.</p><p id="P35">Inhibition of at least some cytochrome P450 enzymes by much lower concentrations of compounds <bold>13</bold>-<bold>15</bold> than of 1-ABT, and greater isoform and tissue selectivity, have also been reported in a number of studies [<xref rid="R97" ref-type="bibr">97</xref>&#8211;<xref rid="R99" ref-type="bibr">99</xref>]. Of particular note is the observation that N-benzyl 1-ABT inhibits CYP1A1 in guinea pig kidney in preference to the enzyme that oxidizes arachidonic acid, and in lung primarily inhibits epoxidation of arachidonic acid, whereas 1-ABT itself inhibits both epoxidation and &#969;-hydroxylation [<xref rid="R100" ref-type="bibr">100</xref>,<xref rid="R101" ref-type="bibr">101</xref>]. N-(&#945;-methyl)-1-ABT has been shown to selectively inhibit dog CYP2B11 relative to CYP3A12 [<xref rid="R102" ref-type="bibr">102</xref>].</p><p id="P36">Incidentally, derivatives of 1-ABT obtained by laccase-catalyzed reaction of 1-ABT with 2,5-dihydroxybenzoic acid methyl ester and 2,5-dihydroxybenzoic acid ethyl ester were found to have low antimicrobial activities [<xref rid="R103" ref-type="bibr">103</xref>].</p><sec id="S11"><title>1-ABT in Analysis of Xenobiotic Metabolism Bioavailability and first pass metabolism</title><p id="P37">The use of 1-ABT in a rat <italic toggle="yes">in vivo</italic> pharmacokinetic screen has been proposed as a tool for determining the relative extent to which absorption and metabolism contribute to low oral systemic exposure of a drug [<xref rid="R104" ref-type="bibr">104</xref>]. The model drugs used in validating this approach were propranolol, metoprolol, and cimetidine. In another study, the low oral (19%) bioavailability of an undefined drug in Sprague Dawley rats was examined by comparing bioavailability in rats pretreated with 50 mg/kg 1-ABT 2 hours prior to both intravenous and oral administration of the drug [<xref rid="R105" ref-type="bibr">105</xref>]. 1-ABT caused a 71% increase in plasma clearance, a 100% increase in half-life, and a marked increase in bioavailability. Similarly, a comparison of bioavailability of oral danazol in rats with and without 1-ABT pretreatment showed that the bioavailability of danazol rose from 2% to 60% and was primarily limited by first pass metabolism [<xref rid="R106" ref-type="bibr">106</xref>]. Comparison of the bioavailability of a &#946;-glucuronidase inhibitor in mice before and after pretreatment with 1-ABT established that its low bioavailability (21%) was due to first pass metabolism [<xref rid="R107" ref-type="bibr">107</xref>]. An investigation of intestinal permeability and first-pass metabolism of acetaminophen, verapamil, and midazolam using single-pass intestinal perfusion showed that 1-ABT increased the intestinal availability of these three drugs to 0.8&#8211;0.85 in cyanomologous monkeys, confirming that they are extensively metabolized in the intestine [<xref rid="R108" ref-type="bibr">108</xref>]. A significant increase in the exposure of mice to midazolam was observed when the mice were pretreated with 1-ABT [<xref rid="R109" ref-type="bibr">109</xref>]. The use of 1-ABT also demonstrated that intestinal metabolism, at least in part by CYP2J2, diminished the bioavailability in rats of AZ&#8217;0908, a prostaglandin E synthase-1 inhibitor [<xref rid="R110" ref-type="bibr">110</xref>]. Using a serial blood sampling method, the administration of 1-ABT (50&#8211;150 mg/kg) 2 hours prior to a single intravenous dose of antipyrine (20 mg/kg) was shown to increase the AUC from 27.3 to upto 333 &#956;g h/ml and the half-life from 0.51 to up to 2.2 hours [<xref rid="R111" ref-type="bibr">111</xref>].</p><p id="P38">1-ABT can be used to potentiate (or &#8220;boost&#8221;) the action of a drug by decreasing its P450 metabolism. Thus, a series of 5-substituted 4-anilinoquinazolines, potent inhibitors of the erbB2 receptor tyrosine kinase, inhibited tumor growth in a mouse xenograft model when 1-ABT was employed to potentiate their action [<xref rid="R112" ref-type="bibr">112</xref>]. In this instance, 1-ABT increased exposure to the tumor inhibitors approximately 100-fold.</p><p id="P39">Human hepatocytes can be used to assay time-dependent inhibition of cytochrome P450 enzymes. These assays correctly distinguished the inactivation of CYP3A4 by 1-ABT and erythromycin from inhibitors that were not time-dependent: for 1-ABT, the values obtained were K<sub>I</sub>=22.0 &#956;M and k<sub>inact</sub>=0.09 min<sup>&#8722;1</sup> [<xref rid="R113" ref-type="bibr">113</xref>]. 1-ABT was employed in the development of this high throughput assay system [<xref rid="R114" ref-type="bibr">114</xref>,<xref rid="R115" ref-type="bibr">115</xref>].</p></sec><sec id="S12"><title>Clarification of oxidative mechanisms</title><p id="P40">The conversion by rat liver microsomes of the esterified pesticide thiazopyr to the free acid is inhibited by 1-ABT and is thus mediated by a cytochrome P450 enzyme rather than by an esterase (<xref rid="F8" ref-type="fig">Figure 8</xref>) [<xref rid="R116" ref-type="bibr">116</xref>]. Using 1-ABT, cytochrome P450 catalysis in the endoplasmic reticulum was found in another instance to contribute to the instability of a TGR5 receptor agonist with a central amide bond [<xref rid="R117" ref-type="bibr">117</xref>]. A more exotic transformation in the metabolism of GNE-892 by rats produces two ring-contracted pyrazole compounds as minor metabolites (<xref rid="F8" ref-type="fig">Figure 8</xref>). This ring contraction is inhibited by 1-ABT and is thus cytochrome P450-dependent [<xref rid="R118" ref-type="bibr">118</xref>].</p><p id="P41">1-ABT was recently used to establish that the deiimination of the sulfoximine moiety in the ATR inhibitor AZD6738 to a sulfoxide and sulfone, a nominally reductive event, is mediated by cytochrome P450 (<xref rid="F9" ref-type="fig">Figure 9</xref>) [<xref rid="R119" ref-type="bibr">119</xref>]. A reasonable oxidative mechanism for this transformation was postulated.</p><p id="P42">In contrast, the reductive metabolism of the dinitrobenzamide mustard anticancer prodrug PR-104, which is activated to its cytotoxic form in the liver, is not inhibited by 1-ABT, indicating that cytochrome P450 itself is not involved in this reductive transformation [<xref rid="R120" ref-type="bibr">120</xref>]. 1-ABT was similarly employed to establish that the metabolism of a vasoactive drug, SK&amp;F 86466, in isolated, perfused rat lungs was not mediated by cytochrome P450 enzymes [<xref rid="R121" ref-type="bibr">121</xref>]. In these studies, 1-ABT administered to the rats before the lung study was shown to suppress P450 activities completely without any effect on the metabolism of the drug. A comparison of the effects of 1-ABT and inhibitors of epoxide hydrolases on the metabolism of oprozomib, an oral proteasome inhibitor, confirmed that the major metabolic pathway was epoxide hydrolysis rather than P450-catalyzed oxidation [<xref rid="R122" ref-type="bibr">122</xref>].</p></sec><sec id="S13"><title>Oxidation of pharmaceutical agents</title><p id="P43">The use of 1-ABT in studies of the action of a variety of agents is summarized in <xref rid="T3" ref-type="table">Table 3</xref>.</p></sec><sec id="S14"><title>1-ABT as a Probe of Physiological Processes Fatty acid oxidation</title><p id="P44">Cytochrome P450 enzymes oxidize fatty acids and these oxidative reactions can be inhibited by 1-ABT. HPLC analysis of the oxidation of radiolabeled lauric acid by control and clofibrate-induced rat liver microsomes showed that 1-ABT inhibits the oxidation of lauric acid to the &#969;-, &#969;&#8722;1, and &#969;&#8722;2 hydroxylated derivatives [<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R144" ref-type="bibr">144</xref>,<xref rid="R145" ref-type="bibr">145</xref>]. Comparison with more specific inhibitors implied the presence of at least one lauric acid &#969;-hydroxylase and two &#969;&#8722;1 hydroxylases [<xref rid="R145" ref-type="bibr">145</xref>,<xref rid="R146" ref-type="bibr">146</xref>]. However, 1-ABT did not alter the ability of clofibrate to decrease serum triglyceride levels in rats, which showed that fatty acid hydroxylation was not critical for the antihyperlipidemic action of this drug [<xref rid="R144" ref-type="bibr">144</xref>]. Furthermore, work with primary hepatocyte cultures indicated that induction of peroxisomal &#946;-oxidation and liver fatty acid binding protein is mediated by a 1-ABT-insensitive mechanism subsequent to P450 oxidation of long-chain fatty acids to dicarboxylic acids [<xref rid="R147" ref-type="bibr">147</xref>].</p></sec><sec id="S15"><title>Arachidonic acid oxidation</title><p id="P45">The oxidation of arachidonic acid to both epoxyeicosatrienoic acids and 16- through 20-hydroxyeicosatetraenoic acids by pulmonary microsomes from &#946;-naphthoflavone-induced guinea pigs was inhibited by more than 95% after preincubation with 1 mM 1-ABT [<xref rid="R101" ref-type="bibr">101</xref>]. Formation of the epoxide metabolites was attributed in this study largely to the guinea pig orthologue of CYP2B4. 1-ABT causes dose-dependent loss of renal cytochrome P450 content, arachidonic acid oxidation, and CYP4A protein content when administered intraperitoneally to Sprague-Dawley rats [<xref rid="R148" ref-type="bibr">148</xref>]. In the cortex and outer medulla, 1-ABT was a potent inhibitor of the formation of 19-hydroxyeicosatetraenoic acid (19-HETE) and 20-hydroxyeicosatetraenoic acid (20-HETE). The activity losses caused by 1-ABT returned to control levels after 72 hours. Interestingly, renal arachidonic acid epoxygenase activity was not impaired under the same conditions. A single dose of 1-ABT given to 7-week old spontaneously hypertensive rats caused an acute reduction in mean arterial pressure that persisted for at least 12 hours. The role of 20-HETE in this antihypertensive effect is supported by the finding that an analogue of 1-ABT, 1-hydroxybenzimidazole, which does not inhibit 20-HETE formation has no effect on mean arterial pressure [<xref rid="R148" ref-type="bibr">148</xref>]. A fluorescent 20-HETE HPLC assay, which distinguishes this metabolite from other HETEs, dihydroxyeicosatrienoic acids, and epoxyeicosatrienoic acids, was used to demonstrate that 1-ABT reduces the excretion of 20-HETE in rats and inhibits its formation by renal microsomes [<xref rid="R149" ref-type="bibr">149</xref>]. <italic toggle="yes">In vivo</italic>, a daily 50 mg/kg injection of 1-ABT to rats over five days greatly lowered the urinary excretion of 20-HETE and the ability of renal cortical microsomes to oxidize arachidonic acid to 20-HETE and epoxyeicosatrienoic acids [<xref rid="R150" ref-type="bibr">150</xref>&#8211;<xref rid="R152" ref-type="bibr">152</xref>]. These examples are part of an extensive body of data (<xref rid="T4" ref-type="table">Table 4</xref>) indicating that 1-ABT is a mechanism-based cytochrome P450 inactivating agent of the enzymes that oxidize arachidonic acid to its diverse metabolites.</p></sec><sec id="S16"><title>Estradiol</title><p id="P46">As discussed in the section on 1-ABT toxicity, this inhibitor does not directly inhibit cytochrome P450 enzymes of the sterol biosynthetic pathway [<xref rid="R51" ref-type="bibr">51</xref>,<xref rid="R52" ref-type="bibr">52</xref>], although an <italic toggle="yes">in vivo</italic> study suggested that inhibition may occur via an indirect mechanism [<xref rid="R53" ref-type="bibr">53</xref>&#8211;<xref rid="R56" ref-type="bibr">56</xref>]. The further metabolism of estradiol, however, is mediated by P450 enzymes that are also involved in drug metabolism. This metabolism has a complicated effect on cell proliferation and growth, as shown in the summary of the studies of these effects carried out with the help of 1-ABT as a cytochrome P450 inhibitor (<xref rid="T5" ref-type="table">Table 5</xref>).</p></sec><sec id="S17"><title>Hypothermia</title><p id="P47">Studies of the effects of hypothermia on the <italic toggle="yes">in vivo</italic> pharmacokinetics of midazolam in rats showed that the K<sub>m</sub> value for CYP3A2 remained unchanged at 37, 32, and 28&#176;C, but the V<sub>max</sub> decreased at the lower temperature [<xref rid="R205" ref-type="bibr">205</xref>]. 1-ABT was used in these studies to determine the contribution of this enzyme to the observed changes in pharmacokinetics.</p></sec><sec id="S18"><title>Other endogenous pathways</title><p id="P48">SKF-93479, a histamine H2 antagonist, caused thyroid lesions in rats linked to increased plasma clearance of thyroxine and elevated TSH concentrations. Inactivation of cytochrome P450 in hepatocytes by 1-ABT did not alter the effect of SKF-93479 on the accumulation of thyroxine, indicating that the enhancement was due to the parent drug and not a metabolite [<xref rid="R206" ref-type="bibr">206</xref>]. Temelastine (SK&amp;F 93944), a histamine H1 antagonist, caused thyroid lesions associated with hypertrophy and colloic depletion in rats [<xref rid="R207" ref-type="bibr">207</xref>]. Again, 1-ABT was used to establish that the effect of the drug was due to the parent and not an oxidatively generated metabolite. In another area, &#969;-hydroxyceramides are the major lipids on the corneocyte envelop in the epidermis. 1-ABT was shown to inhibit incorporation of radiolabeled acetate into this lipid in cultured human keratinocytes [<xref rid="R208" ref-type="bibr">208</xref>]. 1-ABT also inhibited recovery of the skin when damaged in hairless mice. These results confirmed the importance of &#969;-hydroxyceramides in determining the epidermal permeability of skin.</p><p id="P49">A V79-derived cell line overexpressing CYP2E1 and SULT1A1 was found to undergo much higher rates of spontaneous gene mutations and sister chromatid exchanges than control V79 cells [<xref rid="R209" ref-type="bibr">209</xref>]. These elevated rates were completely prevented by 1-ABT or pentachlorophenol, a SULT1A1 inhibitor, suggesting that CYP1A1 in combination with SULT1A1 activates an endogenous molecule to a mutagenic product.</p></sec></sec><sec id="S19"><title>Toxicity Studies</title><sec id="S20"><title>Sepsis</title><p id="P50">Sepsis is a common, sometimes fatal condition during which cytochrome P450 enzymes are significantly downregulated due to a decrease in the levels of the AhR and Arnt receptors [<xref rid="R210" ref-type="bibr">210</xref>&#8211;<xref rid="R212" ref-type="bibr">212</xref>]. 1-ABT has provided evidence that cytochrome P450 enzymes are important for the prevention of hepatic dysfunction during sepsis [<xref rid="R212" ref-type="bibr">212</xref>&#8211;<xref rid="R214" ref-type="bibr">214</xref>]. Thus, treatment with 1-ABT enhanced the levels of proinflammatory cytokines in adult male Sprague-Dawley rats after induction of sepsis [<xref rid="R213" ref-type="bibr">213</xref>,<xref rid="R214" ref-type="bibr">214</xref>]. In sepsis induced by administration of low doses of zymosan, 58% mortality was observed when 1-ABT was co-administered, in contrast to no mortality in the absence of 1-ABT [<xref rid="R215" ref-type="bibr">215</xref>].</p></sec><sec id="S21"><title>Acetaminophen/Phenacetin</title><p id="P51">Intravenously administered phenacetin is oxidized in rats to acetaminophen, but this transformation is inhibited by pretreatment with 1-ABT [<xref rid="R216" ref-type="bibr">216</xref>], which changes the half-life of phenacetin from 34 to 230 min. In contrast, in this same system 1-ABT has little effect on the clearance, half-life, or distribution of intravenously administered acetaminophen. Both intravenous and intraperitoneal pretreatment of rat with 1-ABT greatly inhibited the systemic clearance of phenacetin, with an intraperitoneal dose of 50 mg/kg of 1-ABT resulting in 79% inhibition [<xref rid="R85" ref-type="bibr">85</xref>]. To determine if metabolism differences contributed to the finding that female Sprague-Dawley rats are more susceptible than male rats to acetaminophen-induced nephrotoxicity, incubations of hepatic and renal S9 fractions with radiolabeled acetaminophen in the presence of either 1-ABT or the reversible carboxyesterase inhibitor <italic toggle="yes">bis</italic>-(<italic toggle="yes">p</italic>-nitrophenyl)phosphate were carried out [<xref rid="R217" ref-type="bibr">217</xref>]. No sexdependent differences in covalent binding to protein of acetaminophen were observed and 1-ABT was found to inhibit covalent binding equally in both, whereas the carboxyesterase inhibitor had no effect on covalent binding. In a follow-up experiment, blood urea nitrogen was measured as an index of nephrotoxicity in rats after administration of radiolabeled acetaminophen. In this instance, pretreatment with either 1-ABT or tri-<italic toggle="yes">o</italic>-tolylphosphate, an irreversible carboxyesterase inhibitor, prevented elevation of blood urea nitrogen and decreased covalent binding [<xref rid="R218" ref-type="bibr">218</xref>]. Thus, both P450-catalyzed oxidation and deacetylation appear to contribute to nephrotoxicity. An analysis of the toxicity of acetaminophen to sinusoidal endothelial cells versus hepatocytes in C3H-HEN and Swiss Webster mice showed that it was more toxic to the sinusoidal cells, but the toxicity was suppressed by 1-ABT [<xref rid="R219" ref-type="bibr">219</xref>]. Studies with primary mouse hepatic parenchymal cells revealed that 1-ABT prevented covalent binding and toxicity when acetaminophen was present at concentrations lower than 5 mM, but at higher concentrations a P450-independent toxicity mechanism also intervened that appeared to be related to the presence of <italic toggle="yes">p</italic>-aminophenol [<xref rid="R220" ref-type="bibr">220</xref>]. This second toxicity mechanism was alleviated by a carboxyesterase inhibitor.</p></sec><sec id="S22"><title>Cyclophosphamide</title><p id="P52">Classical P450 inhibitors such as SKF-525A did not attenuate pulmonary thymidine incorporation, a marker of tissue injury, associated with administration of cyclophosphamide, whereas pretreatment with 1-ABT lowered thymidine incorporation into lung DNA on days 3 and 10, but not on day 7. Agents, such as indomethacin and aspirin, which inhibit arachidonic acid pathways independent of cytochrome P450, similarly reduced levels of thymidine incorporation in the lung. Although differences were found in the protective effects of these agents in liver and lung, it appears that oxidation of cyclophosphamide by the cytochrome P450 system is not essential for the development of pulmonary toxicity associated with cyclophosphamide [<xref rid="R221" ref-type="bibr">221</xref>]. Gene therapy to increase expression of CYP2B in tumors provides a strategy for increasing tumor rather than systemic toxicity of cyclophosphamide [<xref rid="R222" ref-type="bibr">222</xref>]. 1-ABT, which is more inhibitory to CYP2C than CYP2B cyclophosphamide activation, increases the C<sub>max</sub> and half-life of the activated anti-tumor metabolite of cyclophosphamide in rats [<xref rid="R222" ref-type="bibr">222</xref>].</p></sec><sec id="S23"><title>Nevirapine</title><p id="P53">Nevirapine, a reverse transcriptase inhibitor, causes skin rash and hepatotoxicity. The 12-hydroxy metabolite causes the skin rash and deuteration of the 12-methyl in the parent drug, which inhibits 12-hydroxylation, suppresses rash formation [<xref rid="R223" ref-type="bibr">223</xref>]. However, blood levels of the deuterated compound were unexpectedly low due to formation of a quinone methide, which inactivates cytochrome P450. Comparable levels of nevirapine and the deuterated analogue were observed when the rats were pretreated with 1-ABT. The results led to the proposal that the quinone methide formed in the liver is responsible for the hepatoxicity of nevirapine, whereas the skin rash is due to formation of the 12-hydroxy metabolite in the skin, probably followed by sulfation to make it a more reactive species. The role of the quinone methide in liver toxicity was substantiated by a subsequent study, again using 1-ABT and the deuterated nevirapine analog, which showed that <italic toggle="yes">in vivo</italic> the quinone methide bound covalently to liver proteins, and <italic toggle="yes">in vitro</italic> specifically to rat CYP3A1 and CYP2C11, and human CYP3A4 (<xref rid="F10" ref-type="fig">Figure 10</xref>) [<xref rid="R224" ref-type="bibr">224</xref>].</p></sec><sec id="S24"><title>Tienilic acid</title><p id="P54">Tienilic acid is a hepatotoxic agent that forms a glutathione adduct (<xref rid="F11" ref-type="fig">Figure 11</xref>), decreases glutathione levels, and upregulates toxicity marker genes [<xref rid="R225" ref-type="bibr">225</xref>]. All of these effects are blocked by pretreatment with an intraperitoneal dose of 66 mg/kg of 1-ABT. The metabolism of tienilic acid, as well as several other drugs, by human hepatocytes was shown to be inhibited by 1-ABT [<xref rid="R226" ref-type="bibr">226</xref>]. As tienilic acid itself inactivates CYP2C9, and other studies indicate that 1-ABT is a good inactivator of most drug metabolizing forms of P450, but less so of CYP2C9 [<xref rid="R41" ref-type="bibr">41</xref>], a cocktail of tienilic acid and 1-ABT has been employed to approach pan-P450 inactivation [<xref rid="R227" ref-type="bibr">227</xref>]. A study of the cytotoxicity of bosentan in sandwich-cultured human hepatocytes showed that tienilic acid, as a CYP2C9-specific inhibitor, plus 1-ABT helped to preserve cell viability [<xref rid="R228" ref-type="bibr">228</xref>].</p></sec><sec id="S25"><title>Valproic acid</title><p id="P55">To explore the mechanism by which valproic acid causes liver damage its effects on levels of 15-F<sub>2t</sub>-isoprostane, a measure of oxidative stress, and the possible role of cytochrome P450 in the process, have been investigated [<xref rid="R229" ref-type="bibr">229</xref>]. Phenobarbital pretreatment was found to increase plasma and liver concentrations of 15-F<sub>2t</sub>-isoprostane in valproic acid-treated rats by several fold. Cytochrome P450 metabolites of valproic acid were also increased. However, 1-ABT attenuated the formation of valproic acid metabolites, but did not lower the levels of 15-F<sub>2t</sub>-isoprostane, suggesting that phenobarbital exacerbated liver damage by a mechanism independent of the P450 oxidation of valproic acid. An extension of this study confirmed that the (<italic toggle="yes">E</italic>)-2,4-diene metabolite of valproic acid did not contribute to the toxicity of the parent compound in hepatocytes, as shown by the failure of 1-ABT to diminish the toxicity despite its inhibitory effect on formation of the metabolite [<xref rid="R230" ref-type="bibr">230</xref>].</p></sec><sec id="S26"><title>Loratadine</title><p id="P56">Desloratadine, a nonsedating antihistamine, is converted <italic toggle="yes">in vivo</italic> to 3-hydroxydesloratadine, but efforts to reproduce this transformation <italic toggle="yes">in vitro</italic> were unsuccessful. More recent work showed that cryopreserved human hepatocytes yield both 3-hydroxydesloratadine and its <italic toggle="yes">O</italic>-glucuronide [<xref rid="R231" ref-type="bibr">231</xref>]. 1-ABT and gemfibrozil glucuronide, a CYP2C8 inhibitor, prevented 3-hydroxydesloratadine formation. Furthermore, the formation of this metabolite required both NADPH and UDPglucuronic acid, leading to the conclusion that 3-hydroxydesloratadine was generated by a sequence involving initial N-glucuronidation, CYP2C8 hydroxylation of the glucuronide, and glucuronidase release of the 3-desloratadine metabolite (<xref rid="F12" ref-type="fig">Figure 12</xref>). The glucuronide, indicated by Glu in the figure, could conceivably be located on the other nitrogen of the molecule.</p><p id="P57">In a different vein, 1-ABT was used to demonstrate that the druginduced phospholipidosis caused by loratadine in three-dimensional cultures of hepatocytes was due to the cytochrome P450-catalyzed formation of desloratadine [<xref rid="R232" ref-type="bibr">232</xref>].</p></sec><sec id="S27"><title>Precocene</title><p id="P58">Precocene, a naturally occurring regulator of insect development, causes P450-dependent hepatic necrosis. Comparison of 24-hour cultures of rat hepatocytes with and without added calf serum showed that addition of serum decreased the toxicity of precocene and prevented glutathione loss [<xref rid="R233" ref-type="bibr">233</xref>]. However, although precocene was also toxic to 72-hour cell cultures, the effect of serum was attenuated and the toxicity was relatively insensitive to inhibition of P450 enzymes by 1-ABT, suggesting that a different mechanism of toxicity might be operative in the older cultures [<xref rid="R233" ref-type="bibr">233</xref>,<xref rid="R234" ref-type="bibr">234</xref>]. A later study of the metabolism of precocene by rat liver slices showed that differences exist in the metabolite profiles obtained with the slices versus <italic toggle="yes">in vivo</italic> in rats, particularly in the amount of dihydrodiol products generated from the epoxide metabolite (<xref rid="F13" ref-type="fig">Figure 13</xref>) by epoxide hydrolases [<xref rid="R235" ref-type="bibr">235</xref>]. 1-ABT decreased the extent of metabolite formation and decreased the observed toxicity of precocene, and was more effective in doing so than ketoconazole and other isoform selective P450 inhibitors.</p></sec><sec id="S28"><title>3-Methylindole</title><p id="P59">The pneumotoxicity of 3-methylindole in cattle, goats, sheep, horses, and other species appears to be mediated by a P450-generated electrophilic metabolite [<xref rid="R236" ref-type="bibr">236</xref>]. Thus, 1-ABT decreased 3-methylindole metabolism and its covalent binding to proteins in goat lung by 50 and 100% when present at a concentration of 10 and 100 &#956;M, respectively. 1-ABT also inhibited the toxicity of 3-methylindole in isolated rabbit lung cells [<xref rid="R237" ref-type="bibr">237</xref>,<xref rid="R238" ref-type="bibr">238</xref>], and abrogated the toxicity of 3-methylindole in human bronchial epithelial cells lines [<xref rid="R239" ref-type="bibr">239</xref>,<xref rid="R240" ref-type="bibr">240</xref>]. As 3-methylindole with a trideuterated methyl group is much less cytotoxic, it appears that oxidation of the methyl group produced the electrophilic metabolite involved in covalent binding and toxicity (<xref rid="F14" ref-type="fig">Figure 14</xref>) [<xref rid="R237" ref-type="bibr">237</xref>].</p></sec><sec id="S29"><label>10</label><title>Acrylamide/acrylonitrile</title><p id="P60">The oxidation by mice of acrylonitrile (CH<sub>2</sub>=CHCN) and acrylamide (CH<sub>2</sub>=CHCONH<sub>2</sub>) to the epoxides glycidamide and cyano ethylene oxide, respectively, was suppressed by pretreatment with 1-ABT or when CYP2E1-null mice were employed. The data suggested that in mice CYP2E1 is the principal cytochrome P450 enzyme responsible for formation of these metabolites [<xref rid="R44" ref-type="bibr">44</xref>]. Other work showed that P450 enzymes other than CYP2E1 contribute to the oxidative metabolism of acrylonitrile and methacrylonitrile, as 1-ABT lowered the formation of cyanide derived from these compounds even in CYP2E1-null mice [<xref rid="R241" ref-type="bibr">241</xref>]. 1-ABT and CYP2E1-null mice were also used to show that CYP2E1 plays a major, but not exclusive, role in the oxidative metabolism of methacrylonitrile [<xref rid="R45" ref-type="bibr">45</xref>]. Acrylamide is a mutagen with clastogenic effects in mice. Pretreatment with 1-ABT prior to acrylamide administration greatly reduced this mutagenesis, providing strong support for the conclusion that the epoxide is the mutagenic metabolite [<xref rid="R242" ref-type="bibr">242</xref>]. However, 1-ABT was not found to decrease the morphological transformation of Syrian hamster embryo cells caused by acrylamide, a process that was inhibited by N-acetylcysteine. This led the authors to postulate that acrylamide itself, not its oxidative metabolite, was responsible for cell transformation [<xref rid="R243" ref-type="bibr">243</xref>]. In another study, the incidence of adrenal, testicular, and thyroid neoplasia in rats upon chronic exposure to acrylamide was investigated [<xref rid="R244" ref-type="bibr">244</xref>]. Acrylonitrile was found to increase DNA synthesis in these tissues, but not in the liver or adrenal cortex, which are not target tissues for acrylamide carcinogenesis. Pretreatment with 1-ABT reduced DNA synthesis caused by acrylamide in the adrenal medulla, but not in the testicular mesothelium or thyroid. Acrylonitrile increases oxidative stress in rat brain and cultured rat glial cells. A study of the possible causes for this effect showed that acrylonitrile decreased the activity of catalase, and increased that of xanthine oxidase, but 1-ABTpretreatment counteracted these effects [<xref rid="R245" ref-type="bibr">245</xref>], suggesting that these protein alterations contribute to the increase in oxidative stress caused by acrylonitrile. Related studies in which 1-ABT was shown to decrease the extent of oxidative damage caused by acrylonitrile in rat brain concurred with the view that its P450-catalyzed oxidation was at the root of the oxidative damage [<xref rid="R246" ref-type="bibr">246</xref>].</p><p id="P61"><italic toggle="yes">Cis</italic>-2-pentenenitrile triggers permanent behavioral defects in rodents. These behavioral changes were prevented by pretreatment with 1-ABT, implicating oxidative metabolism of this substrate in its deleterious effects [<xref rid="R247" ref-type="bibr">247</xref>]. 1-ABT also decreased the mortality and vestibular toxicity of allylnitrile [<xref rid="R248" ref-type="bibr">248</xref>].</p></sec><sec id="S30"><label>11</label><title>Halocarbons</title><p id="P62">A comparison of the toxicity of chloroform in male B6C3F<sub>1</sub>, Sv/129 wild-type mice, and CYP2E1-null mice showed that the pathological changes caused by chloroform were only observed in wild-type mice. Furthermore, pretreatment of wild-type mice with 1-ABT completely protected against the cytotoxic effects of chloroform [<xref rid="R249" ref-type="bibr">249</xref>], leading to the conclusion that CYP2E1 was largely responsible for bioactivation of chloroform to a cytotoxic species. Dimethyl sulfoxide (DMSO) is known to confer some protection against chloroform-induced liver injury. To determine if this protection was due to inhibition of cytochrome P450 enzymes or some other phenomenon, the protective activities of DMSO and 1-ABT were evaluated in male Sprague-Dawley rats [<xref rid="R250" ref-type="bibr">250</xref>]. 1-ABT decreased covalent binding of <sup>14</sup>C-chloroform to liver proteins by 35% and reduced the amount of radiolabel in blood 10 hours after radiolabeled chloroform administration by 50%, whereas DMSO had no effect on these parameters even though it also protected the liver. Thus, DMSO confers protection by mechanisms other than inhibition of the bioactivation of chloroform.</p><p id="P63">The metabolism of inhaled 1-bromopropane by male F344 rats and B6C3F1 mice resulted in exhaled radiolabeled CO<sub>2</sub> and several glutathione-derived conjugates in the urine: <italic toggle="yes">N</italic>-acetyl-<italic toggle="yes">S</italic>-propylcysteine, <italic toggle="yes">N</italic>-acetyl-3-(propylsulfinyl)alanine, <italic toggle="yes">N</italic>-acetyl-<italic toggle="yes">S</italic>-(2-hydroxypropyl)-cysteine, 1-bromo-2-hydroxypropane-<italic toggle="yes">O</italic>-glucuronide, <italic toggle="yes">N</italic>-acetyl-<italic toggle="yes">S</italic>-(2oxopropyl)cysteine, and <italic toggle="yes">N</italic>-acetyl-3-[(2-oxopropyl)sulfinyl]alanine (<xref rid="F15" ref-type="fig">Figure 15</xref>) [<xref rid="R251" ref-type="bibr">251</xref>]. In rats pretreated with 1-ABT, oxidative metabolism was decreased and the single urinary metabolite was that formed by glutathione displacement of bromide from the parent compound. 1-Bromopropane also has neurotoxic effects that are difficult to study <italic toggle="yes">in vivo</italic> due to the hepatotoxicity of the compound. Administration of 1-ABT (50 mg/kg) to rats for three days inhibited 92&#8211;96% of the hepatic microsomal CYP2E1 activity, but only 62&#8211;64% of the same activity in brain microsomes. Under these conditions, it was possible to administer higher doses of 1-bromopropane and to examine their effect on the brain [<xref rid="R252" ref-type="bibr">252</xref>].</p><p id="P64">1,1-Dichloro-2,2-<italic toggle="yes">bis</italic>(4&#8217;-chlorophenyl)ethane (DDD), 1,2-dibromoethane, and trichloroethylene are toxic to rabbit lung Clara cells, alveolar type II cells, and alveolar macrophages [<xref rid="R253" ref-type="bibr">253</xref>]. 1-ABT diminished the cytotoxicity of DDD and 1,2-dibromoethane to Clara cells, indicating that cytotoxic metabolite formation was mediated, at least in part, by cytochrome P450 enzymes.</p><p id="P65">The oxidative metabolism of trichloroethylene, a carcinogen present in the environment, was suggested by <italic toggle="yes">in vitro</italic> studies to be mediated by CYP2E1. To better assess the role of this enzyme, the metabolism of trichloroethylene in wild-type and CYP2E1-null mice was investigated [<xref rid="R254" ref-type="bibr">254</xref>]. The excretion of trichloroethylene as urinary metabolites and CO<sub>2</sub> was much lower, and excretion of the parent compound higher, in the CYP2E1-null than wild-type mice. Pretreatment of both types of mice with 1-ABT inhibited the metabolism of trichloroethylene. These results indicated that CYP2E1 is important in trichloroethylene metabolism, but other P450 enzymes also make a contribution.</p></sec><sec id="S31"><label>12</label><title>Oxidative stress</title><p id="P66">Pretreatment with 1-ABT attenuated the DNA fragmentation and cell death caused by 3-amino-1,2,4-triazole plus mercaptosuccinic acid in primary cultures of rat hepatocytes. This led to the conclusion that endogenous oxidative stress was directly related to the activity of cytochrome P450 enzymes [<xref rid="R255" ref-type="bibr">255</xref>]. The role of cytochrome P450, particularly CYP2E1, in the cellular injury caused by ethanol has been examined in rats, Cyp2e1-knockout mice, and p47(phox)-null mice lacking nicotinamide adenine dinucleotide phosphate oxidase [<xref rid="R256" ref-type="bibr">256</xref>]. The extent of oxidative DNA adducts, mutagenic apurinic/ apyrimidinic sites, and expression of DNA repair genes was measured. Ethanol caused an increase in these parameters in the wild-type rat and mice, and the p47(phox)-null mice, but not in the Cyp2e1-null mice. The increase in DNA repair genes was completely abolished by pretreatment with 1-ABT, implicating CYP2E1 and possibly other cytochrome P450 enzymes in ethanol-induced liver injury. The story is not simple, however, as an earlier study by the same group indicated that 1-ABT did not prevent oxidative stress-associated liver injury in rats and mice caused by alcohol, as judged by examination of liver pathology [<xref rid="R86" ref-type="bibr">86</xref>]. Interestingly, vitamin E and 1-ABT offered protection against oxidative stress, hepatic apoptosis, and necroinflammation associated with non-alcoholic steatohepatitis [<xref rid="R257" ref-type="bibr">257</xref>].</p><p id="P67">Schisandrin B (<xref rid="F16" ref-type="fig">Figure 16</xref>) from the fruit of <italic toggle="yes">Schisandra chinensis</italic>, a traditional Chinese medicine, protects against CCl<sub>4</sub>-induced hepatotoxicity and myocardial ischemia-reperfusion injury in rodents by enhancing mitochondrial glutathione status and inducing expression of the heat shock proteins Hsp25 and Hsp70 [<xref rid="R258" ref-type="bibr">258</xref>,<xref rid="R259" ref-type="bibr">259</xref>]. The finding that 1-ABT pretreatment significantly delays the <italic toggle="yes">in vivo</italic> time-course of the Schisandrin B-induced glutathione and Hsp25/70 responses in Balb/c mice suggests that cytochrome P450 enzymes facilitate the generation of reactive oxygen species in this system [<xref rid="R259" ref-type="bibr">259</xref>].</p><p id="P68">To determine whether cytochrome P450 enzymes contribute <italic toggle="yes">in vivo</italic> to oxidative stress through the production of reactive oxygen species, various cytochrome P450 inducers (&#946;-naphthoflavone, phenobarbital, Aroclor 1254, isoniazid, pregnenolone 16&#945;-carbonitrile, and clofibrate) were examined in male Sprague-Dawley rats with and without pretreatment of the rats with 1-ABT [<xref rid="R260" ref-type="bibr">260</xref>]. Aroclor 1254 and phenobarbital, but not the other agents, enhanced the formation of malondialdehyde and H<sub>2</sub>O<sub>2</sub> formation as well as NADPH oxidation both <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic>. These two agents also increased the formation of F2-isoprostanes, which are markers of oxidative stress, and these changes were attenuated by pretreatment with 1-ABT.</p><p id="P69">Methyl 3-(4-nitrophenyl)propiolate induces tumor cell apoptosis [<xref rid="R261" ref-type="bibr">261</xref>]. 1-ABT inhibited the formation of reactive oxygen species and cell apoptosis, implying a role for cytochrome P450 enzymes in the process.</p></sec><sec id="S32"><label>13</label><title>Free radical formation</title><p id="P70">1-ABT has been used to rule out a role for cytochrome P450 in the formation of certain carbon radicals. Thus, neither 1-ABT nor CO attenuated the amplitude of the ESR spectrum of the phenyl radical produced in incubations of rat hepatic microsomes or cecal microflora with 1,3-diphenyl-1-triazene [<xref rid="R262" ref-type="bibr">262</xref>]. Phenyl radical formation, however, was decreased by antibodies to NADPH cytochrome P450 reductase, pointing to a reductive role of this protein in radical formation. 1-ABT and CO also did not attenuate the formation of phenyl radicals from diazoaminobenzene in incubations with liver microsomes. Furthermore, the radicals were formed on incubation of diazoaminobenzene with NADPH cytochrome P450 reductase, confirming a role for this enzyme rather than cytochrome P450 in the process [<xref rid="R263" ref-type="bibr">263</xref>]. In contrast, 1-ABT did inhibit the formation of the CO<sub>2</sub><sup>-</sup> radical in the metabolism of sodium formate. However, allopurinol, an inhibitor of xanthine oxidase, also inhibited this reaction, which suggested that H<sub>2</sub>O<sub>2</sub> was involved in the process [<xref rid="R264" ref-type="bibr">264</xref>]. This inference is supported by the finding that 3-aminotriazole, a catalase inhibitor, significantly increased the level of spin trapped CO<sub>2</sub><sup>-</sup> radical. As noted earlier, exposure for 24-. 28-, or 60-hours to greater than 95% oxygen after administration of 1-ABT to rats resulted in the death of the 1-ABT-treated animals between 48 and 60 hr, whereas no control rats exposed to similar hyperoxic conditions died at up to 60 hours of exposure [<xref rid="R88" ref-type="bibr">88</xref>]. 1-ABT thus markedly potentiates hyperoxic lung and brain injury. In accord with this, the inhibition by 1-ABT of oxygen radical production by CYP2E1 in the brain of mice, assayed as the delay in the onset of convulsions in a hyperbaric chamber, was not effective and had undesirable side-effects [<xref rid="R265" ref-type="bibr">265</xref>].</p></sec><sec id="S33"><label>14</label><title>Other uses of 1-ABT in analysis of xenobiotic toxicology</title><p id="P71">Many studies have been carried out that employ 1-ABT as a tool to elucidate the roles of cytochrome P450 enzymes in xenobiotic and drug toxicological processes. A summary of these is presented in <xref rid="T6" ref-type="table">Table 6</xref>. On the other hand, some toxicological processes have not been found to involve cytochrome P450, as 1-ABT did not inhibit them, and these results are summarized in <xref rid="T7" ref-type="table">Table 7</xref>.</p></sec></sec><sec id="S34"><title>Non-Mammalian P450 Enzymes</title><sec id="S35"><title>Plant P450 enzymes</title><sec id="S36"><title>Endogenous substrates:</title><p id="P72">Cinnamic acid 4-hydroxylase is a cytochrome P450 enzyme involved in phenylalanine metabolism and the biosynthesis of phenylpropanoids in plants (<xref rid="F15" ref-type="fig">Figure 15</xref>). 1-ABT efficiently inactivated this enzyme in <italic toggle="yes">Helianthus tuberosus</italic> (Jerusalem artichoke) [<xref rid="R58" ref-type="bibr">58</xref>], but much more slowly inactivated the enzyme responsible for the hydroxylation of lauric acid. 1-ABT also exhibited a low activity for inactivation of the lauric acid &#969;-hydroxylase of <italic toggle="yes">Vicia sativa</italic> L cv. <italic toggle="yes">Septimane</italic>, in contrast to the inactivation caused by 11-dodecynoic acid [<xref rid="R301" ref-type="bibr">301</xref>]. Microsomes from marine microalgae were have P450 enzymes that oxidize cinnamic acid, fatty acids, 3-chorobiphenyl, and isoproturon, and 1-ABT was specifically shown to abolish the oxidation of 3-chlorobiphenyl in intact cells [<xref rid="R302" ref-type="bibr">302</xref>].</p><p id="P73">The flavonoid 3&#8217;,5&#8217;-hydroxylase of petunia hybrid flowers was inhibited by both 1-ABT and the growth regulator tetcyclasis [<xref rid="R303" ref-type="bibr">303</xref>]. In a more detailed study in <italic toggle="yes">Solanum lycopersicum</italic> (tomato), 1-ABT was shown to strongly inhibit the formation of flavonoids such as caffeic acid, kaempferol, and quercetin [<xref rid="R304" ref-type="bibr">304</xref>]. This is consistent with inhibition of cinnamic acid 4-hydroxylase. Furthermore, 1-ABT caused the accumulation of 9,12,13-trihydroxy-10(<italic toggle="yes">E</italic>)octadecanoic acid (<xref rid="F17" ref-type="fig">Figure 17</xref>), probably by blocking further oxidative metabolism of this intermediate, whereas tetcyclacis completely suppressed its formation. These results provided clear evidence for differential roles of P450 enzymes in tomato plants.</p><p id="P74">The oxidation of tabersonine to h&#246;rhammericine in <italic toggle="yes">Catharanthus roseus</italic> hairy root cultures (<xref rid="F18" ref-type="fig">Figure 18</xref>) was inhibited by 1-ABT, although it did not appear to inhibit the formation of lochnericine [<xref rid="R305" ref-type="bibr">305</xref>]. In contrast, clotrimazole inhibited the formation of lochnericine, indicating that different P450 enzymes catalyze these two transformations. Both agents inhibited the growth of the root cultures. Inhibition of these reactions is of potential importance in biotechnological channeling of tabersonine into the production of vindoline and the anticancer agents derived from it.</p></sec><sec id="S37"><title>Xenobiotic metabolism:</title><p id="P75">1-ABT strongly, but differentially, inhibited the <italic toggle="yes">O</italic>-dealkylation of 7-ethoxycoumarin and 7-ethoxyresorufin by microsomes from manganese-induced Jerusalem artichoke, implying the action of two different P450 enzymes [<xref rid="R306" ref-type="bibr">306</xref>]. 1-ABT has found wide use in studies of the metabolism of herbicides by plants and the role of this process in herbicide resistance. Thus, 1-ABT inhibits the metabolism of chlortoluron and isoproturon and synergizes the activities of these agents in wheat [<xref rid="R84" ref-type="bibr">84</xref>,<xref rid="R307" ref-type="bibr">307</xref>]. It also inhibits the metabolism of diclofop in wheat, but less effectively than tetcyclasis [<xref rid="R308" ref-type="bibr">308</xref>]. Work with suspension cultures of soybean (<italic toggle="yes">Glycine max</italic> (L.) Merr.) and rice (<italic toggle="yes">Oryza sativa</italic> L.) demonstrated that 1-ABT inhibited the metabolism of the herbicide bentazon in rice, although the data suggested that it could also reduce the uptake of bentazon by the cells [<xref rid="R309" ref-type="bibr">309</xref>]. The oxidation of bentazon (<xref rid="F19" ref-type="fig">Figure 19</xref>) was also inhibited by 100 &#956;M 1-ABT in maize cell suspension cultures, although less effectively than inhibition by the alternative P450 inhibitors tetcyclacis, phenylhydrazine, and piperonyl butoxide [<xref rid="R310" ref-type="bibr">310</xref>]. 1-ABT also synergized the activity of the herbicides clodinafop, haloxyfop, and fenoxaprop by inhibiting their P450 metabolism in blackgrass (<italic toggle="yes">Aloecurus myosuroides</italic> Huds.) [<xref rid="R311" ref-type="bibr">311</xref>]. Analysis of the metabolism of cinnamic acid, lauric acid, metolalchlor, bentazon, and diazinon by microsomes from grain sorghum (<italic toggle="yes">Sorghum bicolor</italic> (L.) Moench) demonstrated differential inhibition of the metabolism of these agents by tetcyclacis, piperonyl butoxide, 1-ABT, SKF-525A, and tridiphane [<xref rid="R312" ref-type="bibr">312</xref>]. Resistance to the herbicidal activity of metamitron (<xref rid="F19" ref-type="fig">Figure 19</xref>) has been observed in the weed <italic toggle="yes">Chenopodium album</italic> (common lambsquarters). A study of the resistant and sensitive strains of this weed taken from sugar beet fields demonstrated that the resistance was due to enhanced metabolism of metamitron in the resistant strains [<xref rid="R313" ref-type="bibr">313</xref>]. 1-ABT inhibited this metabolism, even though piperonyl butoxide did not. 1-ABT was used to establish that the tolerance of <italic toggle="yes">Agrostis stolonifera</italic> (creeping bentgrass) to the herbicide topramezone is due to rapid metabolism of the herbicide [<xref rid="R314" ref-type="bibr">314</xref>].</p><p id="P76">1-ABT was used to establish that 4-monochlorobiphenyl, an environmental pollutant, is metabolized in poplar trees by cytochrome P450 enzymes [<xref rid="R315" ref-type="bibr">315</xref>].</p></sec></sec><sec id="S38"><title>Fish P450 enzymes</title><p id="P77">The inhibition of lauric acid &#969;&#8722;1 hydroxylation, 7,12-dimethylbenz[a]anthracene hydroxylation, and progesterone 6&#946;-hydroxylation in trout was examined using several inhibitory agents [<xref rid="R316" ref-type="bibr">316</xref>]. These activities were used as functional markers for the trout enzymes CYP2K1, CYP1A1, and CYP3A27, respectively. 1-ABT only slightly inhibited dimethylbenz[a]anthracene hydroxylation, but potently inhibited testosterone 6&#946;-hydroxylation.</p><p id="P78">Diazinon is an organophosphate pesticide that is converted to a metabolite in which the sulfur attached to the phosphorus is replaced by an oxygen atom. This metabolite is a more potent inhibitor of acetycholinesterase than diazinon itself. In early life stages of medaka (<italic toggle="yes">Oryzias latipes</italic>), 1-ABT decreased acetycholinesterase inhibition, presumably by inhibiting the oxidation of diazinon to the more toxic metabolite [<xref rid="R317" ref-type="bibr">317</xref>].</p><p id="P79">The absence of inhibition by 1-ABT provided evidence that sulfoxidation of the thiourea herbicide eptam by liver microsomes from striped bass was mediated by a flavoprotein monooxygenase rather than by a cytochrome P450 enzyme [<xref rid="R318" ref-type="bibr">318</xref>].</p></sec><sec id="S39"><title>Insect P450 enzymes</title><p id="P80">1-ABT, which caused a loss of spectroscopically measurable cytochrome P450 and the accumulation of an N-N-bridged porphyrin in housefly microsomes [<xref rid="R83" ref-type="bibr">83</xref>], potentiated the activity of a carbamate insecticide in live houseflies. Based on evidence that methanol oxidation in <italic toggle="yes">Drosophila melanogaster</italic> is partially mediated by cytochrome P450 enzymes, the effect of 1-ABT and other enzyme inhibitors on methanol toxicity has been evaluated [<xref rid="R319" ref-type="bibr">319</xref>].</p></sec><sec id="S40"><title>Fungal and microbial P450 enzymes</title><sec id="S41"><title>Endogenous substrates:</title><p id="P81">Inhibition of the growth of <italic toggle="yes">Fusarium</italic> on cereals and their production of mycotoxins is desirable, as it results in loss of crop yield and poses a health threat to livestock and humans. 1-ABT was shown to inhibit production of the toxin 3-acetyldeoxynivalenol and the growth of the mycelia of <italic toggle="yes">Fusarium graminearum</italic> 4528 [<xref rid="R320" ref-type="bibr">320</xref>].</p><p id="P82">The antimicrobial sesquiterpenes enokipodins A, B, C, and D are obtained from mycelial cultures of the edible mushroom <italic toggle="yes">Flammulina velutipes</italic>. Studies of the biosynthesis of these agents using 1-ABT as a probe led to identification of three intermediates (shown in the boxes) in the biosynthetic sequence (<xref rid="F20" ref-type="fig">Figure 20</xref>) [<xref rid="R321" ref-type="bibr">321</xref>].</p><p id="P83">A strain of <italic toggle="yes">Rhodococcus erythropolis</italic> developed by using &#946;-myrcene as the sole carbon source showed that the major product formed by the cells from this precursor was geraniol [<xref rid="R322" ref-type="bibr">322</xref>]. 1-ABT decreased the production of geraniol by 73%.</p></sec><sec id="S42"><title>Xenobiotics:</title><p id="P84">1-ABT has been used to implicate cytochrome P450 enzymes in the degradation by white-rot fungi of many compounds. In <italic toggle="yes">Phlebia lindtneri</italic>, this included the demonstration that P450 enzymes participate in the degradation of dibenzo-<italic toggle="yes">p</italic>-dioxin, dibenzofuran, diphenyl ether, chloronaphthalenes, and polycyclic aromatic hydrocarbons [<xref rid="R323" ref-type="bibr">323</xref>,<xref rid="R324" ref-type="bibr">324</xref>].</p><p id="P85">1-ABT inhibited the degradation of various chemicals by <italic toggle="yes">Phanerochaete chrysosporium</italic> and related species, including diclofenac and mefenamic acid [<xref rid="R325" ref-type="bibr">325</xref>], ketoprofen [<xref rid="R326" ref-type="bibr">326</xref>], norfloxacin and ciprofloxacin [<xref rid="R327" ref-type="bibr">327</xref>], diuron [<xref rid="R328" ref-type="bibr">328</xref>], and dibenzyl sulfoxide [<xref rid="R329" ref-type="bibr">329</xref>]. The growth of <italic toggle="yes">P. chrysosporium</italic> on diesel fuel was inhibited by 1-ABT, indicdating that P450 enzymes are involved in the utilization of this carbon source for biomass production [<xref rid="R330" ref-type="bibr">330</xref>].</p><p id="P86">The degradation of xenobiotics by <italic toggle="yes">Trametes versicolor</italic>, another white-rot fungus, was also inhibited by 1-ABT, pointing to the involvement of cytochrome P450 enzymes in the degradative pathways. This included the degradation of trichloroethylene [<xref rid="R331" ref-type="bibr">331</xref>], 1,2,3- and 1,2,4-trichlorobenzenes [<xref rid="R332" ref-type="bibr">332</xref>], ibuprofen [<xref rid="R333" ref-type="bibr">333</xref>], naproxen [<xref rid="R334" ref-type="bibr">334</xref>], and diclofenac [<xref rid="R335" ref-type="bibr">335</xref>] <italic toggle="yes">Pleorotus ostreatus</italic> oxidizes phenanthrene to phenanthrene <italic toggle="yes">trans</italic>-9,10-diol and this degradation is inhibited by 1-ABT [<xref rid="R336" ref-type="bibr">336</xref>].</p><p id="P87">1-ABT inhibited the metabolism by the filamentous fungus <italic toggle="yes">Cunninghamella elegans</italic> of phenanthrene [<xref rid="R337" ref-type="bibr">337</xref>], dibenzothiophene [<xref rid="R338" ref-type="bibr">338</xref>], and amitriptyline [<xref rid="R339" ref-type="bibr">339</xref>]. 1-ABT inhibited the oxidation of 4-(cyclohexylamino)benzophenone and other organic compounds by <italic toggle="yes">Beauveria bassiana</italic> [<xref rid="R340" ref-type="bibr">340</xref>]. A comparison of the product distribution obtained with this inhibitor versus other inhibitors indicated the involvement of more than one P450 enzyme. The oxidation of adamantine by <italic toggle="yes">Streptomyces griseoplanus</italic> was inhibited by 1-ABT [<xref rid="R341" ref-type="bibr">341</xref>], as was the degradation of 2,5-dimethylpyrazine by <italic toggle="yes">Rhodococcus erythropolis</italic> [<xref rid="R342" ref-type="bibr">342</xref>], and the degradation of polychlorinated biphenyl by <italic toggle="yes">Ceriporia</italic> sp. ZLY-2010 [<xref rid="R343" ref-type="bibr">343</xref>].</p></sec></sec></sec><sec id="S43"><title>Conclusion</title><p id="P88">1-ABT is an easily administered, mechanism-based inhibitor of most of the drug metabolizing isoforms of the cytochrome P450 family of enzymes, albeit with somewhat different sensitivities for the individual isoforms. Toxicity studies indicate that it is a relatively benign agent, even though <italic toggle="yes">in vivo</italic> it may interfere with sterol biosynthesis. It has been utilized in studies of mammals, insects, fish, and plants, using microsomal assays, intact cells, and <italic toggle="yes">in vivo</italic>. It has proven to be highly useful in situations where a pan-specific agent is required to inhibit the broad range of drug-metabolizing isoforms of cytochrome P450.</p></sec></body><back><ack id="S44"><title>Acknowledgments</title><p id="P89">The preparation of this review was supported by National Institutes of Health grants GM25515 and AI074824.</p></ack><fn-group><fn fn-type="COI-statement" id="FN1"><p id="P90">Disclosure Statement</p><p id="P91">The author reports no conflicts of interest.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Omura</surname><given-names>T</given-names></name> (<year>1999</year>) <article-title>Forty years of cytochrome P450</article-title>. <source>Biochem Biophys Res Commun</source><volume>266</volume>: <fpage>690</fpage>&#8211;<lpage>698</lpage>.<pub-id pub-id-type="pmid">10603307</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/bbrc.1999.1887</pub-id></mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Franklin</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Hathaway</surname><given-names>LB</given-names></name> (<year>2008</year>) <article-title>2-Diethylaminoethyl-2,2-diphenylvalerate-HCl (SKF-525A) revisited: comparative cytochrome P450 inhibition in human liver microsomes by SKR525A, its metabolites, and SKF-acid and SKF-alcohol</article-title>. <source>Drug Metab Dispos</source><volume>36</volume>: <fpage>2539</fpage>&#8211;<lpage>2546</lpage>.<pub-id pub-id-type="pmid">18799803</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.108.023549</pub-id></mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Rossi</surname><given-names>M</given-names></name> (<year>1983</year>) <article-title>Structural studies of metyrapone: A potent inhibitor of cytochrome P-450</article-title>. <source>J Med Chem</source><volume>26</volume>: <fpage>1246</fpage>&#8211;<lpage>1252</lpage>.<pub-id pub-id-type="pmid">6887200</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/jm00363a008</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Guengerich</surname><given-names>FP</given-names></name> (<year>2009</year>) <article-title>Inhibition of drug metabolizing enzymes</article-title>. <source>Handbook of Drug Metabolism, 2<sup>nd</sup> Ed</source>. In: <name name-style="western"><surname>Pearson</surname><given-names>PG</given-names></name>, <name name-style="western"><surname>Wienkers</surname><given-names>LC</given-names></name> (eds.) pp: <fpage>203</fpage>&#8211;<lpage>226</lpage>.</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Correia</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Hollenberg</surname><given-names>PF</given-names></name> (<year>2015</year>) <article-title>Inhibition of cytochrome P450 enzymes</article-title>. <source>Cytochrome P450: Structure, Mechanism, and Biochemistry, 4<sup>th</sup> Ed</source>. In: <name name-style="western"><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name> (ed.) pp: <fpage>177</fpage>&#8211;<lpage>259</lpage>.</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Emoto</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Murase</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sawada</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Iwasaki</surname><given-names>K</given-names></name> (<year>2003</year>) <article-title>In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations catalyzed by human cytochrome P450 enzymes: a comparison with SKF-525A and ketoconazole</article-title>. <source>Drug Metab Pharmacokin</source><volume>18</volume>: <fpage>287</fpage>&#8211;<lpage>295</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2133/dmpk.18.287</pub-id><pub-id pub-id-type="pmid">15618748</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Emoto</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Murase</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sawada</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Iwasaki</surname><given-names>K</given-names></name> (<year>2005</year>) <article-title>In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations in human liver microsomes: a comparison with SKF-525A</article-title>. <source>Drug Metab Pharmacokin</source><volume>20</volume>: <fpage>351</fpage>&#8211;<lpage>357</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2133/dmpk.20.351</pub-id><pub-id pub-id-type="pmid">16272753</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>Q</given-names></name> (<year>2016</year>) <article-title>The cytochrome P450 inhibitor SKF-525A disrupts autophagy in primary rat hepatocytes</article-title>. <source>Chem Biol Interact</source><volume>255</volume>: <fpage>55</fpage>&#8211;<lpage>62</lpage>.<pub-id pub-id-type="pmid">26964495</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cbi.2016.03.007</pub-id></mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bruce</surname><given-names>JIE</given-names></name>, <name name-style="western"><surname>Elliott</surname><given-names>AC</given-names></name> (<year>2000</year>) <article-title>Pharmacological evaluation of the role of cytochrome P450 in intracellular calcium signaling in rat pancreatic acinar cells</article-title>. <source>Br J Pharmacol</source><volume>131</volume>: <fpage>761</fpage>&#8211;<lpage>771</lpage>.<pub-id pub-id-type="pmid">11030726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.bjp.0703631</pub-id><pub-id pub-id-type="pmcid">PMC1572388</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kalgutkar</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Obach</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Maurer</surname><given-names>TS</given-names></name> (<year>2007</year>) <article-title>Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactions</article-title>. <source>Curr Drug Metab</source><volume>8</volume>: <fpage>407</fpage>&#8211;<lpage>447</lpage>.<pub-id pub-id-type="pmid">17584015</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/138920007780866807</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sridhar</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Foroozesh</surname><given-names>M</given-names></name> (<year>2013</year>) <article-title>Cytochrome P450 family 1 inhibitors and structure-activity relationships</article-title>. <source>Molecules</source><volume>18</volume>: <fpage>14470</fpage>&#8211;<lpage>14495</lpage>.<pub-id pub-id-type="pmid">24287985</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/molecules181214470</pub-id><pub-id pub-id-type="pmcid">PMC4216474</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Trave</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bianchetti</surname><given-names>G</given-names></name> (<year>1960</year>) <article-title>Atti Accad Naz Lincei</article-title>, <source>Rend Classe Sci fis mat Nat</source><volume>28</volume>: <fpage>652</fpage>.</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Campbell</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Rees</surname><given-names>CW</given-names></name> (<year>1969</year>) <article-title>Reactive intermediates. Part I. Synthesis and oxidation of 1- and 2-aminobenzotriazole</article-title>. <source>J Chem Soc pp</source>: <fpage>742</fpage>&#8211;<lpage>747</lpage>.</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Campbell</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Rees</surname><given-names>CW</given-names></name> (<year>1964</year>) <article-title>A new synthesis of benzyne</article-title>. <source>Proc Chem Soc London</source><fpage>296</fpage>.</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Campbell</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Rees</surname><given-names>CW</given-names></name> (<year>1969</year>) <article-title>Reactive intermediates. Part III. Oxidation of 1-aminobenzotriazole with oxidants other than lead tetra-acetate</article-title>. <source>J Chem Soc pp</source>: <fpage>752</fpage>&#8211;<lpage>756</lpage>.</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Mathews</surname><given-names>JM</given-names></name> (<year>1981</year>) <article-title>Autocatalytic alkylation of the cytochrome P-450 prosthetic heme by 1-aminobenzotriazole</article-title>. <source>Biochem J</source><volume>195</volume>: <fpage>761</fpage>&#8211;<lpage>764</lpage>.<pub-id pub-id-type="pmid">7316983</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/bj1950761</pub-id><pub-id pub-id-type="pmcid">PMC1162949</pub-id></mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mathews</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Dostal</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Bend</surname><given-names>JR</given-names></name> (<year>1985</year>) <article-title>Inactivation of rabbit pulmonary cytochrome P450 in microsomes and isolated perfused lungs by the suicide substrate 1-aminobenzotriazole</article-title>. <source>J Pharmacol Exp Therap</source><volume>235</volume>: <fpage>186</fpage>&#8211;<lpage>190</lpage>.<pub-id pub-id-type="pmid">4045721</pub-id></mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Oldfield</surname><given-names>NF</given-names></name>, <name name-style="western"><surname>Mortillo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Garland</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Mico</surname><given-names>BA</given-names></name> (<year>1992</year>) <article-title>Inhibition of hepatic and cutaneous biotransformation of resorufin ethers following intraperitoneal administration of 1-aminobenzotriazole</article-title>. <source>Pharmaceut Res</source><volume>9</volume>: <fpage>1099</fpage>&#8211;<lpage>1102</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1023/a:1015827100111</pub-id><pub-id pub-id-type="pmid">1409385</pub-id></mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Carlile</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Hakooz</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Houston</surname><given-names>JB</given-names></name> (<year>1999</year>) <article-title>Kinetics of drug metabolism in rat liver slices: IV. Comparison of ethoxycoumarin clearance by liver slices, isolated hepatocytes, and hepatic microsomes from rats pretreated with known modifiers of cytochrome P-450 activity</article-title>. <source>Drug Metab Dispos</source><volume>27</volume>: <fpage>526</fpage>&#8211;<lpage>532</lpage>.<pub-id pub-id-type="pmid">10101148</pub-id></mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Mathews</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Langry</surname><given-names>KC</given-names></name>. <year>1984</year><article-title>Autocatalytic inactivation of cytochrome P-450 and chloroperoxidase by 1-aminobenzotriazole and other aryne precursors</article-title>. <source>Tetrahedron</source><volume>40</volume>: <fpage>511</fpage>&#8211;<lpage>519</lpage>.</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chuanprasit</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Goh</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Hirao</surname><given-names>H</given-names></name> (<year>2015</year>) <article-title>Benzyne formation in the mechanismbased inactivation of cytochrome P450 by 1-aminobenzotriazole and N-benzyl-1-aminobenzotriazole: computational insights</article-title>. <source>ACS Catalysis</source><volume>5</volume>: <fpage>2952</fpage>&#8211;<lpage>2960</lpage>.</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mathews</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Bend</surname><given-names>JR</given-names></name> (<year>1986</year>) <article-title>N-Alkylaminobenzotriazoles as isozymeselective suicide inhibitors of rabbit pulmonary microsomal cytochrome P450</article-title>. <source>Molec Pharmacol</source><volume>30</volume>: <fpage>25</fpage>&#8211;<lpage>32</lpage>.<pub-id pub-id-type="pmid">3724742</pub-id></mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Town</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Henderson</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Mortillo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Garland</surname><given-names>W</given-names></name> (<year>1993</year>) <article-title>Distribution of 1-aminobenzotriazole in male rats after administration of an oral dose</article-title>. <source>Xenobiotica</source><volume>23</volume>: <fpage>383</fpage>&#8211;<lpage>390</lpage>.<pub-id pub-id-type="pmid">8337896</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/00498259309057026</pub-id></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sun</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Harper</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Dierks</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>S</given-names></name>, <etal/> (<year>2011</year>) <article-title>1-Aminobenzotriazole, a known cytochrome P450 inhibitor, is a substrate and inhibitor of N-acetyltransferase</article-title>. <source>Drug Metab Dispos</source><volume>39</volume>: <fpage>1674</fpage>&#8211;<lpage>1679</lpage>.<pub-id pub-id-type="pmid">21677062</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.111.039834</pub-id></mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mugford</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Mortillo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mico</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Tarloff</surname><given-names>JB</given-names></name> (<year>1992</year>) <article-title>1-Aminobenzotriazoleinduced destruction of hepatic and renal cytochromes P450 in male Sprague-Dawley rats</article-title>. <source>Fund Appl Toxicol</source><volume>19</volume>: <fpage>43</fpage>&#8211;<lpage>49</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0272-0590(92)90026-e</pub-id><pub-id pub-id-type="pmid">1397800</pub-id></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Woodcroft</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Webb</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Weedon</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Bend</surname><given-names>JR</given-names></name> (<year>1997</year>) <article-title>Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole</article-title>. <source>Chem Res Toxicol</source><volume>10</volume>: <fpage>589</fpage>&#8211;<lpage>599</lpage>.<pub-id pub-id-type="pmid">9168258</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx960185g</pub-id></mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Strelevitz</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Foti</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Fisher</surname><given-names>MB</given-names></name> (<year>2006</year>) <article-title>In vivo use of the P450 inactivator 1-aminobenzotriazole in the rat: varied dosing route to elucidate gut and liver contributions to first-pass and systemic clearance</article-title>. <source>J Pharm Sci</source><volume>95</volume>: <fpage>1334</fpage>&#8211;<lpage>1341</lpage>.<pub-id pub-id-type="pmid">16625658</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jps.20538</pub-id></mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Boily</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>Chauret</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Laterreur</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Leblond</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Boudreau</surname><given-names>C</given-names></name>, <etal/> (<year>2015</year>) <article-title>In vitro and in vivo mechanistic studies toward understanding the role of 1-aminobenzotriazole in rat drug-drug interactions</article-title>. <source>Drug Metab Dispos</source><volume>43</volume>:<fpage>1960</fpage>&#8211;<lpage>1965</lpage>.<pub-id pub-id-type="pmid">26438628</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.115.066357</pub-id></mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Parrish</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Mao</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jaochico</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ly</surname><given-names>J</given-names></name>, <etal/> (<year>2016</year>) <article-title>In vitro and in vivo characterization of CYP inhibition by 1-aminobenzotriazole in rats</article-title>. <source>Biopharm Drug Dispos</source><volume>37</volume>: <fpage>200</fpage>&#8211;<lpage>211</lpage>.<pub-id pub-id-type="pmid">26637499</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/bdd.2000</pub-id></mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Stringer</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Weber</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Tigani</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lavan</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Medhurst</surname><given-names>S</given-names></name>, <etal/> (<year>2014</year>) <article-title>1-Aminobenzotriazole modulates oral drug pharmacokinetics through cytochrome P450 inhibition and delay of gastric emptying in rats</article-title>. <source>Drug Metab Dispos</source><volume>42</volume>:<fpage>1117</fpage>&#8211;<lpage>1124</lpage>.<pub-id pub-id-type="pmid">24727486</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.113.056408</pub-id></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Stringer</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Ferreira</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rose</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ronseaux</surname><given-names>S</given-names></name> (<year>2016</year>) <article-title>Application of osmotic pumps for sustained release of 1-aminobenzotriazole and inhibition of cytochrome P450 enzymes in mice: model comparison with the hepatic P450 reductase null mouse</article-title>. <source>Drug Metab Dispos</source><volume>44</volume>:<fpage>1213</fpage>&#8211;<lpage>1216</lpage>.<pub-id pub-id-type="pmid">27271368</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.116.070151</pub-id></mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Balani</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>He</surname><given-names>B</given-names></name>, <etal/> (<year>2002</year>) <article-title>Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys</article-title>. <source>Drug Metab Disp</source><volume>30</volume>:<fpage>1059</fpage>&#8211;<lpage>1062</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.30.10.1059</pub-id><pub-id pub-id-type="pmid">12228180</pub-id></mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Balani</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cardoza</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>H</given-names></name>, <etal/> (<year>2004</year>) <article-title>Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in guinea pigs and mice using serial sampling</article-title>. <source>Drug Metab Dispos</source><volume>32</volume>:<fpage>1092</fpage>&#8211;<lpage>1095</lpage>.<pub-id pub-id-type="pmid">15217988</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.104.000349</pub-id></mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Watanabe</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mayumi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Nishimura</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Osaki</surname><given-names>H</given-names></name> (<year>2016</year>) <article-title>In vivo use of the CYP inhibitor 1-aminobenzotriazole to increase long-term exposure in mice</article-title>. <source>Biopharm Drug Disp</source><volume>37</volume>: <fpage>373</fpage>&#8211;<lpage>378</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/bdd.2020</pub-id><pub-id pub-id-type="pmid">27379984</pub-id></mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Soto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pham</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Almon</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Wagner</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Primack</surname><given-names>R</given-names></name>, <etal/> (<year>2014</year>) <article-title>Evaluation of matrix microsampling methods for therapeutic drug candidate quantification in discovery-stage rodent pharmacokinetic studies</article-title>. <source>Bioanalysis</source><volume>6</volume>: <fpage>2135</fpage>&#8211;<lpage>2146</lpage>.<pub-id pub-id-type="pmid">25331858</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4155/bio.14.184</pub-id></mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Deshmukh</surname><given-names>SV</given-names></name>, <name name-style="western"><surname>Durston</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Shomer</surname><given-names>NH</given-names></name> (<year>2008</year>) <article-title>Validation of the use of non-naive surgically catheterized rats for pharmacokinetics studies</article-title>. <source>J Am Assoc Lab Anim Sci</source><volume>47</volume>: <fpage>41</fpage>&#8211;<lpage>45</lpage>.<pub-id pub-id-type="pmcid">PMC2687136</pub-id><pub-id pub-id-type="pmid">19049252</pub-id></mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Mico</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Mathews</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Kunze</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Miwa</surname><given-names>GT</given-names></name>, <etal/><year>1981</year><article-title>Selective inactivation of cytochrome P-450 isozymes by suicide substrates</article-title>. <source>Arch Biochem Biophys</source><volume>210</volume>: <fpage>717</fpage>&#8211;<lpage>728</lpage>.<pub-id pub-id-type="pmid">7305355</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0003-9861(81)90239-3</pub-id></mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wong</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>EH</given-names></name>, <name name-style="western"><surname>Marks</surname><given-names>GS</given-names></name> (<year>1999</year>) <article-title>Cytochrome CYP sources of N-alkylprotoporphyrin IX after administration of porphyrinogenic xenobiotics to rats</article-title>. <source>Drug Metab Dispos</source><volume>27</volume>: <fpage>960</fpage>&#8211;<lpage>965</lpage>.<pub-id pub-id-type="pmid">10460791</pub-id></mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Knickle</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Bend</surname><given-names>JR</given-names></name> (<year>1992</year>) <article-title>Dose-dependent, mechanism-based inactivation of cytochrome P450 monooxygenases in vivo by 1-aminobenzotriazole in liver, lung, and kidney of untreated, phenobarbital-treated, and &#946;-naphthoflavonetreated guinea pigs</article-title>. <source>Can J Physiol Pharmacol</source><volume>70</volume>: <fpage>1610</fpage>&#8211;<lpage>1617</lpage>.<pub-id pub-id-type="pmid">1301239</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1139/y92-231</pub-id></mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Riddick</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>MacKie</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Massey</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Marks</surname><given-names>GS</given-names></name> (<year>1990</year>) <article-title>3,5-Diethoxycarbonyl-2,6-dimethyl-4-ethyl-1,4-dihydropyridine inactivates rat liver cytochrome P-450c, but not its orthologue, rabbit lung form 6</article-title>. <source>Can J Physiol Pharmacol</source><volume>68</volume>: <fpage>370</fpage>&#8211;<lpage>373</lpage>.<pub-id pub-id-type="pmid">2322893</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1139/y90-051</pub-id></mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Linder</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Renaud</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Hutzler</surname><given-names>JM</given-names></name> (<year>2009</year>) <article-title>Is 1-aminobenzotriazole an appropriate in vitro tool as a nonspecific cytochrome P450 inactivator</article-title>? <source>Drug Metab Dispos</source><volume>37</volume>: <fpage>10</fpage>&#8211;<lpage>13</lpage>.<pub-id pub-id-type="pmid">18936109</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.108.024075</pub-id></mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sodhi</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Ford</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Mukadam</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>S</given-names></name>, <collab>Hop CECA</collab>, <etal/> (<year>2014</year>) 1-<article-title>Aminobenzotriazole coincubated with (S)-warfarin results in potent inactivation of CYP2C9</article-title>. <source>Drug Metab Dispos</source><volume>42</volume>: <fpage>813</fpage>&#8211;<lpage>817</lpage>.<pub-id pub-id-type="pmid">24550229</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.113.055913</pub-id></mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tierney</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Haas</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Koop</surname><given-names>DR</given-names></name> (<year>1992</year>) <article-title>Degradation of cytochrome P4502E1: selective loss after labilization of the enzyme</article-title>. <source>Arch Biochem Biophys</source><volume>293</volume>: <fpage>9</fpage>&#8211;<lpage>16</lpage>.<pub-id pub-id-type="pmid">1309987</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0003-9861(92)90358-4</pub-id></mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sumner</surname><given-names>SCJ</given-names></name>, <name name-style="western"><surname>Fennell</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Chanas</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>F</given-names></name>, <etal/> (<year>1999</year>) <article-title>Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice</article-title>. <source>Chem Res Toxicol</source><volume>12</volume>: <fpage>1110</fpage>&#8211;<lpage>1116</lpage>.<pub-id pub-id-type="pmid">10563837</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx990040k</pub-id></mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ghanayem</surname><given-names>BI</given-names></name>, <name name-style="western"><surname>Sanders</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Chanas</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Burka</surname><given-names>LT</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>FJ</given-names></name> (<year>1999</year>) <article-title>Role of cytochrome P450 2E1 in methacrylonitrile metabolism and disposition</article-title>. <source>J Pharm Exp Therap</source><volume>289</volume>: <fpage>1054</fpage>&#8211;<lpage>1059</lpage>.<pub-id pub-id-type="pmid">10215687</pub-id></mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jackson</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Lilly</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Recio</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Schlosser</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Medinsky</surname><given-names>MA</given-names></name> (<year>2000</year>) <article-title>Inhibition of cytochrome P450 2E1 decreases, but does not eliminate, genotoxicity mediated by 1,3-butadiene</article-title>. <source>Toxicol Sci</source><volume>55</volume>: <fpage>266</fpage>&#8211;<lpage>273</lpage>.<pub-id pub-id-type="pmid">10828257</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/55.2.266</pub-id></mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hoffler</surname><given-names>U</given-names></name>, <name name-style="western"><surname>El-Masri</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Ghanayem</surname><given-names>BI</given-names></name> (<year>2003</year>) <article-title>Cytochrome P450 2E1 is the principal enzyme responsible for urethane metabolism: comparative studies using CYP2E1-null and wild-type mice</article-title>. <source>J Pharmacol Exp Therap</source><volume>305</volume>: <fpage>557</fpage>&#8211;<lpage>564</lpage>.<pub-id pub-id-type="pmid">12704224</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/jpet.102.049072</pub-id></mixed-citation></ref><ref id="R48"><label>48.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Muzeeb</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pasha</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Basha</surname><given-names>SJS</given-names></name>, <name name-style="western"><surname>Mullangi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Srinivas</surname><given-names>NR</given-names></name> (<year>2005</year>) <article-title>Effect of 1-aminobenzotriazole on the in vitro metabolism and single dose pharmacokinetics of chlorzoxazone, a selective CYP2E1 substrate in Wistar rats</article-title>. <source>Xenobiotica</source><volume>35</volume>: <fpage>825</fpage>&#8211;<lpage>838</lpage>.<pub-id pub-id-type="pmid">16278194</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/00498250500307301</pub-id></mixed-citation></ref><ref id="R49"><label>49.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dierks</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>EF</given-names></name>, <name name-style="western"><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name> (<year>1998</year>) <article-title>The catalytic site of cytochrome P4504A11 (CYP4A11) and its L131F mutant</article-title>. <source>J Biol Chem</source><volume>273</volume>: <fpage>23055</fpage>&#8211;<lpage>23061</lpage>.<pub-id pub-id-type="pmid">9722531</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.273.36.23055</pub-id></mixed-citation></ref><ref id="R50"><label>50.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dierks</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name> (<year>1998</year>) <article-title>Glu-320 and Asp-323 are determinants of the CYP4A1 hydroxylation regiospecificity and resistance to inactivation by 1-aminobenzotriazole</article-title>. <source>Biochemistry</source><volume>37</volume>: <fpage>1839</fpage>&#8211;<lpage>1847</lpage>.<pub-id pub-id-type="pmid">9485309</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/bi972458s</pub-id></mixed-citation></ref><ref id="R51"><label>51.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Colby</surname><given-names>HD</given-names></name>, <name name-style="western"><surname>Purcell</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kominami</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Takemori</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kossor</surname><given-names>DC</given-names></name> (<year>1994</year>) <article-title>Adrenal activation of carbon tetrachloride: role of microsomal P450 isozymes</article-title>. <source>Toxicology</source><volume>94</volume>: <fpage>31</fpage>&#8211;<lpage>40</lpage>.<pub-id pub-id-type="pmid">7801328</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0300-483x(94)90026-4</pub-id></mixed-citation></ref><ref id="R52"><label>52.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Voigt</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Mico</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Kominami</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Takemori</surname><given-names>S</given-names></name>, <etal/> (<year>1994</year>) <article-title>Inhibition of adrenal cytochromes P450 by 1-aminobenzotriazole in vitro. Selectivity for xenobiotic metabolism</article-title>. <source>Biochem Pharmacol</source><volume>48</volume>: <fpage>1421</fpage>&#8211;<lpage>1426</lpage>.<pub-id pub-id-type="pmid">7945442</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0006-2952(94)90566-5</pub-id></mixed-citation></ref><ref id="R53"><label>53.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Voigt</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mico</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Colby</surname><given-names>H</given-names></name> (<year>1995</year>) <article-title>Inhibition of adrenal steroid metabolism by administration of 1-aminobenzotriazole to guinea pigs</article-title>. <source>J Steroid Biochem Molec Biol</source><volume>54</volume>: <fpage>281</fpage>&#8211;<lpage>285</lpage>.<pub-id pub-id-type="pmid">7577711</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0960-0760(95)00144-o</pub-id></mixed-citation></ref><ref id="R54"><label>54.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Colby</surname><given-names>HD</given-names></name>, <name name-style="western"><surname>Abbott</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Cachovic</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Debolt</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Mico</surname><given-names>BA</given-names></name> (<year>1995</year>) <article-title>Inactivation of adrenal cytochromes P450 by 1-aminobenzotriazole. Divergence of in vivo and in vitro actions</article-title>. <source>Biochem Pharmacol</source><volume>49</volume>: <fpage>1057</fpage>&#8211;<lpage>1062</lpage>.<pub-id pub-id-type="pmid">7748185</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0006-2952(95)98501-y</pub-id></mixed-citation></ref><ref id="R55"><label>55.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Soltis</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Colby</surname><given-names>H</given-names></name> (<year>1997</year>) <article-title>Inhibition of testicular steroid metabolism by administration of 1-aminobenzotriazole to rats</article-title>. <source>Pharmacol</source><volume>56</volume>: <fpage>51</fpage>&#8211;<lpage>56</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000028182</pub-id><pub-id pub-id-type="pmid">9467188</pub-id></mixed-citation></ref><ref id="R56"><label>56.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shaik</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>LeDuc</surname><given-names>BW</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>AL</given-names></name> (<year>2017</year>) <article-title>Characterization of 1-aminobenzotriazole and ketoconazole as novel inhibitors of monoamine oxidase (MAO): an in vitro investigation</article-title>. <source>Eur J Drug Metab Pharmacokinet</source><volume>42</volume>: <fpage>827</fpage>&#8211;<lpage>834</lpage>.<pub-id pub-id-type="pmid">28185143</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s13318-017-0401-6</pub-id></mixed-citation></ref><ref id="R57"><label>57.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>di Re</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Riddick</surname><given-names>DS</given-names></name> (<year>1999</year>) <article-title>Lack of mechanism-based inactivation of rat hepatic microsomal cytochromes P450 by doxorubicin</article-title>. <source>Can J Physiol Pharmacol</source><volume>77</volume>: <fpage>589</fpage>&#8211;<lpage>597</lpage>.<pub-id pub-id-type="pmid">10543722</pub-id></mixed-citation></ref><ref id="R58"><label>58.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Reichhart</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Simon</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Durst</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Mathews</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name> (<year>1982</year>) <article-title>Autocatalytic inactivation of plant cytochrome P-450 enzymes: Selective inactivation of cinnamic acid 4-hydroxylase from Helianthus tuberosus by 1-aminobenzotriazole</article-title>. <source>Arch Biochem Biophys</source><volume>216</volume>: <fpage>522</fpage>&#8211;<lpage>529</lpage>.<pub-id pub-id-type="pmid">7114850</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0003-9861(82)90241-7</pub-id></mixed-citation></ref><ref id="R59"><label>59.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>M&#246;ssner</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Schmitz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Theurillat</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Thormann</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Mevissen</surname><given-names>M</given-names></name> (<year>2011</year>) <article-title>Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans</article-title>. <source>Am J Vet Res</source><volume>72</volume>: <fpage>1505</fpage>&#8211;<lpage>1513</lpage>.<pub-id pub-id-type="pmid">22023129</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2460/ajvr.72.11.1505</pub-id></mixed-citation></ref><ref id="R60"><label>60.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cashman</surname><given-names>JR</given-names></name> (<year>1986</year>) <article-title>A convenient assay for the flavin-containing monooxygenase</article-title>. <source>Analyt Biochem</source><volume>160</volume>: <fpage>294</fpage>&#8211;<lpage>300</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0003-2697(87)90050-9</pub-id><pub-id pub-id-type="pmid">3578756</pub-id></mixed-citation></ref><ref id="R61"><label>61.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Furnes</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Schlenk</surname><given-names>D</given-names></name> (<year>2005</year>) <article-title>Extrahepatic metabolism of carbamate and organophosphate thioether compounds by the flavin-containing monooxygenase and cytochrome P450 systems</article-title>. <source>Drug Metab Dispos</source><volume>33</volume>: <fpage>214</fpage>&#8211;<lpage>218</lpage>.<pub-id pub-id-type="pmid">15547051</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.104.000984</pub-id></mixed-citation></ref><ref id="R62"><label>62.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cashman</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>DE</given-names></name> (<year>1990</year>) <article-title>Enantioselective S-oxygenation of 2-aryl-1,3-dithiolanes by rabbit lung enzyme preparations</article-title>. <source>Molec Pharmacol</source><volume>37</volume>: <fpage>333</fpage>&#8211;<lpage>339</lpage>.<pub-id pub-id-type="pmid">2304456</pub-id></mixed-citation></ref><ref id="R63"><label>63.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Rettie</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Bogucki</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Meier</surname><given-names>GP</given-names></name> (<year>1990</year>) <article-title>Stereoselective sulfoxidation of a series of alkyl p-tolylsulfides by microsomal and purified flavin-containing monooxygenases</article-title>. <source>Molec Pharmacol</source><volume>37</volume>: <fpage>643</fpage>&#8211;<lpage>651</lpage>.<pub-id pub-id-type="pmid">2338943</pub-id></mixed-citation></ref><ref id="R64"><label>64.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Decker</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Doerge</surname><given-names>DR</given-names></name> (<year>1992</year>) <article-title>Covalent binding of <sup>14</sup>C- and <sup>35</sup>S-labeled thiocarbamides in rat hepatic microsomes</article-title>. <source>Biochem Pharmacol</source><volume>43</volume>: <fpage>881</fpage>&#8211;<lpage>888</lpage>.<pub-id pub-id-type="pmid">1371686</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0006-2952(92)90256-i</pub-id></mixed-citation></ref><ref id="R65"><label>65.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Decker</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Doerge</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Cashman</surname><given-names>JR</given-names></name> (<year>1992</year>) <article-title>Metabolism of benzimidazoline-2-thiones by rat hepatic microsomes and hog liver flavin-containing monooxygenase</article-title>. <source>Chem Res Toxicol</source><volume>5</volume>: <fpage>726</fpage>&#8211;<lpage>733</lpage>.<pub-id pub-id-type="pmid">1446015</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx00029a021</pub-id></mixed-citation></ref><ref id="R66"><label>66.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Josephs</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Humphreys</surname><given-names>WG</given-names></name>, <name name-style="western"><surname>Xhu</surname><given-names>YZ</given-names></name> (<year>2012</year>) <article-title>Bioactivation of 2-(alkylthio)-1,3,4-thiadiazoles and 2-(alkylthio)-1,3-benzothiazoles</article-title>. <source>Chem Res Toxicol</source><volume>25</volume>: <fpage>2770</fpage>&#8211;<lpage>2779</lpage>.<pub-id pub-id-type="pmid">23148672</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx3003998</pub-id></mixed-citation></ref><ref id="R67"><label>67.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Eng</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wolfrd</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Di</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ruggeri</surname><given-names>RB</given-names></name>, <etal/> (<year>2016</year>) <article-title>Species differences in the oxidative desulfurization of a thiouracil-based irreversible myeloperoxidase inactivator by flavin-containing monoxygenase enzymes</article-title>. <source>Drug Metab Dispos</source><volume>44</volume>:<fpage>1262</fpage>&#8211;<lpage>1269</lpage>.<pub-id pub-id-type="pmid">27079250</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.116.070185</pub-id></mixed-citation></ref><ref id="R68"><label>68.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Martinkova</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kubickova</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Stiborova</surname><given-names>M</given-names></name> (<year>2012</year>) <article-title>Effects of cytochrome P450 inhibitors on peroxidase activity</article-title>. <source>Neuro Endocrinol Lett</source><volume>33</volume>: <fpage>33</fpage>&#8211;<lpage>40</lpage>.<pub-id pub-id-type="pmid">23353841</pub-id></mixed-citation></ref><ref id="R69"><label>69.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kim</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>DeBoni</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Wells</surname><given-names>PG</given-names></name> (<year>1997</year>) <article-title>Peroxidase-dependent bioactivation and oxidation of DNA and protein in benzo[a]pyrene-initiated micronucleus formation</article-title>. <source>Free Rad Biol Med</source><volume>23</volume>: <fpage>579</fpage>&#8211;<lpage>596</lpage>.<pub-id pub-id-type="pmid">9215804</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0891-5849(97)00012-9</pub-id></mixed-citation></ref><ref id="R70"><label>70.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bedard</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>GBJ</given-names></name>, <name name-style="western"><surname>Reid</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Petsikas</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Massey</surname><given-names>TE</given-names></name> (<year>2002</year>) <article-title>Investigations of the role of lipoxygenase in bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung</article-title>. <source>Chem Res Toxicol</source><volume>15</volume>: <fpage>1267</fpage>&#8211;<lpage>1273</lpage>.<pub-id pub-id-type="pmid">12387624</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx025524m</pub-id></mixed-citation></ref><ref id="R71"><label>71.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kimoto</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Walsky</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Whalen</surname><given-names>KM</given-names></name>, <etal/> (<year>2012</year>) <article-title>Differential modulation of cytochrome P450 activity and the effect of a-aminobenzotriazole on hepatic transport in sandwich-cultured human hepatocytes</article-title>. <source>Drug Metab Dispos</source><volume>40</volume>: <fpage>407</fpage>&#8211;<lpage>411</lpage>.<pub-id pub-id-type="pmid">22031626</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.111.039297</pub-id></mixed-citation></ref><ref id="R72"><label>72.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Crouch</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Morrison</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Byers</surname><given-names>FW</given-names></name>, <name name-style="western"><surname>Lindsley</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Emmitte</surname><given-names>KA</given-names></name>, <etal/> (<year>2016</year>) <article-title>Evaluating the disposition of a mixed aldehyde oxidase/cytochrome P450 substrate in rats with attenuated P450 activity</article-title>. <source>Drug Metab Dispos</source><volume>44</volume>:<fpage>1296</fpage>&#8211;<lpage>1303</lpage>.<pub-id pub-id-type="pmid">26936972</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.115.068338</pub-id><pub-id pub-id-type="pmcid">PMC4986618</pub-id></mixed-citation></ref><ref id="R73"><label>73.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yu</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sheng</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name>, <etal/> (<year>2013</year>) <article-title>Metabolism of BYZX in human liver microsomes and cytosol: identification of the metabolites and metabolic pathways of BYZX</article-title>. <source>PLOS One</source><volume>8</volume>: <fpage>e59882</fpage>.<pub-id pub-id-type="pmid">23555822</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0059882</pub-id><pub-id pub-id-type="pmcid">PMC3612106</pub-id></mixed-citation></ref><ref id="R74"><label>74.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Walsky</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Bauman</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Bourcier</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Giddens</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lapham</surname><given-names>K</given-names></name>, <etal/> (<year>2012</year>) <article-title>Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors</article-title>. <source>Drug Metab Dispos</source><volume>40</volume>:<fpage>1051</fpage>&#8211;<lpage>1065</lpage>.<pub-id pub-id-type="pmid">22357286</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.111.043117</pub-id></mixed-citation></ref><ref id="R75"><label>75.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Horng</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Benet</surname><given-names>LZ</given-names></name> (<year>2013</year>) <article-title>The effects of 1-aminobenzotriazole inhibition on the formation of acyl-glucuronide and acyl-glutathione metabolites in rat hepatocytes</article-title>. <source>J Diagn Tech Biomed Anal</source><volume>2</volume>:<fpage>1</fpage>.</mixed-citation></ref><ref id="R76"><label>76.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Plise</surname><given-names>EG</given-names></name>, <name name-style="western"><surname>Halladay</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Cheong</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sodhi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Salphati</surname><given-names>L</given-names></name> (<year>2010</year>) <article-title>Commonly used inhibitors of drug metabolizing enzymes: do they also inhibit drug transporters?</article-title><source>Drug Metab Rev</source><volume>42S</volume>: <fpage>P190</fpage>.</mixed-citation></ref><ref id="R77"><label>77.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Fan</surname><given-names>PW</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>JZ</given-names></name>, <name name-style="western"><surname>Jaochico</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>La</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>N</given-names></name>, <etal/> (<year>2016</year>) <article-title>Rate-determining and rate-limiting steps in the clearance and excretion of a potent and selective p21-activated kinase inhibitor: A case study of rapid hepatic uptake and slow elimination in rat</article-title>. <source>Drug Metab Lett</source><volume>10</volume>: <fpage>91</fpage>&#8211;<lpage>100</lpage>.<pub-id pub-id-type="pmid">27063863</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1872312810666160411144358</pub-id><pub-id pub-id-type="pmcid">PMC5405622</pub-id></mixed-citation></ref><ref id="R78"><label>78.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kostrubsky</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Strom</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Kalgutkar</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Kulkarni</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Atherton</surname><given-names>J</given-names></name>, <etal/>(<year>2006</year>) <article-title>Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone</article-title>. <source>Toxicol Sci</source><volume>90</volume>: <fpage>451</fpage>&#8211;<lpage>459</lpage>.<pub-id pub-id-type="pmid">16410371</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfj095</pub-id></mixed-citation></ref><ref id="R79"><label>79.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ogimura</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sekine</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Horie</surname><given-names>T</given-names></name> (<year>2011</year>) <article-title>Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes</article-title>. <source>Biochem Biophys Res Commun</source><volume>416</volume>: <fpage>313</fpage>&#8211;<lpage>317</lpage>.<pub-id pub-id-type="pmid">22108051</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbrc.2011.11.032</pub-id></mixed-citation></ref><ref id="R80"><label>80.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>AK</given-names></name> (<year>1986</year>) <article-title>Dissociation of cytochrome P-450 inactivation and induction</article-title>. <source>Arch Biochem Biophys</source><volume>251</volume>: <fpage>514</fpage>&#8211;<lpage>524</lpage>.<pub-id pub-id-type="pmid">3800382</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0003-9861(86)90359-0</pub-id></mixed-citation></ref><ref id="R81"><label>81.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yang</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Koh</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Jeong</surname><given-names>H</given-names></name> (<year>2010</year>) <article-title>Induction of CYP2B6 and CYP3A4 expression by 1-aminobenzotriazole (ABT) in human hepatocytes</article-title>. <source>Drug Metab Lett</source><volume>4</volume>: <fpage>129</fpage>&#8211;<lpage>133</lpage>.<pub-id pub-id-type="pmid">20642445</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/187231210791698410</pub-id><pub-id pub-id-type="pmcid">PMC3697095</pub-id></mixed-citation></ref><ref id="R82"><label>82.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zangar</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Novak</surname><given-names>RF</given-names></name> (<year>1997</year>) <article-title>Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytes</article-title>. <source>Arch Biochem Biophys</source><volume>337</volume>: <fpage>217</fpage>&#8211;<lpage>224</lpage>.<pub-id pub-id-type="pmid">9016816</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/abbi.1996.9785</pub-id></mixed-citation></ref><ref id="R83"><label>83.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Feyereisen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Langry</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name> (<year>1984</year>) <article-title>Self-catalyzed destruction of insect cytochrome P-450</article-title>. <source>Insect Biochem</source><volume>14</volume>:<fpage>19</fpage>&#8211;<lpage>26</lpage>.</mixed-citation></ref><ref id="R84"><label>84.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gaillardon</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Cabanne</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Scalla</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Durst</surname><given-names>F</given-names></name> (<year>1985</year>) <article-title>Effect of mixed function oxidase inhibitors on the toxicity of chlortoluron and isoproturon to wheat</article-title>. <source>Weed Res</source><volume>25</volume>: <fpage>397</fpage>&#8211;<lpage>402</lpage>.</mixed-citation></ref><ref id="R85"><label>85.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mico</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Federowicz</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Ripple</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Kerns</surname><given-names>W</given-names></name> (<year>1988</year>) <article-title>In vivo inhibition of oxidative drug metabolism by, and acute toxicity of, 1-aminobenzotriazole (ABT). A tool for biochemical toxicology</article-title>. <source>Biochem Pharmacol</source><volume>37</volume>: <fpage>2515</fpage>&#8211;<lpage>2519</lpage>.<pub-id pub-id-type="pmid">3390214</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0006-2952(88)90240-7</pub-id></mixed-citation></ref><ref id="R86"><label>86.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Isayama</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Froh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bradford</surname><given-names>BU</given-names></name>, <name name-style="western"><surname>McKim</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Kadiiska</surname><given-names>MB</given-names></name>, <etal/> (<year>2003</year>) <article-title>The CYP inhibitor 1-aminobenzotriazole does not prevent oxidative stress associated with alcohol-induced liver injury in rats and mice</article-title>. <source>Free Rad Biol Med</source><volume>35</volume>: <fpage>1568</fpage>&#8211;<lpage>1581</lpage>.<pub-id pub-id-type="pmid">14680680</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.freeradbiomed.2003.09.007</pub-id></mixed-citation></ref><ref id="R87"><label>87.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Meschter</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Mico</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Mortillo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Feldman</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Garland</surname><given-names>WA</given-names></name>, <etal/> (<year>1994</year>) <article-title>A 13-week toxicologic and pathologic evaluation of prolonged cytochromes P450 inhibition by 1-aminobenzotriazole in male rats</article-title>. <source>Fundam Appl Toxicol</source><volume>22</volume>: <fpage>369</fpage>&#8211;<lpage>381</lpage>.<pub-id pub-id-type="pmid">8050632</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/faat.1994.1042</pub-id></mixed-citation></ref><ref id="R88"><label>88.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Moorthy</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Parker</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>CV</given-names></name>, <name name-style="western"><surname>Bend</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Welty</surname><given-names>SE</given-names></name> (<year>2000</year>) <article-title>Potentiation of oxygen-induced lung injury in rats by the mechanism-based cytochrome P-450 inhibitor, 1-aminobenzotriazole</article-title>. <source>J Pharmacol Exp Therap</source><volume>292</volume>: <fpage>553</fpage>&#8211;<lpage>560</lpage>.<pub-id pub-id-type="pmid">10640292</pub-id></mixed-citation></ref><ref id="R89"><label>89.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Woodcroft</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Szczepan</surname><given-names>EW</given-names></name>, <name name-style="western"><surname>Knickle</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Bend</surname><given-names>JR</given-names></name> (<year>1990</year>) <article-title>Three N-aralkylated derivatives of 1-aminobenzotriazole as potent and isozyme selective, mechanism-based inhibitors of guinea pig pulmonary cytochrome P450 in vitro</article-title>. <source>Drug Metab Disp</source><volume>18</volume>: <fpage>1031</fpage>&#8211;<lpage>1037</lpage>.<pub-id pub-id-type="pmid">1981509</pub-id></mixed-citation></ref><ref id="R90"><label>90.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sinal</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Bend</surname><given-names>JR</given-names></name> (<year>1995</year>) <article-title>Isozyme-selective metabolic intermediate complex formation of guinea pig hepatic cytochrome P450 by N-aralkylated derivatives of 1-aminobenzotriazole</article-title>. <source>Chem Res Toxicol</source><volume>8</volume>: <fpage>82</fpage>&#8211;<lpage>91</lpage>.<pub-id pub-id-type="pmid">7703371</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx00043a011</pub-id></mixed-citation></ref><ref id="R91"><label>91.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sinal</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bend</surname><given-names>J</given-names></name> (<year>1996</year>) <article-title>Kinetics and selectivity of mechanism-based inhibition of guinea pig hepatic and pulmonary cytochrome P450 by N-benzyl-1aminobenzotriazole and N-&#945;-methylbenzyl-1-aminobenzotriazole</article-title>. <source>Drug Metab Disp</source><volume>24</volume>: <fpage>996</fpage>&#8211;<lpage>1001</lpage>.<pub-id pub-id-type="pmid">8886610</pub-id></mixed-citation></ref><ref id="R92"><label>92.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kent</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Hanna</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Szklarz</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Vaz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Halpert</surname><given-names>J</given-names></name>, <etal/> (<year>1997</year>) <article-title>Significance of glycine 478 in the metabolism of N-benzyl-1-aminobenzotriazole to reactive intermediates by cytochrome P450 2B1</article-title>. <source>Biochemistry</source><volume>36</volume>:<fpage>11707</fpage>&#8211;<lpage>11716</lpage>.<pub-id pub-id-type="pmid">9305960</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/bi971064y</pub-id></mixed-citation></ref><ref id="R93"><label>93.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kent</surname><given-names>UM</given-names></name>, <name name-style="western"><surname>Pascual</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Roof</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Ballou</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Hollenberg</surname><given-names>PF</given-names></name> (<year>2004</year>) <article-title>Mechanistic studies with N-benzyl-1-aminobenzotriazole-inactivated CYP2B1: differential effects on the metabolism of 7-ethoxy-4-(trifluoromethyl)coumarin, testosterone, and benzphetamine</article-title>. <source>Arch Biochem Biophys</source><volume>423</volume>: <fpage>277</fpage>&#8211;<lpage>287</lpage>.<pub-id pub-id-type="pmid">15001392</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.abb.2004.01.007</pub-id></mixed-citation></ref><ref id="R94"><label>94.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>McCallum</surname><given-names>GP</given-names></name>, <name name-style="western"><surname>Horton</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Flakner</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Bend</surname><given-names>JR</given-names></name> (<year>1993</year>) <article-title>Microsomal cytochrome P450 1A1 dependent monooxygenase activity in guinea pig heart: induction, inhibition, and increased activity by addition of exogenous NADPH-cytochrome P450 reductase</article-title>. <source>Can J Physiol Pharmacol</source><volume>71</volume>: <fpage>151</fpage>&#8211;<lpage>156</lpage>.<pub-id pub-id-type="pmid">8319138</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1139/y93-021</pub-id></mixed-citation></ref><ref id="R95"><label>95.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sinal</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hirst</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Webb</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bend</surname><given-names>J</given-names></name> (<year>1998</year>) <article-title>Enantioselective, mechanism-based inactivation of guinea pig hepatic cytochrome P450 by N-(&#945;-methylbenzyl)-1-aminobenzotriazole</article-title>. <source>Drug Metab Disp</source><volume>26</volume>: <fpage>681</fpage>&#8211;<lpage>688</lpage>.<pub-id pub-id-type="pmid">9660851</pub-id></mixed-citation></ref><ref id="R96"><label>96.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Knickle</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Philpot</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Bend</surname><given-names>JR</given-names></name> (<year>1994</year>) <article-title>N-aralkylated derivatives of 1-aminobenzotriazole are potent isozyme- and lung-selective mechanismbased inhibitors of guinea pig cytochrome P450 in vivo</article-title>. <source>J Pharmacol Exp Therap</source><volume>270</volume>: <fpage>377</fpage>&#8211;<lpage>385</lpage>.<pub-id pub-id-type="pmid">8035335</pub-id></mixed-citation></ref><ref id="R97"><label>97.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Woodcroft</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Bend</surname><given-names>JR</given-names></name> (<year>1990</year>) <article-title>N-Aralkylated derivatives of 1-aminobenzotriazole as isozyme-selective, mechanism-based inhibitors of guinea pig hepatic cytochrome P-450 dependent monooxygenase activity</article-title>. <source>Can J Physiol Pharmacol</source><volume>68</volume>: <fpage>1278</fpage>&#8211;<lpage>1285</lpage>.<pub-id pub-id-type="pmid">2276091</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1139/y90-192</pub-id></mixed-citation></ref><ref id="R98"><label>98.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mathews</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Bend</surname><given-names>JR</given-names></name> (<year>1993</year>) <article-title>N-Aralkyl derivatives of 1-aminobenzotriazole as potent isozyme and tissue selective mechanism-based inhibitors of rabbit pulmonary cytochrome P450 in vivo</article-title>. <source>J Pharmacol Exp Therap</source><volume>265</volume>: <fpage>281</fpage>&#8211;<lpage>285</lpage>.<pub-id pub-id-type="pmid">8474011</pub-id></mixed-citation></ref><ref id="R99"><label>99.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Grimm</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Bend</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Halpert</surname><given-names>JR</given-names></name> (<year>1995</year>) <article-title>Selectivity and kinetics of inactivation of rabbit hepatic cytochromes P450 2B4 and 2B5 by N-aralkylated derivatives of 1-aminobenzotriazole</article-title>. <source>Drug Metab Disp</source><volume>23</volume>: <fpage>577</fpage>&#8211;<lpage>583</lpage>.<pub-id pub-id-type="pmid">7587934</pub-id></mixed-citation></ref><ref id="R100"><label>100.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Knickle</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Webb</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>House</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Bend</surname><given-names>JR</given-names></name> (<year>1993</year>) <article-title>Mechanism-based inactivation of cytochrome P450 1A1 by N-aralkyl-1-aminobenzotriazoles in guinea pig kidney in vivo and in vitro: minimal effects on metabolism of arachidonic acid by renal P450-dependent monooxygenases</article-title>. <source>J Pharmacol Exp Therap</source><volume>267</volume>: <fpage>758</fpage>&#8211;<lpage>764</lpage>.<pub-id pub-id-type="pmid">8246152</pub-id></mixed-citation></ref><ref id="R101"><label>101.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Knickle</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Bend</surname><given-names>JR</given-names></name> (<year>1994</year>) <article-title>Bioactivation of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for formation of epoxyeicosatrienoic acid</article-title>. <source>Molec Pharmacol</source><volume>45</volume>:<fpage>1273</fpage>&#8211;<lpage>1280</lpage>.<pub-id pub-id-type="pmid">8022420</pub-id></mixed-citation></ref><ref id="R102"><label>102.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Carr</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xiang</surname><given-names>CD</given-names></name>, <etal/> (<year>2005</year>) <article-title>Selective inhibition of dog hepatic CYP2B11 and CYP3A12</article-title>. <source>J Pharmacol Exp Therap</source><volume>313</volume>: <fpage>518</fpage>&#8211;<lpage>528</lpage>.<pub-id pub-id-type="pmid">15677349</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/jpet.104.077651</pub-id></mixed-citation></ref><ref id="R103"><label>103.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hahn</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Mikolasch</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wende</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bartrow</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lindequist</surname><given-names>U</given-names></name>, <etal/> (<year>2010</year>) <article-title>Derivatization of the azole 1-aminobenzotriazole using laccase of Pycnoporus cinnabarinus and Myceliophthora thermophila: influence of methanol on the reaction and biological evaluation of the derivatives</article-title>. <source>Biotechnol Appl Biochem</source><volume>56</volume>: <fpage>43</fpage>&#8211;<lpage>48</lpage>.<pub-id pub-id-type="pmid">20441569</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/BA20100078</pub-id></mixed-citation></ref><ref id="R104"><label>104.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Caldwell</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>Ritchie</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Masucci</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Hageman</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Cotto</surname><given-names>C</given-names></name>, <etal/> (<year>2005</year>) <article-title>The use of the suicide CYP450 inhibitor ABT for distinguishing absorption and metabolism processes in in-vivo pharmacokinetic screens</article-title>. <source>Eur J Drug Metab Pharmacokinet</source><volume>30</volume>: <fpage>75</fpage>&#8211;<lpage>83</lpage>.<pub-id pub-id-type="pmid">16010865</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF03226411</pub-id></mixed-citation></ref><ref id="R105"><label>105.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>El-Kattan</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Poe</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Buchholz</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>HV</given-names></name>, <name name-style="western"><surname>Brodfuehrer</surname><given-names>J</given-names></name>, <etal/> (<year>2008</year>) <article-title>The use of 1-aminobenzotriazole in differentiating the role of CYP-mediated first pass metabolism and absorption in limiting drug oral bioavailability: a case study</article-title>. <source>Drug Metab Lett</source><volume>2</volume>: <fpage>120</fpage>&#8211;<lpage>124</lpage>.<pub-id pub-id-type="pmid">19356080</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/187231208784041004</pub-id></mixed-citation></ref><ref id="R106"><label>106.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Anby</surname><given-names>MU</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Yeap</surname><given-names>YY</given-names></name>, <name name-style="western"><surname>Feeney</surname><given-names>OM</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>HD</given-names></name>, <etal/> (<year>2014</year>) <article-title>An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in danazol bioavailability from lipid based formulations</article-title>. <source>Mol Pharmaceut</source><volume>11</volume>: <fpage>4069</fpage>&#8211;<lpage>4083</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/mp500197b</pub-id><pub-id pub-id-type="pmid">25265395</pub-id></mixed-citation></ref><ref id="R107"><label>107.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Saitta</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Fujimoto</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Redinbo</surname><given-names>MR</given-names></name>, <etal/> (<year>2014</year>) <article-title>Bacterial b-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics</article-title>. <source>Xenobiotica</source><volume>44</volume>:<fpage>28</fpage>&#8211;<lpage>35</lpage>.<pub-id pub-id-type="pmid">23829165</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/00498254.2013.811314</pub-id><pub-id pub-id-type="pmcid">PMC3972617</pub-id></mixed-citation></ref><ref id="R108"><label>108.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Takahashi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Washio</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Igeta</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yamashita</surname><given-names>S</given-names></name> (<year>2010</year>) <article-title>Investigation of the intestinal permeability and first-pass metabolism of drugs in cynomolgus monkeys using single-pass intestinal perfusion</article-title>. <source>Biol Pharm Bull</source><volume>33</volume>: <fpage>111</fpage>&#8211;<lpage>116</lpage>.<pub-id pub-id-type="pmid">20045946</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1248/bpb.33.111</pub-id></mixed-citation></ref><ref id="R109"><label>109.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Grimsley</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gallagher</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hutchinson</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lundqvist</surname><given-names>A</given-names></name>, <etal/> (<year>2014</year>) <article-title>A comparison of the metabolism of midazolam in C57BL/6J and hepatic reductase null (HRN) mice</article-title>. <source>Biochem Pharmacol</source><volume>92</volume>: <fpage>701</fpage>&#8211;<lpage>711</lpage>.<pub-id pub-id-type="pmid">25450676</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bcp.2014.10.004</pub-id></mixed-citation></ref><ref id="R110"><label>110.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bylund</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bueters</surname><given-names>T</given-names></name> (<year>2013</year>) <article-title>Presystemic metabolism of AZ&#8217;0908, a novel mPGES-1 inhibitor: an in vitro and in vivo cross-species comparison</article-title>. <source>J Pharm Sci</source><volume>102</volume>: <fpage>1106</fpage>&#8211;<lpage>1115</lpage>.<pub-id pub-id-type="pmid">23316000</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jps.23443</pub-id></mixed-citation></ref><ref id="R111"><label>111.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Watanabe</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Watari</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ogawa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Shimizu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Tanaka</surname><given-names>Y</given-names></name>, <etal/> (<year>2015</year>) <article-title>Using improved serial blood sampling method of mice to study pharmacokinetics and drug-drug interactions</article-title>. <source>J Pharmaceut Sci</source><volume>104</volume>: <fpage>955</fpage>&#8211;<lpage>961</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jps.24236</pub-id><pub-id pub-id-type="pmid">25452230</pub-id></mixed-citation></ref><ref id="R112"><label>112.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ballard</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Barlaam</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Bradbury</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Dishington</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hennequin</surname><given-names>LFA</given-names></name>, <etal/> (<year>2007</year>) <article-title>Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase</article-title>. <source>Bioorg Med Chem Lett</source><volume>17</volume>: <fpage>6326</fpage>&#8211;<lpage>6329</lpage>.<pub-id pub-id-type="pmid">17869514</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bmcl.2007.08.073</pub-id></mixed-citation></ref><ref id="R113"><label>113.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Li</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Doshi</surname><given-names>U</given-names></name> (<year>2011</year>) <article-title>Higher throughput human hepatocyte assays for the evaluation of time-dependent inhibition of CYP3A4</article-title>. <source>Drug Metab Lett</source>, <volume>5</volume>: <fpage>183</fpage>&#8211;<lpage>191</lpage>.<pub-id pub-id-type="pmid">21722087</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/187231211796904964</pub-id></mixed-citation></ref><ref id="R114"><label>114.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Li</surname><given-names>AP</given-names></name> (<year>2009</year>) <article-title>Evaluation of luciferin-isopropyl acetal as a CYP3A4 substrate for human hepatocytes: effects of organic solvents, cytochrome P450 (P450) inhibitors, and P450 inducers</article-title>. <source>Drug Metab Dispos</source><volume>37</volume>: <fpage>1598</fpage>&#8211;<lpage>1603</lpage>.<pub-id pub-id-type="pmid">19451401</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.109.027268</pub-id></mixed-citation></ref><ref id="R115"><label>115.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Doshi</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>AP</given-names></name> (<year>2011</year>) <article-title>Luciferin IPA-based higher throughput human hepatocytes screening assays for CYP3A4 inhibition and induction</article-title>. <source>J Biomol Screen</source><volume>16</volume>: <fpage>903</fpage>&#8211;<lpage>909</lpage>.<pub-id pub-id-type="pmid">21832258</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1087057111414900</pub-id></mixed-citation></ref><ref id="R116"><label>116.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Feng</surname><given-names>PCC</given-names></name>, <name name-style="western"><surname>Solsten</surname><given-names>RT</given-names></name> (<year>1994</year>) <article-title>In vitro biotransformation of thiazopyr by rat liver microsomes: oxidative cleavage of a carboxylic methylester by monooxygenases</article-title>. <source>Xenobiotica</source><volume>24</volume>: <fpage>729</fpage>&#8211;<lpage>734</lpage>.<pub-id pub-id-type="pmid">7839696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/00498259409043273</pub-id></mixed-citation></ref><ref id="R117"><label>117.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Eng</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Niosi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McDonald</surname><given-names>TS</given-names></name>, <name name-style="western"><surname>Wolford</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name>, <etal/> (<year>2010</year>) <article-title>Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor</article-title>. <source>Xenobiotica</source><volume>40</volume>: <fpage>369</fpage>&#8211;<lpage>380</lpage>.<pub-id pub-id-type="pmid">20297923</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/00498251003706598</pub-id></mixed-citation></ref><ref id="R118"><label>118.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Takahashi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Deese</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yue</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Kim-Kang</surname><given-names>H</given-names></name>, <etal/> (<year>2014</year>) <article-title>Elucidating the mechanism of cytochrome P450-mediated pyrimidine ring conversion to pyrazole metabolites with the BACE1 inhibitor GNE-892 in rats</article-title>. <source>Drug Metab Dispos</source><volume>42</volume>: <fpage>890</fpage>&#8211;<lpage>898</lpage>.<pub-id pub-id-type="pmid">24595682</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.114.057141</pub-id></mixed-citation></ref><ref id="R119"><label>119.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jones</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Markandu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Scarfe</surname><given-names>G</given-names></name> (<year>2017</year>) <article-title>CYP-mediated sulfoximine deamination of AZD6738</article-title>. <source>Drug Metab Dispos</source><volume>45</volume>: <fpage>1133</fpage>&#8211;<lpage>1138</lpage>.<pub-id pub-id-type="pmid">28835442</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.117.077776</pub-id></mixed-citation></ref><ref id="R120"><label>120.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Guise</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Abbattista</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <etal/> (<year>2011</year>) <article-title>Reductive metabolism of the dinitrobenzamide mustard anticancer prodrug PR-104 in mice</article-title>. <source>Cancer Chemother Pharmacol</source><volume>67</volume>: <fpage>543</fpage>&#8211;<lpage>555</lpage>.<pub-id pub-id-type="pmid">20473609</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00280-010-1354-5</pub-id></mixed-citation></ref><ref id="R121"><label>121.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gombar</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Burak</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Harper</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>BR</given-names></name> (<year>1988</year>) <article-title>Pulmonary clearance of vasoactive drugs: N-oxidation of SK&amp;F 86466 in the isolated perfused rat lung</article-title>. <source>J Pharmacol Exp Therap</source><volume>245</volume>: <fpage>402</fpage>&#8211;<lpage>406</lpage>.<pub-id pub-id-type="pmid">2896791</pub-id></mixed-citation></ref><ref id="R122"><label>122.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Fang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Teague</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Morisseau</surname><given-names>C</given-names></name>, <etal/> (<year>2017</year>) <article-title>In vitro metabolism of oprozomib, an oral proteasome inhibitor: Role of epoxide hydrolases and cytochrome P450</article-title>. <source>Drug Metab Dispos</source><volume>45</volume>: <fpage>712</fpage>&#8211;<lpage>720</lpage>.<pub-id pub-id-type="pmid">28428366</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.117.075226</pub-id><pub-id pub-id-type="pmcid">PMC5452678</pub-id></mixed-citation></ref><ref id="R123"><label>123.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Capello</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Henderson</surname><given-names>L</given-names></name>, <name name-style="western"><surname>DeGrazia</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Liberato</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Garland</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Town</surname><given-names>C</given-names></name> (<year>1990</year>) <article-title>The effect of the cytochrome P450 suicide inactivator, 1-aminobenzotriazole, on the in vivo metabolism and pharmacologic activity of flurazepam</article-title>. <source>Drug Metab Disp</source><volume>18</volume>: <fpage>190</fpage>&#8211;<lpage>196</lpage>.<pub-id pub-id-type="pmid">1971572</pub-id></mixed-citation></ref><ref id="R124"><label>124.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lake</surname><given-names>BG</given-names></name>, <name name-style="western"><surname>Price</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Walters</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>PJ</given-names></name>, <etal/> (<year>2003</year>) <article-title>Studies on the metabolism of the thiofurans furfuryl mercaptan and 2-methyl-3-furanthiol in rat liver</article-title>. <source>Food Chem Toxicol</source><volume>41</volume>: <fpage>1761</fpage>&#8211;<lpage>1770</lpage>.<pub-id pub-id-type="pmid">14563401</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0278-6915(03)00213-8</pub-id></mixed-citation></ref><ref id="R125"><label>125.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sanderson</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Hollis</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Maggs</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Clarke</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Naisbitt</surname><given-names>DJ</given-names></name>, <etal/> (<year>2008</year>) <article-title>Nonenzymatic formation of a novel hydroxylated sulfamethoxazole derivative in human liver microsomes: implications for bioanalysis of sulfamethoxazole metabolites</article-title>. <source>Drug Metab Dispos</source><volume>36</volume>: <fpage>2424</fpage>&#8211;<lpage>2428</lpage>.<pub-id pub-id-type="pmid">18765684</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.108.021246</pub-id></mixed-citation></ref><ref id="R126"><label>126.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Charman</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Arbe-Barnes</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bathurst</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Brun</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>M</given-names></name>, <etal/> (<year>2011</year>) <article-title>Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria</article-title>. <source>Proc Natl Acad Sci USA</source><volume>108</volume>: <fpage>4400</fpage>&#8211;<lpage>4405</lpage>.<pub-id pub-id-type="pmid">21300861</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1015762108</pub-id><pub-id pub-id-type="pmcid">PMC3060245</pub-id></mixed-citation></ref><ref id="R127"><label>127.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mishra</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Manickavasagam</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jain</surname><given-names>GK</given-names></name> (<year>2012</year>) <article-title>Determination of metabolic profile of anti-malarial trioxane CDRI 99/411 in rat liver microsomes using HPLC</article-title>. <source>Biomed Chromatogr</source><volume>26</volume>: <fpage>115</fpage>&#8211;<lpage>122</lpage>.<pub-id pub-id-type="pmid">21503937</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/bmc.1635</pub-id></mixed-citation></ref><ref id="R128"><label>128.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Soroka</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sang</surname><given-names>S</given-names></name> (<year>2013</year>) <article-title>Metabolism of ginger component [6]-shogaol in liver microsomes from mouse, rat, dog, monkey, and human</article-title>. <source>Mol Nutr Food Res</source><volume>57</volume>: <fpage>865</fpage>&#8211;<lpage>876</lpage>.<pub-id pub-id-type="pmid">23322474</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mnfr.201200708</pub-id><pub-id pub-id-type="pmcid">PMC3815528</pub-id></mixed-citation></ref><ref id="R129"><label>129.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yue</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Mulder</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Rudewicz</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Solon</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Budha</surname><given-names>N</given-names></name>, <etal/> (<year>2013</year>) <article-title>Evaluation of metabolism and disposition of GDC-0152 in rats using <sup>14</sup>C-labeling strategy at two different positions: a novel formation of hippuric acid from 4-phenyl-5-amino-1,2,3-thiadiazole</article-title>. <source>Drug Metab Dispos</source><volume>41</volume>: <fpage>508</fpage>&#8211;<lpage>517</lpage>.<pub-id pub-id-type="pmid">23223496</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.112.047019</pub-id></mixed-citation></ref><ref id="R130"><label>130.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ning</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>ZL</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>LH</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Huo</surname><given-names>XK</given-names></name>, <etal/> (<year>2015</year>) <article-title>Characterization of phase I metabolism of resibufogenin and evaluation of the metabolic effects on its antitumor activity and toxicity</article-title>. <source>Drug Metab Dispos</source><volume>43</volume>: <fpage>299</fpage>&#8211;<lpage>308</lpage>.<pub-id pub-id-type="pmid">25504504</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.114.060996</pub-id></mixed-citation></ref><ref id="R131"><label>131.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Joubran</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Luzietti</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Basarab</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Grimm</surname><given-names>SW</given-names></name>, <etal/> (<year>2017</year>) <article-title>Absorption, distribution, metabolism and elimination of <sup>14</sup>C-ETX0914, a novel inhibitor of bacterial type-II topoisomerases in rodents</article-title>. <source>Xenobiotica</source><volume>47</volume>: <fpage>3149</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/00498254.2016.1156186</pub-id><pub-id pub-id-type="pmid">27122100</pub-id></mixed-citation></ref><ref id="R132"><label>132.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hale</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>C</given-names></name>, <etal/> (<year>2015</year>) <article-title>Cytochrome P450 isoforms in the metabolism of decursin and decursinol angelate from Koean angelica</article-title>. <source>Am J Chin Med</source><volume>43</volume>: <fpage>1211</fpage>&#8211;<lpage>1230</lpage>.<pub-id pub-id-type="pmid">26394652</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1142/S0192415X1550069X</pub-id><pub-id pub-id-type="pmcid">PMC4872390</pub-id></mixed-citation></ref><ref id="R133"><label>133.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Klieber</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Arabeyre-Fabre</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Moliner</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Marti</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Mandray</surname><given-names>M</given-names></name>, <etal/> (<year>2014</year>) <article-title>Identification of metabolic pathways and enzyme systems involved in the in vitro human hepatic metabolism of dronedarone, a potent new oral antiarrhythmic drug</article-title>. <source>Pharmacol Res Perspect</source><volume>2</volume>: <fpage>e00044</fpage>.<pub-id pub-id-type="pmid">25505590</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/prp2.44</pub-id><pub-id pub-id-type="pmcid">PMC4186413</pub-id></mixed-citation></ref><ref id="R134"><label>134.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dalmadi</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Leibinger</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Szeber&#233;nyi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Borb&#225;s</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Farkas</surname><given-names>S</given-names></name>, <etal/> (<year>2003</year>) <article-title>Identification of metabolic pathways involved in the biotransformation of tolperisone by human microsomal enzymes</article-title>. <source>Drug Metab Dispos</source><volume>31</volume>: <fpage>631</fpage>&#8211;<lpage>636</lpage>.<pub-id pub-id-type="pmid">12695352</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.31.5.631</pub-id></mixed-citation></ref><ref id="R135"><label>135.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wang</surname><given-names>MZ</given-names></name>, <name name-style="western"><surname>Saulter</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Usuki</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Cheung</surname><given-names>YL</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>M</given-names></name>, <etal/> (<year>2006</year>) <article-title>CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl) furan-bis-O-methylamidoxime</article-title>. <source>Drug Metab Dispos</source><volume>34</volume>: <fpage>1985</fpage>&#8211;<lpage>1994</lpage>.<pub-id pub-id-type="pmid">16997912</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.106.010587</pub-id><pub-id pub-id-type="pmcid">PMC2077835</pub-id></mixed-citation></ref><ref id="R136"><label>136.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Stevens</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Hitchcock</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>YK</given-names></name>, <name name-style="western"><surname>Coppola</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Versace</surname><given-names>RW</given-names></name>, <etal/> (<year>1997</year>) <article-title>In vitro metabolism of N-(5-chloro-2-methylphenyl)-N&#8217;-(2-methylpropyl) thiourea: species comparison and identification of a novel thiocarbamideglutathione adduct</article-title>. <source>Chem Res Toxicol</source><volume>10</volume>: <fpage>733</fpage>&#8211;<lpage>741</lpage>.<pub-id pub-id-type="pmid">9250406</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx9700230</pub-id></mixed-citation></ref><ref id="R137"><label>137.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Boer</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Young-Sciame</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Bowman</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X</given-names></name>, <etal/> (<year>2016</year>) <article-title>The role of UGT, CYP and gut microbiota in the metabolism of epacadostat (EPA) in humans</article-title>. <source>Drug Metab Dispos</source><volume>44</volume>: <fpage>1668</fpage>&#8211;<lpage>1674</lpage>.<pub-id pub-id-type="pmid">27457784</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.116.070680</pub-id></mixed-citation></ref><ref id="R138"><label>138.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Leong</surname><given-names>BK</given-names></name>, <name name-style="western"><surname>Sabaitis</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Rop</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Jeffrey</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Parker</surname><given-names>TJ</given-names></name>, <etal/> (<year>1997</year>) <article-title>Alterations in the cardiopulmonary effects and pharmacokinetics of a bisphosphonate drug by a cytochrome P-450 inhibitor in conscious rats</article-title>. <source>J Appl Toxicol</source><volume>17</volume>: <fpage>279</fpage>&#8211;<lpage>288</lpage>.<pub-id pub-id-type="pmid">9339740</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(sici)1099-1263(199709)17:5&lt;279::aid-jat438&gt;3.0.co;2-b</pub-id></mixed-citation></ref><ref id="R139"><label>139.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Stearns</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Bleasby</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Teffera</surname><given-names>Y</given-names></name>, <etal/> (<year>2008</year>) <article-title>Importance of mechanistic drug metabolism studies in support of drug discovery: A case study with an N-sulfonylated dipeptide VLA-4 antagonist in rats</article-title>. <source>Xenobiotica</source><volume>38</volume>: <fpage>223</fpage>&#8211;<lpage>237</lpage>.<pub-id pub-id-type="pmid">18197560</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/00498250701744682</pub-id></mixed-citation></ref><ref id="R140"><label>140.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kenneke</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Mazur</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Ritger</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Sack</surname><given-names>TJ</given-names></name> (<year>2008</year>) <article-title>Mechanistic investigation of the noncytochrome P450-mediated metabolism of triadimefon to triadimenol in hepatic microsomes</article-title>. <source>Chem Res Toxicol</source><volume>21</volume>: <fpage>1997</fpage>&#8211;<lpage>2004</lpage>.<pub-id pub-id-type="pmid">18763812</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx800211t</pub-id></mixed-citation></ref><ref id="R141"><label>141.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wityak</surname><given-names>J</given-names></name>, <name name-style="western"><surname>McGee</surname><given-names>KF</given-names></name>, <name name-style="western"><surname>Conlon</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Duffy</surname><given-names>BC</given-names></name>, <etal/> (<year>2015</year>) <article-title>Lead optimization towards proof-of-concept tools for Huntington&#8217;s disease within a 4-(1H-pyrazol-4-yl)pyrimidine class of pan-JNK inhibitors</article-title>. <source>J Med Chem</source><volume>58</volume>: <fpage>2967</fpage>&#8211;<lpage>2987</lpage>.<pub-id pub-id-type="pmid">25760409</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/jm5013598</pub-id></mixed-citation></ref><ref id="R142"><label>142.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kurata</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gentry</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Kokubo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>HP</given-names></name>, <name name-style="western"><surname>Bridges</surname><given-names>TM</given-names></name>, <etal/> (<year>2015</year>) <article-title>Further optimization of the M5 NAM MLPCN probe ML375: tactics and challenges</article-title>. <source>Bioorg Med Chem Lett</source><volume>25</volume>: <fpage>690</fpage>&#8211;<lpage>694</lpage>.<pub-id pub-id-type="pmid">25542588</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bmcl.2014.11.082</pub-id><pub-id pub-id-type="pmcid">PMC4535335</pub-id></mixed-citation></ref><ref id="R143"><label>143.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kaul</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mark</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Parhi</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Lyu</surname><given-names>YL</given-names></name>, <etal/> (<year>2015</year>) <article-title>TXA709, an FtsZtargeting benzamide prodrug with improved pharmacokinetics and enhanced in vivo efficacy against methicillin-resistant Staphylococcus aureus</article-title>. <source>Antimicrob Agents Chemother</source><volume>59</volume>: <fpage>4845</fpage>&#8211;<lpage>4855</lpage>.<pub-id pub-id-type="pmid">26033735</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.00708-15</pub-id><pub-id pub-id-type="pmcid">PMC4505295</pub-id></mixed-citation></ref><ref id="R144"><label>144.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Reich</surname><given-names>NO</given-names></name>, <name name-style="western"><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name> (<year>1986</year>) <article-title>Dissociation of increased lauric acid omega-hydroxylase activity from the antilipidemic action of clofibrate</article-title>. <source>Biochem Pharmacol</source><volume>35</volume>: <fpage>1227</fpage>&#8211;<lpage>1233</lpage>.<pub-id pub-id-type="pmid">3964299</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0006-2952(86)90264-9</pub-id></mixed-citation></ref><ref id="R145"><label>145.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Romano</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Straub</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Yodis</surname><given-names>LAP</given-names></name>, <name name-style="western"><surname>Eckhardt</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Newton</surname><given-names>JF</given-names></name> (<year>1988</year>) <article-title>Determination of microsomal lauric acid hydroxylase activity by HPLC with flow-through radiochemical quantitation</article-title>. <source>Anal Biochem</source><volume>170</volume>: <fpage>83</fpage>&#8211;<lpage>93</lpage>.<pub-id pub-id-type="pmid">3389520</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0003-2697(88)90093-0</pub-id><pub-id pub-id-type="pmcid">PMC7119439</pub-id></mixed-citation></ref><ref id="R146"><label>146.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Reich</surname><given-names>NO</given-names></name> (<year>1984</year>) <article-title>Specific inactivation of hepatic fatty acid hydroxylases by acetylenic fatty acids</article-title>. <source>J Biol Chem</source><volume>259</volume>: <fpage>4136</fpage>&#8211;<lpage>4141</lpage>.<pub-id pub-id-type="pmid">6706995</pub-id></mixed-citation></ref><ref id="R147"><label>147.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kaikaus</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>WK</given-names></name>, <name name-style="western"><surname>Lysenko</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ray</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name>, <etal/> (<year>1993</year>) <article-title>Induction of peroxisomal fatty acid b-oxidation and liver fatty acidbinding protein by peroxisome proliferators. Mediation via the cytochrome P-450IVA1 w-hydroxylase pathway</article-title>. <source>J Biol Chem</source><volume>268</volume>: <fpage>9593</fpage>&#8211;<lpage>9603</lpage>.<pub-id pub-id-type="pmid">8486647</pub-id></mixed-citation></ref><ref id="R148"><label>148.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Su</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kaushal</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Kroetz</surname><given-names>DL</given-names></name> (<year>1998</year>) <article-title>Inhibition of renal arachidonic acid w-hydroxylase activity with ABT reduces blood pressure in the SHR</article-title>. <source>Am J Physiol</source><volume>275</volume>: <fpage>R426</fpage>&#8211;<lpage>R438</lpage>.<pub-id pub-id-type="pmid">9688677</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpregu.1998.275.2.R426</pub-id></mixed-citation></ref><ref id="R149"><label>149.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Maier</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Henderson</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Narayanan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Alonso-Galicia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Falck</surname><given-names>JR</given-names></name>, <etal/> (<year>2000</year>) <article-title>Fluorescent HPLC assay for 20-HETE and other P-450 metabolites of arachidonic acid</article-title>. <source>Am. J Physiol Heart Circ Physiol</source><volume>279</volume>: <fpage>H863</fpage>&#8211;<lpage>H871</lpage>.<pub-id pub-id-type="pmid">10924088</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpheart.2000.279.2.H863</pub-id></mixed-citation></ref><ref id="R150"><label>150.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hoagland</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Flasch</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Roman</surname><given-names>RJ</given-names></name> (<year>2003</year>) <article-title>Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats</article-title>. <source>Hypertension</source><volume>42</volume>: <fpage>669</fpage>&#8211;<lpage>673</lpage>.<pub-id pub-id-type="pmid">12874093</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.HYP.0000084634.97353.1A</pub-id></mixed-citation></ref><ref id="R151"><label>151.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dos Santos</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Dahly-Vernon</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Hoagland</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Roman</surname><given-names>RJ</given-names></name> (<year>2004</year>) <article-title>Inhibition of the formation of EETs and 20-HETE with 1-aminobenzotriazole attenuates pressure natriuresis</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source><volume>287</volume>: <fpage>R58</fpage>&#8211;<lpage>R68</lpage>.<pub-id pub-id-type="pmid">15031141</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpregu.00713.2003</pub-id></mixed-citation></ref><ref id="R152"><label>152.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sarkis</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Mori</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kohzuki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>S</given-names></name>, <etal/> (<year>2005</year>) <article-title>Cytochrome P450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus</article-title>. <source>Am J Physiol Renal Physiol</source><volume>289</volume>: <fpage>F1333</fpage>&#8211;<lpage>F1340</lpage>.<pub-id pub-id-type="pmid">16014574</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajprenal.00188.2005</pub-id></mixed-citation></ref><ref id="R153"><label>153.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Coceani</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kelsey</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Seidlitz</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Korzekwa</surname><given-names>K</given-names></name> (<year>1996</year>) <article-title>Inhibition of the contraction of the ductus arteriosus to oxygen by 1-aminobenzotriazole, a mechanism-based inactivator of cytochrome P450</article-title>. <source>Brit J Pharmacol</source><volume>117</volume>: <fpage>1586</fpage>&#8211;<lpage>1592</lpage>.<pub-id pub-id-type="pmid">8730758</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1476-5381.1996.tb15325.x</pub-id><pub-id pub-id-type="pmcid">PMC1909445</pub-id></mixed-citation></ref><ref id="R154"><label>154.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Pagliaro</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Penna</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rastaldo</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Mancardi</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Crisafulli</surname><given-names>A</given-names></name>, <etal/> (<year>2004</year>) <article-title>Endothelial cytochrome P450 contributes to the acetylcholine-induced cardiodepression in isolated rat hearts</article-title>. <source>Acta Physiol Scand</source><volume>182</volume>: <fpage>11</fpage>&#8211;<lpage>20</lpage>.<pub-id pub-id-type="pmid">15329052</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-201X.2004.01339.x</pub-id></mixed-citation></ref><ref id="R155"><label>155.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Vanheel</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Van de Voorde</surname><given-names>J</given-names></name> (<year>1997</year>) <article-title>Evidence against the involvement of cytochrome P450 metabolites in endothelium-dependent hyperpolarization of the rat main mesenteric artery</article-title>. <source>J Physiol</source><volume>501</volume>: <fpage>331</fpage>&#8211;<lpage>341</lpage>.<pub-id pub-id-type="pmid">9192305</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1469-7793.1997.331bn.x</pub-id><pub-id pub-id-type="pmcid">PMC1159481</pub-id></mixed-citation></ref><ref id="R156"><label>156.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Vanheel</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Calders</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Van den Bossche</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Van de Voorde</surname><given-names>J</given-names></name> (<year>1999</year>) <article-title>Influence of some phospholipase A<sub>2</sub> and cytochrome P450 inhibitors on rat arterial smooth muscle K<sup>+</sup> currents</article-title>. <source>Can J Physiol Pharmacol</source><volume>77</volume>: <fpage>481</fpage>&#8211;<lpage>489</lpage>.<pub-id pub-id-type="pmid">10535708</pub-id></mixed-citation></ref><ref id="R157"><label>157.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Walkowska</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kuczeriszka</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sadowski</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Olszynski</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Dobrowolski</surname><given-names>L</given-names></name>, <etal/> (<year>2015</year>) <article-title>High salt intake increases blood pressure in normal rats: putative role of 20-HETE and no evidence on changes in renal vascular reactivity</article-title>. <source>Kidney Blood Press Res</source><volume>40</volume>: <fpage>323</fpage>&#8211;<lpage>334</lpage>.<pub-id pub-id-type="pmid">26067851</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000368508</pub-id><pub-id pub-id-type="pmcid">PMC4583220</pub-id></mixed-citation></ref><ref id="R158"><label>158.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Rastaldo</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Paolocci</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Chiribiri</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Penna</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gattullo</surname><given-names>D</given-names></name>, <etal/> (<year>2001</year>) <article-title>Cytochrome P-450 metabolite of arachidonic acid mediates bradykinininduced negative inotropic effect</article-title>. <source>Am J Physiol Heart Circ Physiol</source><volume>280</volume>: <fpage>H2823</fpage>&#8211;<lpage>H2832</lpage>.<pub-id pub-id-type="pmid">11356641</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpheart.2001.280.6.H2823</pub-id></mixed-citation></ref><ref id="R159"><label>159.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Badzy&#180;nska</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Sadowski</surname><given-names>J</given-names></name> (<year>2009</year>) <article-title>Differential action of bradykinin on intrarenal regional perfusion in the rat: waning effect in the cortex and major impact in the medulla</article-title>. <source>J Physiol (Lond)</source><volume>587</volume>: <fpage>3943</fpage>&#8211;<lpage>3953</lpage>.<pub-id pub-id-type="pmid">19528250</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1113/jphysiol.2009.172007</pub-id><pub-id pub-id-type="pmcid">PMC2746621</pub-id></mixed-citation></ref><ref id="R160"><label>160.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ceresa</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Delfino</surname><given-names>A</given-names></name>, <name name-style="western"><surname>de Matteis</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ferrero</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Novarino</surname><given-names>M</given-names></name>, <etal/> (<year>1999</year>) <article-title>The coronary vasculature and the myocardium</article-title>. <source>Boll Soc Ital Biol Sper</source><volume>75</volume>: <fpage>1</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">11148981</pub-id></mixed-citation></ref><ref id="R161"><label>161.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Blanton</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nsaif</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hercule</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Oyekan</surname><given-names>A</given-names></name> (<year>2006</year>) <article-title>Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat</article-title>. <source>J Hypertens</source><volume>24</volume>: <fpage>1865</fpage>&#8211;<lpage>1872</lpage>.<pub-id pub-id-type="pmid">16915037</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.hjh.0000242412.88653.f2</pub-id></mixed-citation></ref><ref id="R162"><label>162.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>L&#243;pez</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Moreno</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Salom</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Roman</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Fenoy</surname><given-names>FJ</given-names></name> (<year>2001</year>) <article-title>Role of guanylyl cyclase and cytochrome P-450 on renal response to nitric oxide</article-title>. <source>Am J Physiol Renal Physiol</source><volume>281</volume>: <fpage>F420</fpage>&#8211;<lpage>F427</lpage>.<pub-id pub-id-type="pmid">11502591</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajprenal.2001.281.3.F420</pub-id></mixed-citation></ref><ref id="R163"><label>163.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dobrowolski</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Walkowska</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kompanowska-Jezierska</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kuczeriszka</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sadowski</surname><given-names>J</given-names></name> (<year>2007</year>) <article-title>Effects of ATP on rat renal haemodynamics and excretion: role of sodium intake, nitric oxide and cytochrome P450</article-title>. <source>Acta Physiol (Oxf)</source><volume>189</volume>: <fpage>77</fpage>&#8211;<lpage>85</lpage>.<pub-id pub-id-type="pmid">17280559</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1748-1716.2006.01627.x</pub-id></mixed-citation></ref><ref id="R164"><label>164.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tunctan</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Yaghini</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Estes</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Malik</surname><given-names>KU</given-names></name> (<year>2006</year>) <article-title>Inhibition by nitric oxide of cytochrome P450 4A activity contributes to endotoxin-induced hypotension in rats</article-title>. <source>Nitric Oxide</source><volume>14</volume>: <fpage>51</fpage>&#8211;<lpage>57</lpage>.<pub-id pub-id-type="pmid">16288975</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.niox.2005.09.006</pub-id></mixed-citation></ref><ref id="R165"><label>165.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wang</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Zand</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>M</given-names></name>, <etal/> (<year>2003</year>) <article-title>Regulation of renal CYP4A expression and 20-HETE synthesis by nitric oxide in pregnant rats</article-title>. <source>Am J Physiol Renal Physiol</source><volume>285</volume>: <fpage>F295</fpage>&#8211;<lpage>F302</lpage>.<pub-id pub-id-type="pmid">12684227</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajprenal.00065.2003</pub-id></mixed-citation></ref><ref id="R166"><label>166.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>He</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Podymow</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zimpelmann</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Burns</surname><given-names>KD</given-names></name> (<year>2003</year>) <article-title>NO inhibits Na<sup>+</sup>-K<sup>+</sup>&#8722;2Cl<sup>-</sup> cotransport via a cytochrome P450-dependent pathway in renal epithelial cells (MMDD1)</article-title>. <source>Am J Physiol Renal Physiol</source><volume>284</volume>: <fpage>F1235</fpage>&#8211;<lpage>F1244</lpage>.<pub-id pub-id-type="pmid">12582005</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajprenal.00192.2002</pub-id></mixed-citation></ref><ref id="R167"><label>167.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Benter</surname><given-names>IF</given-names></name>, <name name-style="western"><surname>Francis</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Cojocel</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Juggi</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Yousif</surname><given-names>MHM</given-names></name>, <etal/> (<year>2005</year>) <article-title>Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME</article-title>. <source>Auton Autacoid Pharmacol</source><volume>25</volume>: <fpage>143</fpage>&#8211;<lpage>154</lpage>.<pub-id pub-id-type="pmid">16176445</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1474-8673.2005.00343.x</pub-id></mixed-citation></ref><ref id="R168"><label>168.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hatton</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Peers</surname><given-names>C</given-names></name> (<year>1996</year>) <article-title>Effects of cytochrome P-450 inhibitors on ionic currents in isolated rat type I carotid body cells</article-title>. <source>Am J Physiol</source><volume>271</volume>: <fpage>C85</fpage>&#8211;<lpage>C92</lpage>.<pub-id pub-id-type="pmid">8760033</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpcell.1996.271.1.C85</pub-id></mixed-citation></ref><ref id="R169"><label>169.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hatton</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Peers</surname><given-names>C</given-names></name> (<year>1996</year>) <article-title>Is cytochrome P-450 involved in hypoxic inhibition of K<sup>+</sup> currents in rat type I carotid body cells?</article-title><source>Adv Exp Med Biol</source><volume>410</volume>: <fpage>89</fpage>&#8211;<lpage>92</lpage>.<pub-id pub-id-type="pmid">9030282</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-4615-5891-0_12</pub-id></mixed-citation></ref><ref id="R170"><label>170.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hatton</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Peers</surname><given-names>C</given-names></name> (<year>1998</year>) <article-title>Arachidonic acid inhibits both K<sup>+</sup> and Ca<sup>2+</sup> currents in isolated type I cells of the rat carotid body</article-title>. <source>Brain Res</source><volume>787</volume>: <fpage>315</fpage>&#8211;<lpage>320</lpage>.<pub-id pub-id-type="pmid">9518667</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0006-8993(97)01486-8</pub-id></mixed-citation></ref><ref id="R171"><label>171.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Van der Voorde</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Vanheel</surname><given-names>B</given-names></name> (<year>1997</year>) <article-title>Influence of cytochrome P-450 inhibitors on endothelium-dependent nitro-L-arginine-resistant relaxation and cromakalim-induced relaxation in rat mesenteric arteries</article-title>. <source>J Cardiovas Pharmacol</source><volume>29</volume>: <fpage>827</fpage>&#8211;<lpage>832</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00005344-199706000-00018</pub-id><pub-id pub-id-type="pmid">9234666</pub-id></mixed-citation></ref><ref id="R172"><label>172.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Iftinca</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Waldron</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Triggle</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Cole</surname><given-names>WC</given-names></name> (<year>2001</year>) <article-title>State-dependent block of rabbit vascular smooth muscle delayed rectifier and Kv1.5 channels by inhibitors of cytochrome P450-dependent enzymes</article-title>. <source>J Pharmacol Exp Ther</source><volume>298</volume>: <fpage>718</fpage>&#8211;<lpage>728</lpage>.<pub-id pub-id-type="pmid">11454936</pub-id></mixed-citation></ref><ref id="R173"><label>173.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yuan</surname><given-names>XJ</given-names></name>, <name name-style="western"><surname>Tod</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Rubin</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Blaustein</surname><given-names>MP</given-names></name> (<year>1995</year>) <article-title>Inhibition of cytochrome P-450 reduces voltage-gated K<sup>+</sup> currents in pulmonary arterial myocytes</article-title>. <source>Am J Physiol</source><volume>268</volume>: <fpage>C259</fpage>&#8211;<lpage>C270</lpage>.<pub-id pub-id-type="pmid">7840155</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpcell.1995.268.1.C259</pub-id></mixed-citation></ref><ref id="R174"><label>174.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Muthalif</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Karzoun</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Gaber</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Khandekar</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Benter</surname><given-names>IF</given-names></name>, <etal/> (<year>2000</year>) <article-title>Angiotensin II-induced hypertension: contribution of Ras GTPase/mitogenactivated protein kinase and cytochrome P450 metabolites</article-title>. <source>Hypertension</source><volume>36</volume>: <fpage>604</fpage>&#8211;<lpage>609</lpage>.<pub-id pub-id-type="pmid">11040243</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.hyp.36.4.604</pub-id></mixed-citation></ref><ref id="R175"><label>175.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Alonso-Galicia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Maier</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Greene</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Cowley</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Roman</surname><given-names>RJ</given-names></name> (<year>2002</year>) <article-title>Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source><volume>283</volume>: <fpage>R60</fpage>&#8211;<lpage>R68</lpage>.<pub-id pub-id-type="pmid">12069931</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpregu.00664.2001</pub-id></mixed-citation></ref><ref id="R176"><label>176.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lima</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Yanes</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Reckelhoff</surname><given-names>JF</given-names></name> (<year>2013</year>) <article-title>Roles played by 20-HETE, angiotensin II and endothelin in mediating the hypertension in aging female spontaneously hypertensive rats</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source><volume>304</volume>: <fpage>R248</fpage>&#8211;<lpage>R251</lpage>.<pub-id pub-id-type="pmid">23220478</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpregu.00380.2012</pub-id><pub-id pub-id-type="pmcid">PMC3567350</pub-id></mixed-citation></ref><ref id="R177"><label>177.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yousif</surname><given-names>MHM</given-names></name>, <name name-style="western"><surname>Benter</surname><given-names>IF</given-names></name>, <name name-style="western"><surname>Dunn</surname><given-names>KMJ</given-names></name>, <name name-style="western"><surname>Dahly-Vernon</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Akhtar</surname><given-names>S</given-names></name>, <etal/> (<year>2009</year>) <article-title>Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes</article-title>. <source>Auton Autacoid Pharmacol</source><volume>29</volume>: <fpage>1</fpage>&#8211;<lpage>12</lpage>.<pub-id pub-id-type="pmid">19302551</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1474-8673.2009.00426.x</pub-id><pub-id pub-id-type="pmcid">PMC2831294</pub-id></mixed-citation></ref><ref id="R178"><label>178.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yanes</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Lima</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Moulana</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Romero</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>K</given-names></name>, <etal/> (<year>2011</year>) <article-title>Postmenopausal hypertension: role of 20-HETE</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source><volume>300</volume>: <fpage>R1543</fpage>&#8211;<lpage>1548</lpage>.<pub-id pub-id-type="pmid">21474427</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpregu.00387.2010</pub-id><pub-id pub-id-type="pmcid">PMC3119152</pub-id></mixed-citation></ref><ref id="R179"><label>179.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wang</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Zand</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Nasjletti</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Laniado-Schwartzman</surname><given-names>M</given-names></name> (<year>2002</year>) <article-title>Renal 20-hydroxyeicosatetraenoic acid synthesis during pregnancy</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source><volume>282</volume>: <fpage>R383</fpage>&#8211;<lpage>R389</lpage>.<pub-id pub-id-type="pmid">11792647</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpregu.2002.282.2.R383</pub-id></mixed-citation></ref><ref id="R180"><label>180.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Llin&#225;s</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Alexander</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Capparelli</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Carroll</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Granger</surname><given-names>JP</given-names></name> (<year>2004</year>) <article-title>Cytochrome P-450 inhibition attenuates hypertension induced by reductions in uterine perfusion pressure in pregnant rats</article-title>. <source>Hypertension</source><volume>43</volume>: <fpage>623</fpage>&#8211;<lpage>628</lpage>.<pub-id pub-id-type="pmid">14757776</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.HYP.0000117721.83371.9f</pub-id></mixed-citation></ref><ref id="R181"><label>181.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Benter</surname><given-names>IF</given-names></name>, <name name-style="western"><surname>Yousif</surname><given-names>MHM</given-names></name>, <name name-style="western"><surname>Canatan</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Akhtar</surname><given-names>S</given-names></name> (<year>2005</year>) <article-title>Inhibition of Ca<sup>2+</sup>/calmodulin-dependent protein kinase II, RAS-GTPase and 20-hydroxyeicosatetraenoic acid attenuates the development of diabetesinduced vascular dysfunction in the rat carotid artery</article-title>. <source>Pharmacol Res</source><volume>52</volume>: <fpage>252</fpage>&#8211;<lpage>257</lpage>.<pub-id pub-id-type="pmid">15886012</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phrs.2005.04.001</pub-id></mixed-citation></ref><ref id="R182"><label>182.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Vasudevan</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yuen</surname><given-names>VG</given-names></name>, <name name-style="western"><surname>McNeill</surname><given-names>JH</given-names></name> (<year>2012</year>) <article-title>Testosterone-dependent increase in blood pressure is mediated by elevated Cyp4A expression in fructose-fed rats</article-title>. <source>Mol Cell Biochem</source><volume>359</volume>: <fpage>409</fpage>&#8211;<lpage>418</lpage>.<pub-id pub-id-type="pmid">21894443</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11010-011-1035-7</pub-id></mixed-citation></ref><ref id="R183"><label>183.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Williams</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Sarkis</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lopez</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ryan</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Flasch</surname><given-names>AK</given-names></name>, <etal/> (<year>2007</year>) <article-title>Elevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosatetraenoic acid contribute to pressure natriuresis</article-title>. <source>Hypertension</source><volume>49</volume>: <fpage>687</fpage>&#8211;<lpage>694</lpage>.<pub-id pub-id-type="pmid">17210834</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.HYP.0000255753.89363.47</pub-id></mixed-citation></ref><ref id="R184"><label>184.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Fernandez</surname><given-names>MMF</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Roman</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Nowicki</surname><given-names>S</given-names></name> (<year>2012</year>) <article-title>Inhibitors of 20-hydroxyeicosatetraenoic acid (20-HETE) formation attenuate the natriuretic effect of dopamine</article-title>. <source>Eur J Pharmacol</source><volume>686</volume>: <fpage>97</fpage>&#8211;<lpage>103</lpage>.<pub-id pub-id-type="pmid">22575524</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejphar.2012.04.039</pub-id><pub-id pub-id-type="pmcid">PMC3367097</pub-id></mixed-citation></ref><ref id="R185"><label>185.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Oyekan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>McAward</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Conetta</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rosenfeld</surname><given-names>L</given-names></name>, <name name-style="western"><surname>McGiff</surname><given-names>J</given-names></name> (<year>1999</year>) <article-title>Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension</article-title>. <source>Am J Physiol Regul Integr C</source><volume>45</volume>: <fpage>R766</fpage>&#8211;<lpage>R775</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpregu.1999.276.3.R766</pub-id><pub-id pub-id-type="pmid">10070137</pub-id></mixed-citation></ref><ref id="R186"><label>186.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kuczeriszka</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Badzynska</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Kompanowska-Jezierska</surname><given-names>E</given-names></name> (<year>2006</year>) <article-title>Cytochrome P-450 monooxygenases in control of renal haemodynamics and arterial pressure in anaesthetized rats</article-title>. <source>J Physiol Pharmacol</source><volume>57</volume>: <fpage>179</fpage>&#8211;<lpage>185</lpage>.<pub-id pub-id-type="pmid">17244949</pub-id></mixed-citation></ref><ref id="R187"><label>187.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ch&#225;bov&#225;</surname><given-names>CV</given-names></name>, <name name-style="western"><surname>Kramer</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Vaneckov&#225;</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Vernerov&#225;</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Eis</surname><given-names>V</given-names></name>, <etal/> (<year>2007</year>) <article-title>Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats</article-title>. <source>Vascul Pharmacol</source><volume>47</volume>: <fpage>145159</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vph.2007.05.005</pub-id><pub-id pub-id-type="pmid">17604232</pub-id></mixed-citation></ref><ref id="R188"><label>188.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kauser</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Masters</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>YH</given-names></name>, <etal/> (<year>1991</year>) <article-title>Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries</article-title>. <source>Circ Res</source><volume>68</volume>: <fpage>1154</fpage>&#8211;<lpage>1163</lpage>.<pub-id pub-id-type="pmid">1901255</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.res.68.4.1154</pub-id></mixed-citation></ref><ref id="R189"><label>189.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Orozco</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Perkins</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>BB</given-names></name>, <etal/> (<year>2013</year>) <article-title>20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries</article-title>. <source>J Pharmacol Exp Ther</source><volume>346</volume>: <fpage>67</fpage>&#8211;<lpage>74</lpage>.<pub-id pub-id-type="pmid">23658377</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/jpet.113.203844</pub-id><pub-id pub-id-type="pmcid">PMC3684845</pub-id></mixed-citation></ref><ref id="R190"><label>190.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Amaral</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Maier</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Schippers</surname><given-names>DN</given-names></name>, <name name-style="western"><surname>Roman</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Greene</surname><given-names>AS</given-names></name> (<year>2003</year>) <article-title>CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis</article-title>. <source>Am J Physiol Heart Circ Physiol</source><volume>284</volume>: <fpage>H1528</fpage>&#8211;<lpage>H1535</lpage>.<pub-id pub-id-type="pmid">12521947</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpheart.00406.2002</pub-id></mixed-citation></ref><ref id="R191"><label>191.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>El Azher</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Havet</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Singer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dumarey</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Touqui</surname><given-names>L</given-names></name> (<year>2000</year>) <article-title>Inhibition by unsaturated fatty acids of type II secretory phospholipase A2 synthesis in guinea-pig alveolar macrophages evidence for the eicosanoid-independent pathway</article-title>. <source>Eur J Biochem</source><volume>267</volume>: <fpage>3633</fpage>&#8211;<lpage>3639</lpage>.<pub-id pub-id-type="pmid">10848980</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1432-1327.2000.01392.x</pub-id></mixed-citation></ref><ref id="R192"><label>192.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Saxena</surname><given-names>NC</given-names></name> (<year>2000</year>) <article-title>Inhibition of GABA(A) receptor (GABAR) currents by arachidonic acid in HEK 293 cells stably transfected with alpha1beta2gamma2 GABAR subunits</article-title>. <source>Pflugers Arch</source><volume>440</volume>: <fpage>380</fpage>&#8211;<lpage>392</lpage>.<pub-id pub-id-type="pmid">10954324</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s004240000289</pub-id></mixed-citation></ref><ref id="R193"><label>193.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nieves</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Moreno</surname><given-names>JJ</given-names></name> (<year>2006</year>) <article-title>Hydroxyeicosatetraenoic acids released through the cytochrome P-450 pathway regulate 3T6 fibroblast growth</article-title>. <source>J Lipid Res</source><volume>47</volume>: <fpage>2681</fpage>&#8211;<lpage>2689</lpage>.<pub-id pub-id-type="pmid">16980726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1194/jlr.M600212-JLR200</pub-id></mixed-citation></ref><ref id="R194"><label>194.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Feddersen</surname><given-names>CO</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Czartalomna</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Voelkel</surname><given-names>NF</given-names></name> (<year>1990</year>) <article-title>Arachidonic acid causes cyclooxygenase-dependent and -independent pulmonary vasodilation</article-title>. <source>J Appl Physiol</source><volume>68</volume>: <fpage>1799</fpage>&#8211;<lpage>1808</lpage>.<pub-id pub-id-type="pmid">2113900</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/jappl.1990.68.5.1799</pub-id></mixed-citation></ref><ref id="R195"><label>195.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chang</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Dutton</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>He</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Stearns</surname><given-names>R</given-names></name>, <etal/> (<year>1992</year>) <article-title>Intact lung cytochrome P-450 is not required for hypoxic pulmonary vasoconstriction</article-title>. <source>Am J Physiol</source><volume>263</volume>: <fpage>L446</fpage>&#8211;<lpage>L453</lpage>.<pub-id pub-id-type="pmid">1415722</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajplung.1992.263.4.L446</pub-id></mixed-citation></ref><ref id="R196"><label>196.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Weissmann</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Seeger</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Conzen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kiss</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Grimminger</surname><given-names>F</given-names></name> (<year>1998</year>) <article-title>Effects of arachidonic acid metabolism on hypoxic vasoconstriction in rabbit lungs</article-title>. <source>Eur J Pharmacol</source><volume>356</volume>: <fpage>231</fpage>&#8211;<lpage>237</lpage>.<pub-id pub-id-type="pmid">9774254</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0014-2999(98)00563-9</pub-id></mixed-citation></ref><ref id="R197"><label>197.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cooper</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Mesaros</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Christmas</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Stark</surname><given-names>CM</given-names></name>, <etal/> (<year>2010</year>) <article-title>20-HETE mediates ozone-induced, neutrophil-independent airway hyperresponsiveness in mice</article-title>. <source>PLoS ONE</source><volume>5</volume>: <fpage>e10235</fpage>.<pub-id pub-id-type="pmid">20422032</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0010235</pub-id><pub-id pub-id-type="pmcid">PMC2857875</pub-id></mixed-citation></ref><ref id="R198"><label>198.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dubey</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Gillespie</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Zacharia</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Rosselli</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Imthurn</surname><given-names>B</given-names></name>, <etal/> (<year>2002</year>) <article-title>Methoxyestradiols mediate the antimitogenic effects of locally applied estradiol on cardiac fibroblast growth</article-title>. <source>Hypertension</source><volume>39</volume>: <fpage>412</fpage>&#8211;<lpage>417</lpage>.<pub-id pub-id-type="pmid">11882582</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/hy0202.102837</pub-id></mixed-citation></ref><ref id="R199"><label>199.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dubey</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Gillespie</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Keller</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Imthurn</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Zacharia</surname><given-names>LC</given-names></name>, <etal/> (<year>2002</year>) <article-title>Role of methoxyestradiols in the growth inhibitory effects of estradiol on human glomerular mesangial cells</article-title>. <source>Hypertension</source><volume>39</volume>: <fpage>418</fpage>&#8211;<lpage>424</lpage>.<pub-id pub-id-type="pmid">11882583</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/hy0202.103297</pub-id></mixed-citation></ref><ref id="R200"><label>200.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Barchiesi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Jackson</surname><given-names>EK</given-names></name>, <name name-style="western"><surname>Gillespie</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Zacharia</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Fingerie</surname><given-names>J</given-names></name>, <etal/> (<year>2002</year>) <article-title>Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCs</article-title>. <source>Hypertension</source><volume>39</volume>: <fpage>874</fpage>&#8211;<lpage>879</lpage>.<pub-id pub-id-type="pmid">11967242</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.hyp.0000013863.25970.ba</pub-id></mixed-citation></ref><ref id="R201"><label>201.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dubey</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Gillespie</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Zacharia</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Barchiesi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Imthurn</surname><given-names>B</given-names></name>, <etal/> (<year>2003</year>) <article-title>CYP450- and COMT-derived estradiol metabolites inhibit activity of human coronary artery SMCs</article-title>. <source>Hypertension</source><volume>41</volume>: <fpage>807</fpage>&#8211;<lpage>813</lpage>.<pub-id pub-id-type="pmid">12624000</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.HYP.0000048862.28501.72</pub-id></mixed-citation></ref><ref id="R202"><label>202.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dubey</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Jackson</surname><given-names>EK</given-names></name>, <name name-style="western"><surname>Gillespie</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Rosselli</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Barchiesi</surname><given-names>F</given-names></name>, <etal/> (<year>2005</year>) <article-title>Cytochromes 1A1/1B1- and catechol-O-methyltransferase-derived metabolites mediate estradiol-induced antimitogenesis in human cardiac fibroblast</article-title>. <source>J Clin Endocrinol Metab</source><volume>90</volume>: <fpage>247</fpage>&#8211;<lpage>255</lpage>.<pub-id pub-id-type="pmid">15507517</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1210/jc.2003-032154</pub-id></mixed-citation></ref><ref id="R203"><label>203.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Wan</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>J</given-names></name> (<year>2011</year>) <article-title>Dual effects of estrogen on vascular smooth muscle cells: receptor-mediated proliferative vs. metaboliteinduced pro-senescent actions</article-title>. <source>Steroids</source><volume>76</volume>: <fpage>309</fpage>&#8211;<lpage>316</lpage>.<pub-id pub-id-type="pmid">21163284</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.steroids.2010.12.002</pub-id></mixed-citation></ref><ref id="R204"><label>204.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gui</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>XL</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Walsh</surname><given-names>MP</given-names></name> (<year>2008</year>) <article-title>Inhibition of rat aortic smooth muscle contraction by 2-methoxyestradiol</article-title>. <source>Am J Physiol Heart Circ Physiol</source><volume>295</volume>: <fpage>H1935</fpage>&#8211;<lpage>H1942</lpage>.<pub-id pub-id-type="pmid">18775847</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpheart.00723.2008</pub-id></mixed-citation></ref><ref id="R205"><label>205.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Miyamoto</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Matsueda</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Moritsuka</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Shimokawa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hirata</surname><given-names>H</given-names></name>, <etal/> (<year>2015</year>) <article-title>Evaluation of hypothermia on the in vitro metabolism and binding and in vivo disposition of midazolam in rats</article-title>. <source>Biopharm Drug Dispos</source><volume>36</volume>: <fpage>481</fpage>&#8211;<lpage>489</lpage>.<pub-id pub-id-type="pmid">26037413</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/bdd.1960</pub-id></mixed-citation></ref><ref id="R206"><label>206.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Poole</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Pritchard</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Catto</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Leonard</surname><given-names>T</given-names></name> (<year>1989</year>) <article-title>In vitro accumulation of thyroid hormones by cultured rat hepatocytes and the biliary excretion of iodothyronines in rats treated with a novel histamine H2-receptor antagonist</article-title>. <source>Toxicology</source><volume>59</volume>: <fpage>23</fpage>&#8211;<lpage>36</lpage>.<pub-id pub-id-type="pmid">2573172</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0300-483x(89)90154-6</pub-id></mixed-citation></ref><ref id="R207"><label>207.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Poole</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pritchard</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Catto</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Leonard</surname><given-names>T</given-names></name> (<year>1990</year>) <article-title>In vivo biliary excretion and in vitro cellular accumulation of thyroxine by rats or cultured rat hepatocytes treated with a novel histamine H1-receptor antagonist</article-title>. <source>Arch Toxicol</source><volume>64</volume>: <fpage>474</fpage>&#8211;<lpage>481</lpage>.<pub-id pub-id-type="pmid">1980408</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF01977630</pub-id></mixed-citation></ref><ref id="R208"><label>208.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Behne</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Uchida</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Seki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Elias</surname><given-names>PM</given-names></name>, <etal/> (<year>2000</year>) <article-title>Omega-ydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function</article-title>. <source>J Invest Dermatol</source><volume>114</volume>: <fpage>185</fpage>&#8211;<lpage>192</lpage>.<pub-id pub-id-type="pmid">10620136</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1523-1747.2000.00846.x</pub-id></mixed-citation></ref><ref id="R209"><label>209.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Glatt</surname><given-names>H</given-names></name> (<year>2010</year>) <article-title>Human cytochrome P450 2E1 and sulfotransferase 1A1 coexpressed in Chinese hamster V79 cells enhance spontaneous mutagenesis</article-title>. <source>Environ Mol Mutagen</source><volume>51</volume>: <fpage>23</fpage>&#8211;<lpage>30</lpage>.<pub-id pub-id-type="pmid">19484729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/em.20503</pub-id></mixed-citation></ref><ref id="R210"><label>210.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lee</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>SM</given-names></name> (<year>2005</year>) <article-title>Suppression of hepatic cytochrome p450-mediated drug metabolism during the late stage of sepsis in rats</article-title>. <source>Shock</source><volume>23</volume>: <fpage>144</fpage>&#8211;<lpage>149</lpage>.<pub-id pub-id-type="pmid">15665729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.shk.0000150778.39484.54</pub-id></mixed-citation></ref><ref id="R211"><label>211.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Maitra</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>P</given-names></name> (<year>2008</year>) <article-title>The potential role of transcription factor aryl hydrocarbon receptor in downregulation of hepatic cytochrome P-450 during sepsis</article-title>. <source>Int J Mol Med</source><volume>21</volume>: <fpage>423</fpage>&#8211;<lpage>428</lpage>.<pub-id pub-id-type="pmid">18360687</pub-id><pub-id pub-id-type="pmcid">PMC2694573</pub-id></mixed-citation></ref><ref id="R212"><label>212.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jacob</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>P</given-names></name> (<year>2009</year>) <article-title>The role of hepatic cytochrome P-450 in sepsis</article-title>. <source>Int J Clin Exp Med</source><volume>2</volume>: <fpage>203</fpage>&#8211;<lpage>211</lpage>.<pub-id pub-id-type="pmid">19918313</pub-id><pub-id pub-id-type="pmcid">PMC2770183</pub-id></mixed-citation></ref><ref id="R213"><label>213.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Crawford</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Simms</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>P</given-names></name> (<year>2004</year>) <article-title>Down-regulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsis</article-title>. <source>Crit Care Med</source><volume>32</volume>: <fpage>502</fpage>&#8211;<lpage>508</lpage>.<pub-id pub-id-type="pmid">14758170</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.CCM.0000109453.57709.E2</pub-id></mixed-citation></ref><ref id="R214"><label>214.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Morgan</surname><given-names>ET</given-names></name> (<year>2005</year>) <article-title>A role for one or more P450 enzymes in the response to sepsis</article-title>. <source>Crit Care Med</source><volume>33</volume>: <fpage>268</fpage>&#8211;<lpage>269</lpage>.<pub-id pub-id-type="pmid">15644701</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.ccm.0000151050.41539.5f</pub-id></mixed-citation></ref><ref id="R215"><label>215.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Carcillo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Korzekwa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Parise</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gillespie</surname><given-names>D</given-names></name>, <etal/> (<year>1998</year>) <article-title>The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity</article-title>. <source>Res Commun Molec Pathol Pharmacol</source><volume>102</volume>: <fpage>57</fpage>&#8211;<lpage>68</lpage>.<pub-id pub-id-type="pmid">9920346</pub-id></mixed-citation></ref><ref id="R216"><label>216.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mico</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Federowicz</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Burak</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Swagzdis</surname><given-names>JR</given-names></name> (<year>1987</year>) <article-title>In vivo inhibition of phenacetin oxidation by suicide substrate 1-aminobenzotriazole</article-title>. <source>Drug Metab Disp</source><volume>15</volume>: <fpage>274</fpage>&#8211;<lpage>276</lpage>.<pub-id pub-id-type="pmid">2882991</pub-id></mixed-citation></ref><ref id="R217"><label>217.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mugford</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Tarloff</surname><given-names>JB</given-names></name> (<year>1995</year>) <article-title>Contribution of oxidation and deacetylation to the bioactivation of acetaminophen in vitro in liver and kidney from male and female Sprague-Dawley rats</article-title>. <source>Drug Metab Dispos</source><volume>23</volume>: <fpage>290</fpage>&#8211;<lpage>294</lpage>.<pub-id pub-id-type="pmid">7736927</pub-id></mixed-citation></ref><ref id="R218"><label>218.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mugford</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Tarloff</surname><given-names>JB</given-names></name> (<year>1997</year>) <article-title>The contribution of oxidation and deacetylation to acetaminophen nephrotoxicity in female Sprague-Dawley rats</article-title>. <source>Toxicol Lett</source><volume>93</volume>: <fpage>15</fpage>&#8211;<lpage>22</lpage>.<pub-id pub-id-type="pmid">9381478</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0378-4274(97)00063-5</pub-id></mixed-citation></ref><ref id="R219"><label>219.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Deleve</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Kaplowitz</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Shulman</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Bart</surname><given-names>JA</given-names></name>, <etal/> (<year>1997</year>) <article-title>Sinusoidal endothelial cells as a target for acetaminophen toxicity. Direct action versus requirement for hepatocyte activation in different mouse strains</article-title>. <source>Biochem Pharmacol</source><volume>53</volume>: <fpage>1339</fpage>&#8211;<lpage>1345</lpage>.<pub-id pub-id-type="pmid">9214695</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0006-2952(97)00048-8</pub-id></mixed-citation></ref><ref id="R220"><label>220.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Miyakawa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Albee</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Letzig</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Lehner</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>MA</given-names></name>, <etal/> (<year>2015</year>) <article-title>A cytochrome P450-independent mechanism of acetaminophen-induced injury in cultured mouse hepatocytes</article-title>. <source>J Pharmacol Exp Therap</source><volume>354</volume>: <fpage>230</fpage>&#8211;<lpage>237</lpage>.<pub-id pub-id-type="pmid">26065700</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/jpet.115.223537</pub-id><pub-id pub-id-type="pmcid">PMC4518070</pub-id></mixed-citation></ref><ref id="R221"><label>221.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Smith</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Kehrer</surname><given-names>JP</given-names></name> (<year>1991</year>) <article-title>Cooxidation of cyclophosphamide as an alternative pathway for its bioactivation and lung toxicity</article-title>. <source>Cancer Res</source><volume>51</volume>: <fpage>542</fpage>&#8211;<lpage>548</lpage>.<pub-id pub-id-type="pmid">1985772</pub-id></mixed-citation></ref><ref id="R222"><label>222.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Huang</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Waxman</surname><given-names>DJ</given-names></name> (<year>2001</year>) <article-title>Modulation of cyclophosphamide-based cytochrome P450 gene therapy using liver P450 inhibitors</article-title>. <source>Cancer Gene Ther</source><volume>8</volume>: <fpage>450</fpage>&#8211;<lpage>458</lpage>.<pub-id pub-id-type="pmid">11498765</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.cgt.7700325</pub-id></mixed-citation></ref><ref id="R223"><label>223.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mannargudi</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Uetrecht</surname><given-names>J</given-names></name> (<year>2008</year>) <article-title>Demonstration of the metabolic pathway responsible for nevirapine-induced skin rash</article-title>. <source>Chem Res Toxicol</source><volume>21</volume>: <fpage>1862</fpage>&#8211;<lpage>1870</lpage>.<pub-id pub-id-type="pmid">18729332</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx800177k</pub-id></mixed-citation></ref><ref id="R224"><label>224.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sharma</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Novalen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hayes</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Uetrecht</surname><given-names>J</given-names></name> (<year>2012</year>) <article-title>Bioactivation of nevirapine to a reactive quinone methide: implications for liver injury</article-title>. <source>Chem Res Toxicol</source><volume>25</volume>: <fpage>1708</fpage>&#8211;<lpage>1719</lpage>.<pub-id pub-id-type="pmid">22793666</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx300172s</pub-id><pub-id pub-id-type="pmcid">PMC3475366</pub-id></mixed-citation></ref><ref id="R225"><label>225.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nishiya</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Maru</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kataoka</surname><given-names>H</given-names></name>, <etal/> (<year>2008</year>) <article-title>Involvement of cytochrome P450-mediated metabolism in tienilic acid hepatotoxicity in rats</article-title>. <source>Toxicol Lett</source><volume>183</volume>: <fpage>81</fpage>&#8211;<lpage>89</lpage>.<pub-id pub-id-type="pmid">18992796</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxlet.2008.10.009</pub-id></mixed-citation></ref><ref id="R226"><label>226.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jinno</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Tagashira</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tsurui</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yamada</surname><given-names>S</given-names></name> (<year>2014</year>) <article-title>Contribution of cytochrome P450 and UDT-glucuronosyltransferase to the metabolism of drugs containing carboxylic acid groups: risk assessment of acylglucuronides using human hepatocytes</article-title>. <source>Xenobiotica</source><volume>44</volume>: <fpage>677</fpage>&#8211;<lpage>686</lpage>.<pub-id pub-id-type="pmid">24575896</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/00498254.2014.894219</pub-id></mixed-citation></ref><ref id="R227"><label>227.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Atkinson</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Di</surname><given-names>L</given-names></name> (<year>2016</year>) <article-title>Novel cytochrome P450 reaction phenotyping for low-clearance compounds using the hepatocyte relay method</article-title>. <source>Drug Metab Dispos</source><volume>44</volume>: <fpage>460</fpage>&#8211;<lpage>465</lpage>.<pub-id pub-id-type="pmid">26700955</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.115.067876</pub-id></mixed-citation></ref><ref id="R228"><label>228.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Matsunaga</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kaneko</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Staub</surname><given-names>AY</given-names></name>, <name name-style="western"><surname>Nakanishi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nunoya</surname><given-names>K</given-names></name>, <etal/> (<year>2016</year>) <article-title>Analysis of the metabolic pathway of bosentan and of the cytotoxicity of bosentan metabolites based on a quantitative modeling of metabolism and transport in sandwich-cultured human hepatocytes</article-title>. <source>Drug Metab Dispos</source><volume>44</volume>: <fpage>16</fpage>&#8211;<lpage>27</lpage>.<pub-id pub-id-type="pmid">26502773</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.115.067074</pub-id></mixed-citation></ref><ref id="R229"><label>229.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tong</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>TKH</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Abbott</surname><given-names>FS</given-names></name> (<year>2003</year>) <article-title>The effect of valproic acid on hepatic and plasma levels of 15-F2t-isoprostane in rats</article-title>. <source>Free Rad Biol Med</source><volume>34</volume>: <fpage>1435</fpage>&#8211;<lpage>1446</lpage>.<pub-id pub-id-type="pmid">12757854</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0891-5849(03)00151-5</pub-id></mixed-citation></ref><ref id="R230"><label>230.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Surendradoss</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>TKH</given-names></name>, <name name-style="western"><surname>Abbott</surname><given-names>FS</given-names></name> (<year>2012</year>) <article-title>Assessment of the role of in situ generated (E)-2,4-diene-valproic acid in the toxicity of valproic acid and (E)-2-ene-valproic acid in sandwich-cultured rat hepatocytes</article-title>. <source>Toxicol Appl Pharmacol</source><volume>264</volume>: <fpage>413</fpage>&#8211;<lpage>422</lpage>.<pub-id pub-id-type="pmid">22940460</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2012.08.018</pub-id></mixed-citation></ref><ref id="R231"><label>231.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kazmi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Barbara</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Yerino</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Parkinson</surname><given-names>A</given-names></name> (<year>2015</year>) <article-title>A long-standing mystery solved: the formation of 3-hydroxydesloratadine is catalyzed by CYP2C8 but prior glucuronidation of desloratadine by UDP-glucuronosyltransferase 2B10 is an obligatory requirement</article-title>. <source>Drug Metab Dispos</source><volume>43</volume>: <fpage>523</fpage>&#8211;<lpage>533</lpage>.<pub-id pub-id-type="pmid">25595597</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.114.062620</pub-id></mixed-citation></ref><ref id="R232"><label>232.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Takagi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sanoh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Santoh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ejiri</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kotake</surname><given-names>Y</given-names></name>, <etal/> (<year>2016</year>) <article-title>Detection of metabolic activation leading to drug-induced phospholipidosis in rat hepatocyte spheroids</article-title>. <source>J Toxicol Sci</source><volume>41</volume>: <fpage>155</fpage>&#8211;<lpage>164</lpage>.<pub-id pub-id-type="pmid">26763403</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2131/jts.41.155</pub-id></mixed-citation></ref><ref id="R233"><label>233.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hammond</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Fry</surname><given-names>JR</given-names></name> (<year>1994</year>) <article-title>Toxicity of precocene II in rat hepatocyte cultures: effects of serum and culture time</article-title>. <source>Toxicol Lett</source><volume>70</volume>: <fpage>337</fpage>&#8211;<lpage>342</lpage>.<pub-id pub-id-type="pmid">8284801</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0378-4274(94)90128-7</pub-id></mixed-citation></ref><ref id="R234"><label>234.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hammond</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Garle</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Fry</surname><given-names>JR</given-names></name> (<year>1995</year>) <article-title>Mechanism of toxicity of precocene II in rat hepatocyte cultures</article-title>. <source>J Biochem Toxicol</source><volume>10</volume>: <fpage>265</fpage>&#8211;<lpage>273</lpage>.<pub-id pub-id-type="pmid">8847709</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jbt.2570100507</pub-id></mixed-citation></ref><ref id="R235"><label>235.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ly</surname><given-names>VT</given-names></name>, <name name-style="western"><surname>Brock</surname><given-names>B</given-names></name><year>2011</year>) <article-title>Effects of CYP inhibitors on precocene I metabolism and toxicity in rat liver slices</article-title>. <source>Chem Biol Interact</source><volume>193</volume>: <fpage>109</fpage>&#8211;<lpage>118</lpage>.<pub-id pub-id-type="pmid">21741958</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cbi.2011.05.011</pub-id></mixed-citation></ref><ref id="R236"><label>236.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Huijzer</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Jaw</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Yost</surname><given-names>GS</given-names></name> (<year>1989</year>) <article-title>Inhibition of 3-methylindole bioactivation by the cytochrome P450 suicide substrates 1-aminobenzotriazole and-methylbenzylaminobenzotriazole</article-title>. <source>Drug Metab Disp</source><volume>17</volume>: <fpage>37</fpage>&#8211;<lpage>42</lpage>.<pub-id pub-id-type="pmid">2566467</pub-id></mixed-citation></ref><ref id="R237"><label>237.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nichols</surname><given-names>WK</given-names></name>, <name name-style="western"><surname>Larson</surname><given-names>DN</given-names></name>, <name name-style="western"><surname>Yost</surname><given-names>GS</given-names></name> (<year>1990</year>) <article-title>Bioactivation of 3-methylindole by isolated rabbit lung cells</article-title>. <source>Toxicol Appl Pharmacol</source><volume>105</volume>: <fpage>264</fpage>&#8211;<lpage>270</lpage>.<pub-id pub-id-type="pmid">2219119</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0041-008x(90)90188-z</pub-id></mixed-citation></ref><ref id="R238"><label>238.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Thornton-Manning</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Nichols</surname><given-names>WK</given-names></name>, <name name-style="western"><surname>Manning</surname><given-names>BW</given-names></name>, <name name-style="western"><surname>Skiles</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Yost</surname><given-names>GS</given-names></name> (<year>1993</year>) <article-title>Metabolism and bioactivation of 3-methylindole by Clara cells, alveolar macrophages, and subcellular fractions from rabbit lungs</article-title>. <source>Toxicol Appl Pharmacol</source><volume>122</volume>: <fpage>182</fpage>&#8211;<lpage>190</lpage>.<pub-id pub-id-type="pmid">8212000</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/taap.1993.1186</pub-id></mixed-citation></ref><ref id="R239"><label>239.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nichols</surname><given-names>WK</given-names></name>, <name name-style="western"><surname>Mehta</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Skordos</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Mac&#233;</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Pfeifer</surname><given-names>AM</given-names></name>, <etal/> (<year>2003</year>) <article-title>3-Methylindole-induced toxicity to human bronchial epithelial cell lines</article-title>. <source>Toxicol Sci</source><volume>71</volume>: <fpage>229</fpage>&#8211;<lpage>236</lpage>.<pub-id pub-id-type="pmid">12563108</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/71.2.229</pub-id></mixed-citation></ref><ref id="R240"><label>240.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Weems</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Yost</surname><given-names>GS</given-names></name> (<year>2010</year>) <article-title>3-Methylindole metabolites induce lung CYP1A1 and CYP2F1 enzymes by AhR and non-AhR mechanisms, respectively</article-title>. <source>Chem Res Toxico</source><volume>23</volume>: <fpage>696</fpage>&#8211;<lpage>704</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx9004506</pub-id><pub-id pub-id-type="pmcid">PMC2843511</pub-id><pub-id pub-id-type="pmid">20187624</pub-id></mixed-citation></ref><ref id="R241"><label>241.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>El Hadri</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Bhanas</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ghanayem</surname><given-names>BI</given-names></name> (<year>2005</year>) <article-title>Comparative metabolism of methacrylonitrile and acrylonitrile to cyanide using cytochrome P4502E1 and microsomal epoxide hydrolase-null mice</article-title>. <source>Toxicol Appl Pharmacol</source><volume>205</volume>: <fpage>116</fpage>&#8211;<lpage>125</lpage>.<pub-id pub-id-type="pmid">15893539</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2004.10.002</pub-id></mixed-citation></ref><ref id="R242"><label>242.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Adler</surname><given-names>ID</given-names></name>, <name name-style="western"><surname>Baumgartner</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gonda</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Friedman</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Skerhut</surname><given-names>M</given-names></name> (<year>2000</year>) <article-title>1-Aminobenzotriazole inhibits acrylamide-induced dominant lethal effects in spermatids of male mice</article-title>. <source>Mutagenesis</source><volume>15</volume>: <fpage>133</fpage>&#8211;<lpage>136</lpage>.<pub-id pub-id-type="pmid">10719038</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/mutage/15.2.133</pub-id></mixed-citation></ref><ref id="R243"><label>243.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Park</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kamendulis</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Friedman</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Klaunig</surname><given-names>JE</given-names></name> (<year>2002</year>) <article-title>Acrylamideinduced cellular transformation</article-title>. <source>Toxicol Sci</source><volume>65</volume>: <fpage>177</fpage>&#8211;<lpage>183</lpage>.<pub-id pub-id-type="pmid">11812921</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/65.2.177</pub-id></mixed-citation></ref><ref id="R244"><label>244.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lafferty</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Kamendulis</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Kaster</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Klaunig</surname><given-names>JE</given-names></name> (<year>2004</year>) <article-title>Subchronic acrylamide treatment induces a tissue-specific increase in DNA synthesis in the rat</article-title>. <source>Toxicol Lett</source><volume>154</volume>: <fpage>95</fpage>&#8211;<lpage>103</lpage>.<pub-id pub-id-type="pmid">15475183</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxlet.2004.07.008</pub-id></mixed-citation></ref><ref id="R245"><label>245.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kamendulis</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Klaunig</surname><given-names>JE</given-names></name> (<year>2002</year>) <article-title>Mechanisms for the induction of oxidative stress in Syrian hamster embryo cells by acrylonitrile</article-title>. <source>Toxicol Sci</source><volume>67</volume>: <fpage>247</fpage>&#8211;<lpage>255</lpage>.<pub-id pub-id-type="pmid">12011484</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/67.2.247</pub-id></mixed-citation></ref><ref id="R246"><label>246.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Pu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Kamendulis</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Klaunig</surname><given-names>JE</given-names></name> (<year>2006</year>) <article-title>Acrylonitrile-induced oxidative DNA damage in rat astrocytes</article-title>. <source>Environ Mol Mutagen</source><volume>47</volume>: <fpage>631</fpage>&#8211;<lpage>638</lpage>.<pub-id pub-id-type="pmid">16917936</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/em.20249</pub-id></mixed-citation></ref><ref id="R247"><label>247.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Salda&#241;a-Ru&#237;z</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hern&#225;ndez-Mir</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sed&#243;-Cabez&#243;n</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Cutillas</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Llorens</surname><given-names>J</given-names></name> (<year>2012</year>) <article-title>Vestibular toxicity of cis-2-pentenenitrile in the rat</article-title>. <source>Toxicol Lett</source><volume>211</volume>: <fpage>281</fpage>&#8211;<lpage>288</lpage>.<pub-id pub-id-type="pmid">22546275</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxlet.2012.04.010</pub-id></mixed-citation></ref><ref id="R248"><label>248.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Boadas-Vaello</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Jover</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Salda&#241;a-Ru&#237;z</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Soler-Martin</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chabbert</surname><given-names>C</given-names></name>, <etal/> (<year>2009</year>) <article-title>Allylnitrile metabolism by CYP2E1 and other CYPs leads to distinct lethal and vestibulotoxic effects in the mouse</article-title>. <source>Toxicol Sci</source><volume>107</volume>: <fpage>461</fpage>&#8211;<lpage>472</lpage>.<pub-id pub-id-type="pmid">18990727</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfn233</pub-id></mixed-citation></ref><ref id="R249"><label>249.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Constan</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Sprankle</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Peters</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Kedderis</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Everitt</surname><given-names>JI</given-names></name>, <etal/> (<year>1999</year>) <article-title>Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver, kidney, and nose of male mice</article-title>. <source>Toxicol Appl Pharmacol</source><volume>160</volume>: <fpage>120</fpage>&#8211;<lpage>126</lpage>.<pub-id pub-id-type="pmid">10527910</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/taap.1999.8756</pub-id></mixed-citation></ref><ref id="R250"><label>250.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lind</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Begay</surname><given-names>CK</given-names></name>, <name name-style="western"><surname>Gandolfi</surname><given-names>AJ</given-names></name> (<year>2000</year>) <article-title>Hepatoprotection by dimethyl sulfoxide. III. Role of inhibition of the bioactivation and covalent bonding of chloroform</article-title>. <source>Toxicol Appl Pharmacol</source><volume>166</volume>: <fpage>145</fpage>&#8211;<lpage>150</lpage>.<pub-id pub-id-type="pmid">10896856</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/taap.2000.8949</pub-id></mixed-citation></ref><ref id="R251"><label>251.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Garner</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Sumner</surname><given-names>SCJ</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Burgess</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Yueh</surname><given-names>Y</given-names></name>, <etal/> (<year>2006</year>) <article-title>Metabolism and disposition of 1-bromopropane in rats and mice following inhalation or intravenous administration</article-title>. <source>Toxicol Appl Pharmacol</source><volume>215</volume>: <fpage>23</fpage>&#8211;<lpage>36</lpage>.<pub-id pub-id-type="pmid">16513153</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2006.01.010</pub-id></mixed-citation></ref><ref id="R252"><label>252.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zong</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Garner</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <etal/> (<year>2016</year>) <article-title>Preliminary characterization of a murine model for 1-bromopropane neurotoxicity: Role of cytochrome P450</article-title>. <source>Toxicol Lett</source><volume>258</volume>: <fpage>249</fpage>&#8211;<lpage>258</lpage>.<pub-id pub-id-type="pmid">27421776</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxlet.2016.07.006</pub-id></mixed-citation></ref><ref id="R253"><label>253.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nichols</surname><given-names>WK</given-names></name>, <name name-style="western"><surname>Covington</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>Seiders</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Safiullah</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yost</surname><given-names>GS</given-names></name> (<year>1992</year>) <article-title>Bioactivation of halogenated hydrocarbons by rabbit pulmonary cells</article-title>. <source>Pharmacol Toxicol</source><volume>71</volume>: <fpage>335</fpage>&#8211;<lpage>339</lpage>.<pub-id pub-id-type="pmid">1448445</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0773.1992.tb00557.x</pub-id></mixed-citation></ref><ref id="R254"><label>254.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kim</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ghanayem</surname><given-names>BI</given-names></name> (<year>2006</year>) <article-title>Comparative metabolism and disposition of trichloroethylene in Cyp2e1-/ - and wild-type mice</article-title>. <source>Drug Metab Dispos</source><volume>34</volume>: <fpage>2020</fpage>&#8211;<lpage>2027</lpage>.<pub-id pub-id-type="pmid">16959879</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/dmd.106.010538</pub-id></mixed-citation></ref><ref id="R255"><label>255.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shiba</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Shimamoto</surname><given-names>N</given-names></name> (<year>1999</year>) <article-title>Attenuation of endogenous oxidative stressinduced cell death by cytochrome P450 inhibitors in primary cultures of rat hepatocytes</article-title>. <source>Free Rad Biol Med</source><volume>27</volume>: <fpage>1019</fpage>&#8211;<lpage>1026</lpage>.<pub-id pub-id-type="pmid">10569634</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0891-5849(99)00150-1</pub-id></mixed-citation></ref><ref id="R256"><label>256.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bradford</surname><given-names>BU</given-names></name>, <name name-style="western"><surname>Kono</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Isayama</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kosyk</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Wheeler</surname><given-names>MD</given-names></name>, <etal/> (<year>2005</year>) <article-title>Cytochrome P450 2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver</article-title>. <source>Hepatology</source><volume>41</volume>: <fpage>336</fpage>&#8211;<lpage>344</lpage>.<pub-id pub-id-type="pmid">15660387</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hep.20532</pub-id></mixed-citation></ref><ref id="R257"><label>257.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nan</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>R</given-names></name>, <etal/> (<year>2009</year>) <article-title>Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice</article-title>. <source>Scand J Gastroenterol</source><volume>44</volume>: <fpage>1121</fpage>&#8211;<lpage>1131</lpage>.<pub-id pub-id-type="pmid">19606393</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/00365520903114912</pub-id></mixed-citation></ref><ref id="R258"><label>258.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chiu</surname><given-names>PY</given-names></name>, <name name-style="western"><surname>Mak</surname><given-names>DHF</given-names></name>, <name name-style="western"><surname>Poon</surname><given-names>MKT</given-names></name>, <name name-style="western"><surname>Ko</surname><given-names>KM</given-names></name> (<year>2005</year>) <article-title>Role of cytochrome P-450 in schisandrin B-induced antioxidant and heat shock responses in mouse liver</article-title>. <source>Life Sci</source><volume>77</volume>: <fpage>2887</fpage>&#8211;<lpage>2895</lpage>.<pub-id pub-id-type="pmid">15958272</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lfs.2005.03.026</pub-id></mixed-citation></ref><ref id="R259"><label>259.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chen</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Chiu</surname><given-names>PY</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Ko</surname><given-names>KM</given-names></name> (<year>2012</year>) <article-title>Cytochrome P-450-catalyzed reactive oxygen species production mediates the (&#8722;)schisandrin B-induced glutathione and heat shock responses in H9c2 cardiomyocytes</article-title>. <source>Indian J Pharmacol</source><volume>44</volume>: <fpage>204</fpage>&#8211;<lpage>209</lpage>.<pub-id pub-id-type="pmid">22529476</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/0253-7613.93849</pub-id><pub-id pub-id-type="pmcid">PMC3326913</pub-id></mixed-citation></ref><ref id="R260"><label>260.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dostalek</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Brooks</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Hardy</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Milne</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>MM</given-names></name>, <etal/> (<year>2007</year>) <article-title>In vivo oxidative damage is associated with barbiturate response but not other cytochrome P450 inducers</article-title>. <source>Molec Pharmacol</source><volume>72</volume>: <fpage>1419</fpage>&#8211;<lpage>1424</lpage>.<pub-id pub-id-type="pmid">17898314</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/mol.107.040238</pub-id></mixed-citation></ref><ref id="R261"><label>261.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sun</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Ai</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>Y</given-names></name>, <etal/> (<year>2013</year>) <article-title>Selective induction of tumor cell apoptosis by a novel P450-mediated reactive oxygen species (ROS) inducer methyl 3-(4-nitrophenyl)propiolate</article-title>. <source>J Biol Chem</source><volume>288</volume>: <fpage>8826</fpage>&#8211;<lpage>8837</lpage>.<pub-id pub-id-type="pmid">23382387</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M112.429316</pub-id><pub-id pub-id-type="pmcid">PMC3610958</pub-id></mixed-citation></ref><ref id="R262"><label>262.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kadiiska</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>De Costa</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Mason</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Mathews</surname><given-names>JM</given-names></name> (<year>2000</year>) <article-title>Reduction of 1,3-diphenyl-1-triazene by rat hepatic microsomes, by cecal microflora, and in rats generates the phenyl radical metabolite: an ESR spin trapping investigation</article-title>. <source>Chem Res Toxicol</source><volume>13</volume>: <fpage>1082</fpage>&#8211;<lpage>1086</lpage>.<pub-id pub-id-type="pmid">11087429</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx000098v</pub-id></mixed-citation></ref><ref id="R263"><label>263.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ress</surname><given-names>NB</given-names></name> (<year>2002</year>) <article-title>NTP technical report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene.</article-title><source>Toxic Rep Ser</source><volume>73</volume>: <fpage>1</fpage>&#8211;<lpage>23</lpage>.<pub-id pub-id-type="pmid">12370695</pub-id></mixed-citation></ref><ref id="R264"><label>264.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dikalova</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Kadiiska</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Mason</surname><given-names>RP</given-names></name> (<year>2001</year>) <article-title>An in vivo ESR spin-trapping study: Free radical generation in rats from formate intoxication - role of the Fenton reaction</article-title>. <source>Proc Natl Acad Sci USA</source><volume>98</volume>: <fpage>13549</fpage>&#8211;<lpage>13553</lpage>.<pub-id pub-id-type="pmid">11717423</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.251091098</pub-id><pub-id pub-id-type="pmcid">PMC61078</pub-id></mixed-citation></ref><ref id="R265"><label>265.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Whelan</surname><given-names>HT</given-names></name>, <name name-style="western"><surname>Bajic</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Karlovits</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Houle</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Kindwall</surname><given-names>EP</given-names></name> (<year>1998</year>) <article-title>Use of cytochrome-P450 monooxygenase 2E1 isozyme inhibitors for delay seizures caused by central nervous system oxygen toxicity</article-title>. <source>Aviat Space Environ Med</source><volume>69</volume>: <fpage>480</fpage>&#8211;<lpage>485</lpage>.<pub-id pub-id-type="pmid">9591618</pub-id></mixed-citation></ref><ref id="R266"><label>266.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Muta</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fukami</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nakajima</surname><given-names>M</given-names></name> (<year>2015</year>) <article-title>A proposed mechanism for the adverse effects of acebutolol: CES2 and CYP2C19-mediated metabolism and antinuclear antibody production</article-title>. <source>Biochem Pharmacol</source><volume>98</volume>: <fpage>659</fpage>&#8211;<lpage>670</lpage>.<pub-id pub-id-type="pmid">26408002</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bcp.2015.09.016</pub-id></mixed-citation></ref><ref id="R267"><label>267.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shimizu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Atsumi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Itokawa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Iwasaki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Aoki</surname><given-names>T</given-names></name>, <etal/> (<year>2009</year>) <article-title>Metabolismdependent hepatotoxicity of amodiaquine in glutathione-depleted mice</article-title>. <source>Arch Toxicol</source><volume>83</volume>: <fpage>701</fpage>&#8211;<lpage>707</lpage>.<pub-id pub-id-type="pmid">19479240</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00204-009-0436-9</pub-id></mixed-citation></ref><ref id="R268"><label>268.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lillibridge</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Amore</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Slattery</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Kalhorn</surname><given-names>TF</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>SD</given-names></name>, <etal/> (<year>1996</year>) <article-title>Protein-reactive metabolites of carbamazepine in mouse liver microsomes</article-title>. <source>Drug Metab Dispos</source><volume>24</volume>: <fpage>509</fpage>&#8211;<lpage>514</lpage>.<pub-id pub-id-type="pmid">8723729</pub-id></mixed-citation></ref><ref id="R269"><label>269.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sanderson</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Farrell</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Drummond</surname><given-names>NS</given-names></name>, <name name-style="western"><surname>Hanson</surname><given-names>A</given-names></name>, <etal/> (<year>2006</year>) <article-title>Activation of T cells by carbamazepine and carbamazepine metabolites</article-title>. <source>J Allergy Clin Immunol</source><volume>118</volume>: <fpage>233</fpage>&#8211;<lpage>241</lpage>.<pub-id pub-id-type="pmid">16815161</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2006.03.005</pub-id></mixed-citation></ref><ref id="R270"><label>270.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>S</given-names></name>, <etal/> (<year>2016</year>) <article-title>The mechanism and risk factors of clopidogrel-induced liver injury</article-title>. <source>Drug Chem Toxicol</source><volume>39</volume>: <fpage>367</fpage>&#8211;<lpage>374</lpage>.<pub-id pub-id-type="pmid">26654298</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/01480545.2015.1122606</pub-id></mixed-citation></ref><ref id="R271"><label>271.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bumpus</surname><given-names>NN</given-names></name> (<year>2011</year>) <article-title>Efavirenz and 8-hydroxyefavirenz induce cell death via a JNK- and BimEL-dependent mechanism in primary human hepatocytes</article-title>. <source>Toxicol Appl Pharmacol</source><volume>257</volume>: <fpage>227</fpage>&#8211;<lpage>234</lpage>.<pub-id pub-id-type="pmid">21958719</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.taap.2011.09.008</pub-id></mixed-citation></ref><ref id="R272"><label>272.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shi</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Greenhaw</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Salminen</surname><given-names>WF</given-names></name> (<year>2011</year>) <article-title>Hepatic cytochrome P450s attenuate the cytotoxicity induced by leflunomide and its active metabolite A77 1726 in primary cultured rat hepatocytes</article-title>. <source>Toxicol Sci</source><volume>122</volume>: <fpage>579</fpage>&#8211;<lpage>586</lpage>.<pub-id pub-id-type="pmid">21546349</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kfr106</pub-id></mixed-citation></ref><ref id="R273"><label>273.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Seah</surname><given-names>QM</given-names></name>, <name name-style="western"><surname>New</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>ECY</given-names></name>, <name name-style="western"><surname>Boelsterli</surname><given-names>UA</given-names></name> (<year>2008</year>) <article-title>Oxidative bioactivation and toxicity of leflunomide in immortalized human hepatocytes and kinetics of the non-enzymatic conversion to its major metabolite, A77&#8211;1726</article-title>. <source>Drug Metab Lett</source><volume>2</volume>: <fpage>153</fpage>&#8211;<lpage>157</lpage>.<pub-id pub-id-type="pmid">19356086</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/187231208785425791</pub-id></mixed-citation></ref><ref id="R274"><label>274.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Graham</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Walsh</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Hirst</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Maggs</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>S</given-names></name>, <etal/> (<year>2008</year>) <article-title>Identification of the thiophene ring of methapyrilene as a novel bioactivationdependent hepatic toxicophore</article-title>. <source>J Pharmacol Exp Therap</source><volume>326</volume>: <fpage>657</fpage>&#8211;<lpage>671</lpage>.<pub-id pub-id-type="pmid">18451316</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/jpet.107.135483</pub-id></mixed-citation></ref><ref id="R275"><label>275.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Priestley</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Regan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>BK</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>DP</given-names></name> (<year>2011</year>) <article-title>The genotoxic potential of methapyrilene using the alkaline Comet assay in vitro and in vivo</article-title>. <source>Toxicology</source><volume>290</volume>: <fpage>249</fpage>&#8211;<lpage>257</lpage>.<pub-id pub-id-type="pmid">22015589</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tox.2011.10.002</pub-id></mixed-citation></ref><ref id="R276"><label>276.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shimizu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Atsumi</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Nakazawa</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Izumi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sudo</surname><given-names>K</given-names></name>, <etal/> (<year>2011</year>) <article-title>Ticlopidineinduced hepatotoxicity in a GSH-depleted rat model</article-title>. <source>Arch Toxicol</source><volume>85</volume>: <fpage>347</fpage>&#8211;<lpage>353</lpage>.<pub-id pub-id-type="pmid">20871981</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00204-010-0594-9</pub-id></mixed-citation></ref><ref id="R277"><label>277.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Li</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Uzgare</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yumiko</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Laforge</surname><given-names>YS</given-names></name> (<year>2012</year>) <article-title>Definition of metabolismdependent xenobiotic toxicity with co-cultures of human hepatocytes and mouse 3T3 fibroblasts in the novel integrated discrete multiple organ coculture (IdMOC) experimental system: results with model toxicants aflatoxin B1</article-title>. <source>Chem Biol Interact</source><volume>199</volume>: <fpage>1</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">22640811</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cbi.2012.05.003</pub-id></mixed-citation></ref><ref id="R278"><label>278.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Li</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Jiao</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name> (<year>2012</year>) <article-title>Metabolic detoxification of bakuchiol is mediated by cytochrome P450 enzymes in human liver microsomes</article-title>. <source>Beijing Da Xue Xue Bao</source><volume>44</volume>: <fpage>431</fpage>&#8211;<lpage>436</lpage>.<pub-id pub-id-type="pmid">22692316</pub-id></mixed-citation></ref><ref id="R279"><label>279.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Reilly</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Ehlhardt</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Jackson</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Kulanthaivel</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Mutlib</surname><given-names>AE</given-names></name>, <etal/> (<year>2003</year>) <article-title>Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells</article-title>. <source>Chem Res Toxicol</source><volume>16</volume>: <fpage>336</fpage>&#8211;<lpage>349</lpage>.<pub-id pub-id-type="pmid">12641434</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx025599q</pub-id></mixed-citation></ref><ref id="R280"><label>280.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yeh</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>SH</given-names></name> (<year>2006</year>) <article-title>Effects of quercetin on beta-apo-8&#8217;-carotenal-induced DNA damage and cytochrome P1A2 expression in A549 cells</article-title>. <source>Chem Biol Interact</source><volume>163</volume>: <fpage>199</fpage>&#8211;<lpage>206</lpage>.<pub-id pub-id-type="pmid">16970932</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cbi.2006.08.002</pub-id></mixed-citation></ref><ref id="R281"><label>281.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Beier</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Norman</surname><given-names>JO</given-names></name>, <name name-style="western"><surname>Irvin</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Witzel</surname><given-names>DA</given-names></name> (<year>1987</year>) <article-title>Microsomal activation of constituents of white snakeroot (Eupatorium rugosum Houtt) to form toxic products</article-title>. <source>Am J Vet Res</source><volume>48</volume>: <fpage>583</fpage>&#8211;<lpage>585</lpage>.<pub-id pub-id-type="pmid">3592355</pub-id></mixed-citation></ref><ref id="R282"><label>282.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Marczylo</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ioannides</surname><given-names>C</given-names></name> (<year>1999</year>) <article-title>Evidence for the presence of a microsomal NADH-dependent enzyme system that can bioactivate aromatic amines in the liver of rats and mice</article-title>. <source>Toxicology</source><volume>134</volume>: <fpage>127</fpage>&#8211;<lpage>141</lpage>.<pub-id pub-id-type="pmid">10403632</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0300-483x(99)00034-7</pub-id></mixed-citation></ref><ref id="R283"><label>283.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jiang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name> (<year>2014</year>) <article-title>Human CYP2E1-dependent and human sulfotransferase 1A1-modulated induction of micronuclei by benzene and its hydroxylated metabolites in Chinese hamster V79-derived cells</article-title>. <source>Mutat Res</source><volume>770</volume>: <fpage>37</fpage>&#8211;<lpage>44</lpage>.<pub-id pub-id-type="pmid">25771868</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mrfmmm.2014.09.008</pub-id></mixed-citation></ref><ref id="R284"><label>284.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bolton</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>JA</given-names></name> (<year>1991</year>) <article-title>Oxidation of butylated hydroxytoluene to toxic metabolites. Factors influencing hydroxylation and quinone methide formation by hepatic and pulmonary microsomes</article-title>. <source>Drug Metab Dispos</source><volume>19</volume>: <fpage>467</fpage>&#8211;<lpage>472</lpage>.<pub-id pub-id-type="pmid">1676656</pub-id></mixed-citation></ref><ref id="R285"><label>285.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>van Ravenzwaay</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Gamer</surname><given-names>AO</given-names></name>, <name name-style="western"><surname>Leibold</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kaufmann</surname><given-names>W</given-names></name> (<year>2003</year>) <article-title>Effect of cytochrome P450 inhibition of tetrahydrofuran-induced hepatocellular proliferation in female mice</article-title>. <source>Arch Toxicol</source><volume>77</volume>: <fpage>459</fpage>&#8211;<lpage>464</lpage>.<pub-id pub-id-type="pmid">12802580</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00204-003-0474-7</pub-id></mixed-citation></ref><ref id="R286"><label>286.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mann</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Matulka</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Hahn</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Trombino</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Lawrence</surname><given-names>BP</given-names></name>, <etal/> (<year>1999</year>) <article-title>The role of polycyclic aromatic hydrocarbon metabolism in dimethylbenz[a] anthracene-induced pre-B lymphocyte apoptosis</article-title>. <source>Toxicol Appl Pharmacol</source><volume>161</volume>: <fpage>10</fpage>&#8211;<lpage>22</lpage>.<pub-id pub-id-type="pmid">10558919</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/taap.1999.8778</pub-id></mixed-citation></ref><ref id="R287"><label>287.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Glatt</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>Q</given-names></name>, <etal/> (<year>2016</year>) <article-title>Human CYP2E1-dependent mutagenicity of mono- and dichlorobiphenyls in Chinese hamster (V79(-derived cells</article-title>. <source>Chemosphere</source><volume>144</volume>: <fpage>1908</fpage>&#8211;<lpage>1915</lpage>.<pub-id pub-id-type="pmid">26547025</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chemosphere.2015.10.083</pub-id></mixed-citation></ref><ref id="R288"><label>288.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nyarko</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Kellner-Weibel</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Harvison</surname><given-names>PJ</given-names></name> (<year>1997</year>) <article-title>Cytochrome P450mediated metabolism and nephrotoxicity of N-(3,5-dichlorophenyl) succinimide in Fischer 344 rats</article-title>. <source>Fundam Appl Toxicol</source><volume>37</volume>: <fpage>117</fpage>&#8211;<lpage>124</lpage>.<pub-id pub-id-type="pmid">9242584</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/faat.1997.2321</pub-id></mixed-citation></ref><ref id="R289"><label>289.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Henesey</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Harvison</surname><given-names>PJ</given-names></name> (<year>2002</year>) <article-title>Renal damage, metabolism and covalent binding following administration of the nephrotoxicant N-(3,5-dichlorophenyl) succinimide to male Fischer 344 rats</article-title>. <source>Toxicology</source><volume>170</volume>: <fpage>187</fpage>&#8211;<lpage>200</lpage>.<pub-id pub-id-type="pmid">11788156</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0300-483x(01)00543-1</pub-id></mixed-citation></ref><ref id="R290"><label>290.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Crincoli</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>NN</given-names></name>, <name name-style="western"><surname>Tchao</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Harvison</surname><given-names>PJ</given-names></name> (<year>2008</year>) <article-title>Role of biotransformation in 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity</article-title>. <source>Toxicology</source><volume>250</volume>: <fpage>100</fpage>&#8211;<lpage>108</lpage>.<pub-id pub-id-type="pmid">18621092</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tox.2008.06.006</pub-id><pub-id pub-id-type="pmcid">PMC2570351</pub-id></mixed-citation></ref><ref id="R291"><label>291.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Deng</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name> (<year>2011</year>) <article-title>Biotransformation enzyme-dependent formation of micronucleus and multinuclei in cell line V79-hCYP2E1-hSULT1A1 by 2-nitropropane and N-nitrosodimethylamine</article-title>. <source>Mutat Res</source><volume>726</volume>: <fpage>84</fpage>&#8211;<lpage>87</lpage>.<pub-id pub-id-type="pmid">21903177</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mrgentox.2011.08.001</pub-id></mixed-citation></ref><ref id="R292"><label>292.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yeh</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>WY</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>ML</given-names></name> (<year>2006</year>) <article-title>Flavonoids suppress the enhancing effect of beta-carotene on DNA damage induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A549 cells</article-title>. <source>Chem Biol Interact</source><volume>160</volume>: <fpage>175</fpage>&#8211;<lpage>182</lpage>.<pub-id pub-id-type="pmid">16497287</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cbi.2006.01.006</pub-id></mixed-citation></ref><ref id="R293"><label>293.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>King</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Kohan</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Brooks</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>GB</given-names></name>, <name name-style="western"><surname>Ross</surname><given-names>JA</given-names></name>, <etal/> (<year>2001</year>) <article-title>An evaluation of the mutagenicity, metabolism, and DNA adduct formation of 5-nitrobenzo[b]naptho[2,1-d]thiophenes</article-title>. <source>Chem Res Toxicol</source><volume>14</volume>: <fpage>661</fpage>&#8211;<lpage>671</lpage>.<pub-id pub-id-type="pmid">11409936</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx0001373</pub-id></mixed-citation></ref><ref id="R294"><label>294.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Flint</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Gupta</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Westhouse</surname><given-names>RA</given-names></name>, <etal/> (<year>2012</year>) <article-title>Cytochrome P450 11A1 bioactivation of a kinase inhibitor in rats: use of radioprofiling, modulation of metabolism, and adrenocortical cell lines to evaluate adrenal toxicity</article-title>. <source>Chem Res Toxicol</source><volume>25</volume>: <fpage>556</fpage>&#8211;<lpage>571</lpage>.<pub-id pub-id-type="pmid">22295996</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx200524d</pub-id></mixed-citation></ref><ref id="R295"><label>295.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jackson</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Birnbaum</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Diliberto</surname><given-names>JJ</given-names></name> (<year>1998</year>) <article-title>Effects of age, sex, and pharmacologic agents on the biliary elimination of 2,3,7,8-tetrachlorodibenzop-dioxin (TCDD) in F344 rats</article-title>. <source>Drug Metab Dispos</source><volume>26</volume>: <fpage>714</fpage>&#8211;<lpage>719</lpage>.<pub-id pub-id-type="pmid">9660856</pub-id></mixed-citation></ref><ref id="R296"><label>296.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Vyas</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Roychowdhury</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>FD</given-names></name>, <name name-style="western"><surname>Prinsinzano</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Lamba</surname><given-names>J</given-names></name>, <etal/> (<year>2006</year>) <article-title>Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: I. Expression and role of cytochrome P450s</article-title>. <source>J Pharm Exp Therap</source><volume>319</volume>: <fpage>488</fpage>&#8211;<lpage>496</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/jpet.106.105858</pub-id><pub-id pub-id-type="pmid">16857728</pub-id></mixed-citation></ref><ref id="R297"><label>297.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Aloysius</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>VW</given-names></name>, <name name-style="western"><surname>Yabut</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bradley</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Shang</surname><given-names>J</given-names></name>, <etal/> (<year>2012</year>) <article-title>Metabolic activation and major protein target of a 1-benzyl-carboxyazetidine sphigosine1-phosphate-1 receptor agonist</article-title>. <source>Chem Res Toxicol</source><volume>25</volume>: <fpage>1412</fpage>&#8211;<lpage>1422</lpage>.<pub-id pub-id-type="pmid">22765480</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx300017s</pub-id></mixed-citation></ref><ref id="R298"><label>298.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhou</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zhong</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X</given-names></name> (<year>2015</year>) <article-title>Chemical and enzymatic transformations of nimesulide to GSH conjugates through reductive and oxidative mechanisms</article-title>. <source>Chem Res Toxicol</source><volume>28</volume>: <fpage>2267</fpage>&#8211;<lpage>2277</lpage>.<pub-id pub-id-type="pmid">26524229</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.chemrestox.5b00290</pub-id></mixed-citation></ref><ref id="R299"><label>299.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shao</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ring</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Tarloff</surname><given-names>JB</given-names></name> (<year>1997</year>) <article-title>Coincubation of rat renal proximal tubules with hepatic subcellular fractions potentiates the effects of paraaminophenol</article-title>. <source>Fundam. Appl Toxicol</source><volume>39</volume>: <fpage>101</fpage>&#8211;<lpage>108</lpage>.<pub-id pub-id-type="pmid">9344622</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/faat.1997.2364</pub-id></mixed-citation></ref><ref id="R300"><label>300.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dierickx</surname><given-names>PJ</given-names></name> (<year>1999</year>) <article-title>CYP1/2 activation and glutathione-dependent cytotoxicity of four pesticides in Hep G2 and Fa32 cells</article-title>. <source>Toxicol in Vitro</source><volume>13</volume>: <fpage>779</fpage>&#8211;<lpage>783</lpage>.<pub-id pub-id-type="pmid">20654549</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0887-2333(99)00045-4</pub-id></mixed-citation></ref><ref id="R301"><label>301.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sala&#252;n</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Simon</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Durst</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Reich</surname><given-names>NO</given-names></name>, <name name-style="western"><surname>Ortiz de Montellano</surname><given-names>PR</given-names></name> (<year>1988</year>) <article-title>Differential inactivation of plant lauric acid omega- and in-chain hydroxylases by terminally unsaturated fatty acids</article-title>. <source>Arch Biochem Biophys</source><volume>260</volume>: <fpage>540</fpage>&#8211;<lpage>545</lpage>.<pub-id pub-id-type="pmid">3341756</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0003-9861(88)90479-1</pub-id></mixed-citation></ref><ref id="R302"><label>302.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Pflugmacher</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sandermann</surname><given-names>H</given-names><suffix>Jr</suffix></name> (<year>1998</year>) <article-title>Cytochrome P450 monooxygenases for fatty acids and xenobiotics in marine macroalgae</article-title>. <source>Plant Physiol</source><volume>117</volume>: <fpage>123</fpage>&#8211;<lpage>128</lpage>.<pub-id pub-id-type="pmid">9576781</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1104/pp.117.1.123</pub-id><pub-id pub-id-type="pmcid">PMC34995</pub-id></mixed-citation></ref><ref id="R303"><label>303.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Menting</surname><given-names>JGT</given-names></name>, <name name-style="western"><surname>Scopes</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Stevenson</surname><given-names>TW</given-names></name> (<year>1994</year>) <article-title>Characterization of flavonoid 3&#8217;,5&#8217;-hydroxylase in microsomal membrane fraction of petunia hybrida flowers</article-title>. <source>Plant Physiol</source><volume>106</volume>: <fpage>633</fpage>&#8211;<lpage>642</lpage>.<pub-id pub-id-type="pmid">12232356</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1104/pp.106.2.633</pub-id><pub-id pub-id-type="pmcid">PMC159570</pub-id></mixed-citation></ref><ref id="R304"><label>304.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Aghofack-Nguemezi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fuchs</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Yeh</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Hoffmann</surname><given-names>T</given-names></name>, <etal/> (<year>2011</year>) <article-title>An oxygenase inhibitor study in Solanum lycopersicum combined with metabolite profiling analysis revealed a potent peroxygenase inactivator</article-title>. <source>J Exp Bot</source><volume>62</volume>: <fpage>1313</fpage>&#8211;<lpage>1323</lpage>.<pub-id pub-id-type="pmid">21115664</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jxb/erq368</pub-id></mixed-citation></ref><ref id="R305"><label>305.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Morgan</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Shanks</surname><given-names>JV</given-names></name> (<year>1999</year>) <article-title>Inhibitor studies of tabersonine metabolism in C. roseus hairy roots</article-title>. <source>Phytochemistry</source><volume>51</volume>: <fpage>61</fpage>&#8211;<lpage>68</lpage>.<pub-id pub-id-type="pmid">10349729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0031-9422(98)00585-8</pub-id></mixed-citation></ref><ref id="R306"><label>306.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Werck-Reichhart</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gabriac</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Teutsch</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Durst</surname><given-names>F</given-names></name> (<year>1990</year>) <article-title>Two cytochrome P450 isoforms catalyzing O-de-ethylation of ethoxycoumarin and ethoxyresorufin in higher plants</article-title>. <source>Biochem J</source><volume>270</volume>: <fpage>729</fpage>&#8211;<lpage>735</lpage>.<pub-id pub-id-type="pmid">2241905</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/bj2700729</pub-id><pub-id pub-id-type="pmcid">PMC1131792</pub-id></mixed-citation></ref><ref id="R307"><label>307.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cabanne</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Huby</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gaillardon</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Scalla</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Durst</surname><given-names>F</given-names></name> (<year>1987</year>) <article-title>Effect of the cytochrome P450 inactivator 1-aminobenzotriazole on the metabolism of chlortoluron and isoproturon in wheat</article-title>. <source>Pest Biochem Physiol</source><volume>28</volume>: <fpage>371</fpage>&#8211;<lpage>380</lpage>.</mixed-citation></ref><ref id="R308"><label>308.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>McFadden</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Frear</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Mansager</surname><given-names>ER</given-names></name> (<year>1989</year>) <article-title>Aryl hydroxylation of diclofop by a cytochrome P450 dependent monooxygenase from wheat</article-title>. <source>Pest Biochem Physiol</source><volume>34</volume>: <fpage>92</fpage>&#8211;<lpage>100</lpage>.</mixed-citation></ref><ref id="R309"><label>309.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sterling</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Balke</surname><given-names>NE</given-names></name> (<year>1990</year>) <article-title>Bentazon uptake and metabolism by cultured plant cells in the presence of monooxygenase inhibitors and cinnamic acid</article-title>. <source>Pest Biochem Physiol</source><volume>38</volume>: <fpage>66</fpage>&#8211;<lpage>75</lpage>.</mixed-citation></ref><ref id="R310"><label>310.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gronwald</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Connelly</surname><given-names>JA</given-names></name> (<year>1991</year>) <article-title>Effect of monooxygenase inhibitors on bentazon uptake and metabolism in maize cell suspension cultures</article-title>. <source>Pest Biochem Physiol</source><volume>40</volume>: <fpage>284</fpage>&#8211;<lpage>294</lpage>.</mixed-citation></ref><ref id="R311"><label>311.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Letouz&#233;</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gasquez</surname><given-names>J</given-names></name> (<year>2003</year>) <article-title>Enhanced activity of several herbicidedegrading enzymes; a suggested mechanism responsible for multiple resistance in blackgrass (Aloecurus myosuroides Huds.)</article-title>. <source>Agronomie</source><volume>23</volume>: <fpage>601</fpage>&#8211;<lpage>608</lpage>.</mixed-citation></ref><ref id="R312"><label>312.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Moreland</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Corbin</surname><given-names>FT</given-names></name>, <name name-style="western"><surname>McFarland</surname><given-names>JE</given-names></name> (<year>1993</year>) <article-title>Effects of safeners on the oxidation of multiple substrates by grain sorghum microsomes</article-title>. <source>Pest Biochem Physiol</source><volume>45</volume>: <fpage>43</fpage>&#8211;<lpage>53</lpage>.</mixed-citation></ref><ref id="R313"><label>313.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Aper</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mechant</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Rubin</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Heyerick</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Callebaut</surname><given-names>G</given-names></name>, <etal/> (<year>2012</year>) <article-title>Absorption, translocation and metabolism of metamitron in Chenopodium album</article-title>. <source>Pest Manag Sci</source><volume>68</volume>: <fpage>209</fpage>&#8211;<lpage>216</lpage>.<pub-id pub-id-type="pmid">21800410</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ps.2246</pub-id></mixed-citation></ref><ref id="R314"><label>314.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Elmore</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Brosnan</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Armel</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Kopsell</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Best</surname><given-names>MD</given-names></name>, <etal/> (<year>2015</year>) <article-title>Cytochrome P450 inhibitors reduce creeping bentgrass (Agrostis stolonifera) tolerance to topramezone</article-title>. <source>Plos One</source><volume>10</volume>: <fpage>e0130947</fpage>.<pub-id pub-id-type="pmid">26186714</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0130947</pub-id><pub-id pub-id-type="pmcid">PMC4506071</pub-id></mixed-citation></ref><ref id="R315"><label>315.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhai</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lehmler</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Schnoor</surname><given-names>JL</given-names></name> (<year>2013</year>) <article-title>Inhibition of cytochromes P450 and the hydroxylation of 4-monochlorobiphenyl in whole poplar</article-title>. <source>Environ Sci Technol</source><volume>47</volume>: <fpage>29</fpage>&#8211;<lpage>35</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/es304298m</pub-id><pub-id pub-id-type="pmcid">PMC3652898</pub-id><pub-id pub-id-type="pmid">23320482</pub-id></mixed-citation></ref><ref id="R316"><label>316.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Miranda</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Henderson</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Buhler</surname><given-names>DR</given-names></name> (<year>1998</year>) <article-title>Evaluation of chemicals as inhibitors of trout cytochrome P450s</article-title>. <source>Toxicol App Pharmacol</source><volume>148</volume>: <fpage>237</fpage>&#8211;<lpage>244</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/taap.1997.8341</pub-id><pub-id pub-id-type="pmid">9473531</pub-id></mixed-citation></ref><ref id="R317"><label>317.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hamm</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>BW</given-names></name>, <name name-style="western"><surname>Hinton</surname><given-names>DE</given-names></name> (<year>2001</year>) <article-title>Increasing uptake and bioactivation with development positively modulate diazinon toxicity in early life stage medaka (Oryzias latipes)</article-title>. <source>Toxicol Sci</source><volume>61</volume>: <fpage>304</fpage>&#8211;<lpage>313</lpage>.<pub-id pub-id-type="pmid">11353139</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/61.2.304</pub-id></mixed-citation></ref><ref id="R318"><label>318.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cashman</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Olsen</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Bern</surname><given-names>H</given-names></name> (<year>1989</year>) <article-title>S-oxygenation of eptam in hepatic microsomes from fresh- and salt-water striped bass (Morone saxatilis)</article-title>. <source>Chem Res Toxicol</source><volume>2</volume>: <fpage>392</fpage>&#8211;<lpage>399</lpage>.<pub-id pub-id-type="pmid">2519729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/tx00012a007</pub-id></mixed-citation></ref><ref id="R319"><label>319.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wang</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>XX</given-names></name>, <name name-style="western"><surname>Meng</surname><given-names>QM</given-names></name>, <name name-style="western"><surname>Muhammad</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>RR</given-names></name>, <etal/> (<year>2013</year>) <article-title>The involvement of several enzymes in methanol detoxification in Drosophila melanogaster adults</article-title>. <source>Comp Biochem Physiol B Biochem Mol Biol</source><volume>166</volume>: <fpage>7</fpage>&#8211;<lpage>14</lpage>.<pub-id pub-id-type="pmid">23751173</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cbpb.2013.05.008</pub-id></mixed-citation></ref><ref id="R320"><label>320.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mathies</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Buchenauer</surname><given-names>H</given-names></name> (<year>1999</year>) <article-title>Interference of selected fungicides, plant growth retardants as well as piperonyl butoxide and 1-aminobenzotriazole in trichothecene production of Fusarium graminearum (strain 4528) in vitro</article-title>. <source>J Plant Dis Protect</source><volume>106</volume>: <fpage>198</fpage>&#8211;<lpage>212</lpage>.</mixed-citation></ref><ref id="R321"><label>321.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ishikawa</surname><given-names>NK</given-names></name>, <name name-style="western"><surname>Tahara</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Namatame</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Farooq</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fukushi</surname><given-names>Y</given-names></name> (<year>2013</year>) <article-title>Use of cytochrome P450 inhibitors in studies of enokipodin biosynthesis</article-title>. <source>Brazil J Microbiol</source><volume>44</volume>: <fpage>1285</fpage>&#8211;<lpage>1290</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/s1517-83822013000400037</pub-id><pub-id pub-id-type="pmcid">PMC3958200</pub-id><pub-id pub-id-type="pmid">24688524</pub-id></mixed-citation></ref><ref id="R322"><label>322.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Thompson</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Marriott</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Dowle</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Grogan</surname><given-names>G</given-names></name> (<year>2010</year>) <article-title>Biotransformation of beta-myrcene to geraniol by a strain of Rhodococcus erythropolis isolated by selective enrichment from hop plants</article-title>. <source>Appl Microbiol Biotechnol</source><volume>85</volume>: <fpage>721</fpage>&#8211;<lpage>730</lpage>.<pub-id pub-id-type="pmid">19707757</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00253-009-2182-6</pub-id></mixed-citation></ref><ref id="R323"><label>323.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mori</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kondo</surname><given-names>R</given-names></name> (<year>2002</year>) <article-title>Oxidation of dibenzo-p-dioxin, dibenzofuran, biphenyl, and diphenyl ether by the white-rot fungus Phlebia lindtneri</article-title>. <source>Appl Microbiol Biotechnol</source><volume>60</volume>: <fpage>200</fpage>&#8211;<lpage>205</lpage>.<pub-id pub-id-type="pmid">12382064</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00253-002-1090-9</pub-id></mixed-citation></ref><ref id="R324"><label>324.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mori</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kitano</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kondo</surname><given-names>R</given-names></name> (<year>2003</year>) <article-title>Biodegradation of chloronaphthalenes and polycyclic aromatic hydrocarbons by the white-rot fungus Phlebia lindtneri</article-title>. <source>Appl Microbiol Biotechnol</source><volume>61</volume>: <fpage>380</fpage>&#8211;<lpage>383</lpage>.<pub-id pub-id-type="pmid">12743769</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00253-003-1253-3</pub-id></mixed-citation></ref><ref id="R325"><label>325.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hata</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kawai</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Okamura</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Nishida</surname><given-names>T</given-names></name> (<year>2010</year>) <article-title>Removal of diclofenac and mefenamic acid by the white rot fungus Phanerochaete sordida YK-624 and identification of their metabolites after fungal transformation</article-title>. <source>Biodegradation</source><volume>21</volume>: <fpage>681</fpage>&#8211;<lpage>689</lpage>.<pub-id pub-id-type="pmid">20127144</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10532-010-9334-3</pub-id></mixed-citation></ref><ref id="R326"><label>326.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Marco-Urrea</surname><given-names>E</given-names></name>, <name name-style="western"><surname>P&#233;rez-Trujillo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cruz-Morat&#243;</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Caminal</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Vicent</surname><given-names>T</given-names></name> (<year>2010</year>) <article-title>White-rot fungus-mediated degradation of the analgesic ketoprofen and identification of intermediates by HPLC-DAD-MS and NMR</article-title>. <source>Chemosphere</source><volume>78</volume>: <fpage>478</fpage>&#8211;<lpage>481</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chemosphere.2009.10.009</pub-id><pub-id pub-id-type="pmid">19913277</pub-id></mixed-citation></ref><ref id="R327"><label>327.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Prieto</surname><given-names>A</given-names></name>, <name name-style="western"><surname>M&#246;der</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rodil</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Adrian</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Marco-Urrea</surname><given-names>E</given-names></name> (<year>2011</year>) <article-title>Degradation of the antibiotics norfloxacin and ciprofloxacin by a white-rot fungus and identification of degradation products</article-title>. <source>Bioresour.Technol</source><volume>102</volume>: <fpage>10987</fpage>&#8211;<lpage>10995</lpage>.<pub-id pub-id-type="pmid">21937221</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biortech.2011.08.055</pub-id></mixed-citation></ref><ref id="R328"><label>328.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>da Silva Celho-Moreira</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bracht</surname><given-names>A</given-names></name>, <name name-style="western"><surname>da Silva de Souza</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Oliveira</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>Babeto de S&#225;-Nakanishi</surname><given-names>A</given-names></name>, <etal/> (<year>2013</year>) <article-title>Degradation of diuron by Phanerochaete chrysosporium: role of ligninolytic enzymes and cytochrome P450</article-title>. <source>BioMed Res Internat</source><volume>2013</volume>: <fpage>1</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2013/251354</pub-id><pub-id pub-id-type="pmcid">PMC3892757</pub-id><pub-id pub-id-type="pmid">24490150</pub-id></mixed-citation></ref><ref id="R329"><label>329.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Van Damme</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Dettman</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gray</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Pickard</surname><given-names>MA</given-names></name> (<year>2003</year>) <article-title>Dibenzyl sulfide metabolism by white rot fungi</article-title>. <source>Appl Environ Microbiol</source><volume>69</volume>: <fpage>1320</fpage>&#8211;<lpage>1324</lpage>.<pub-id pub-id-type="pmid">12571066</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AEM.69.2.1320-1324.2003</pub-id><pub-id pub-id-type="pmcid">PMC143626</pub-id></mixed-citation></ref><ref id="R330"><label>330.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kanaly</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Hur</surname><given-names>HG</given-names></name> (<year>2006</year>) <article-title>Growth of Phanerochaete chrysosporium on diesel fuel hydrocarbons at neutral pH</article-title>. <source>Chemosphere</source><volume>63</volume>: <fpage>202</fpage>&#8211;<lpage>211</lpage>.<pub-id pub-id-type="pmid">16226785</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chemosphere.2005.08.022</pub-id></mixed-citation></ref><ref id="R331"><label>331.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Marco-Urrea</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Parella</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Gabarrell</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Caminal</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Vicent</surname><given-names>T</given-names></name>, <etal/> (<year>2008</year>) <article-title>Mechanistics of trichloroethylene mineralization by the white-rot fungus Trametes versicolor</article-title>. <source>Chemosphere</source><volume>70</volume>: <fpage>404</fpage>&#8211;<lpage>410</lpage>.<pub-id pub-id-type="pmid">17697698</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chemosphere.2007.06.074</pub-id></mixed-citation></ref><ref id="R332"><label>332.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Marco-Urrea E P&#233;rez-Trujillo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Caminal</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Vicent</surname><given-names>T</given-names></name> (<year>2009</year>) <article-title>Dechlorination of 1,2,3- and 1,2,4-trichlorobenzene by the white-rot fungus Trametes versicolor</article-title>. <source>J Hazard Mater</source><volume>166</volume>: <fpage>1141</fpage>&#8211;<lpage>1147</lpage>.<pub-id pub-id-type="pmid">19179004</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhazmat.2008.12.076</pub-id></mixed-citation></ref><ref id="R333"><label>333.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Marco-Urrea</surname><given-names>E</given-names></name>, <name name-style="western"><surname>P&#233;rez-Trujillo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Vicent</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Caminal</surname><given-names>G</given-names></name> (<year>2009</year>) <article-title>Ability of whiterot fungi to remove selected pharmaceuticals and identification of degradation products of ibuprofen by Trametes versicolor</article-title>. <source>Chemosphere</source><volume>74</volume>: <fpage>765</fpage>&#8211;<lpage>772</lpage>.<pub-id pub-id-type="pmid">19062071</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chemosphere.2008.10.040</pub-id></mixed-citation></ref><ref id="R334"><label>334.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Marco-Urrea</surname><given-names>E</given-names></name>, <name name-style="western"><surname>P&#233;rez-Trujillo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bl&#225;nquez</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Vicent</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Caminal</surname><given-names>G</given-names></name> (<year>2010</year>) <article-title>Biodegradation of the analgesic naproxen by Trametes versicolor and identification of intermediates using HPLC-DAD-MS and NMR</article-title>. <source>Bioresour Technol</source><volume>101</volume>: <fpage>2159</fpage>&#8211;<lpage>2166</lpage>.<pub-id pub-id-type="pmid">20004093</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biortech.2009.11.019</pub-id></mixed-citation></ref><ref id="R335"><label>335.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Marco-Urrea</surname><given-names>E</given-names></name>, <name name-style="western"><surname>P&#233;rez-Trujillo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Criuz-Morat&#243;</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Caminal</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Vicent</surname><given-names>T</given-names></name> (<year>2010</year>) <article-title>Degradation of the drug sodium diclofenac by Trametes versicolor pellets and identification of some intermediates by NMR</article-title>. <source>J Hazard Mater</source><volume>176</volume>: <fpage>836</fpage>&#8211;<lpage>842</lpage>.<pub-id pub-id-type="pmid">20031320</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhazmat.2009.11.112</pub-id></mixed-citation></ref><ref id="R336"><label>336.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bezalel</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hadar</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Cerniglia</surname><given-names>CE</given-names></name> (<year>1997</year>) <article-title>Enzymatic mechanisms involved in phenanthrene degradation by the white rot fungus Pleurotus ostreatus</article-title>. <source>Appl Environ Microbiol</source><volume>63</volume>: <fpage>2495</fpage>&#8211;<lpage>2501</lpage>.<pub-id pub-id-type="pmid">16535634</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/aem.63.7.2495-2501.1997</pub-id><pub-id pub-id-type="pmcid">PMC1389189</pub-id></mixed-citation></ref><ref id="R337"><label>337.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lisowska</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Diugonski</surname><given-names>J</given-names></name> (<year>2003</year>) <article-title>Concurrent corticosteroid and phenanthrene transformation by filamentous fungus Cunninghamella elegans</article-title>. <source>J Steroid Biochem Mol Biol</source><volume>85</volume>: <fpage>63</fpage>&#8211;<lpage>69</lpage>.<pub-id pub-id-type="pmid">12798358</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0960-0760(03)00136-5</pub-id></mixed-citation></ref><ref id="R338"><label>338.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Schlenk</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Bevers</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Vertino</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Cerniglia</surname><given-names>CE</given-names></name> (<year>1994</year>) <article-title>P450 catalyzed S-oxidation of dibenzothiophene by Cunninghamella elegans</article-title>. <source>Xenobiotica</source><volume>24</volume>: <fpage>1077</fpage>&#8211;<lpage>1083</lpage>.<pub-id pub-id-type="pmid">7701849</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/00498259409038667</pub-id></mixed-citation></ref><ref id="R339"><label>339.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>FE</given-names></name>, <name name-style="western"><surname>Freeman</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Duhart</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Cerniglia</surname><given-names>CE</given-names></name> (<year>1995</year>) <article-title>Biotransformation of amitriptyline by Cunninghamella elegans</article-title>. <source>Drug Metab Disp</source><volume>23</volume>: <fpage>1417</fpage>&#8211;<lpage>1425</lpage>.<pub-id pub-id-type="pmid">8689954</pub-id></mixed-citation></ref><ref id="R340"><label>340.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Holland</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Nava</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Zabic</surname><given-names>M</given-names></name> (<year>1999</year>) <article-title>A new paradigm for biohydroxylation by Beauveria bassiana ATCC 7159</article-title>. <source>Tetrahedron</source><volume>55</volume>: <fpage>7441</fpage>&#8211;<lpage>7460</lpage>.</mixed-citation></ref><ref id="R341"><label>341.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Mitsukura</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kondo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nagasawa</surname><given-names>T</given-names></name> (<year>2006</year>) <article-title>Regioselective hydroxylation of adamantane by Streptomyces griseoplanus cells</article-title>. <source>Appl Microbiol Biotechnol</source><volume>71</volume>: <fpage>502</fpage>&#8211;<lpage>504</lpage>.<pub-id pub-id-type="pmid">16187097</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00253-005-0167-7</pub-id></mixed-citation></ref><ref id="R342"><label>342.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Rappert</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kokova</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Antholz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nagorny</surname><given-names>S</given-names></name>, <etal/> (<year>2007</year>) <article-title>Degradation of 2,5-dimethylpyrazine by Rhodococcus erythropolis strain DP-45 isolated from a waste gas treatment plant of a fishmeal processing company</article-title>. <source>Biodegradation</source><volume>18</volume>: <fpage>585</fpage>&#8211;<lpage>596</lpage>.<pub-id pub-id-type="pmid">17120096</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10532-006-9091-5</pub-id></mixed-citation></ref><ref id="R343"><label>343.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hong</surname><given-names>CY</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>SM</given-names></name>, <etal/> (<year>2013</year>) <article-title>Involvement of extracellular and intracellular enzymes of Ceriporia sp. ZLY-2010 for biodegradation of polychlorinated biphenyls (PCBs)</article-title>. <source>J Environ Sci Health A Tox Hazard Subst Environ Eng</source><volume>48</volume>: <fpage>1280</fpage>&#8211;<lpage>1291</lpage>.<pub-id pub-id-type="pmid">23647119</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/10934529.2013.777242</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1:</label><caption><p id="P92">Oxidation of 1-ABT (compound <bold>1</bold>) produces benzyne, which can be chemically trapped to give 1,2,3,4-tetraphenylnaphthalene.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0001.jpg"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2:</label><caption><p id="P93">Heme adduct formed by reaction of the heme of cytochrome P450 with autocatalytically activated 1-ABT. The peripheral substituents on the porphyrin are only shown schematically, as isomeric structures that differ in the pattern of peripheral substitution are possible.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0002.jpg"/></fig><fig id="F3" orientation="portrait" position="float"><label>Figure 3:</label><caption><p id="P94">Two possible mechanisms for the P450-catalyzed oxidation of 1-ABT to benzyne, where [Por<sup>+</sup>.Fe(IV)=O] stands for the activated iron oxo species of cytochrome P450.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0003.jpg"/></fig><fig id="F4" orientation="portrait" position="float"><label>Figure 4:</label><caption><p id="P95">Metabolites of 1-ABT formed <italic toggle="yes">in vivo</italic> in rats.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0004.jpg"/></fig><fig id="F5" orientation="portrait" position="float"><label>Figure 5:</label><caption><p id="P96">Possible mechanism for the P450-catalyzed conversion of 1-ABT to benzotriazole.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0005.jpg"/></fig><fig id="F6" orientation="portrait" position="float"><label>Figure 6:</label><caption><p id="P97">Analogues of 1-ABT with variants of the core 1-aminobenzotriazole structure are not effective mechanism-based inactivating agents.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0006.jpg"/></fig><fig id="F7" orientation="portrait" position="float"><label>Figure 7:</label><caption><p id="P98">A possible mechanism for the formation of a nitroso compound that could coordinate to the heme iron of P450, resulting in observation of MI complexes. The reaction scheme shown is a modified version of that proposed by Sinal and Bend [<xref rid="R90" ref-type="bibr">90</xref>]. The R stands for H, Me, or Et, depending on whether it refers to experiments with compound <bold>13</bold>, <bold>14</bold>, or <bold>15</bold> (<xref rid="T2" ref-type="table">Table 2</xref>), respectively.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0007.jpg"/></fig><fig id="F8" orientation="portrait" position="float"><label>Figure 8:</label><caption><p id="P99">Metabolites of thiazopyr and GNE-892 produced by cytochrome P450.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0008.jpg"/></fig><fig id="F9" orientation="portrait" position="float"><label>Figure 9:</label><caption><p id="P100">Cytochrome P450 catalyzed oxidation resulting in a reduced metabolite.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0009.jpg"/></fig><fig id="F10" orientation="portrait" position="float"><label>Figure 10:</label><caption><p id="P101">Metabolites of nevirapine formed by cytochrome P450 enzymes.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0010.jpg"/></fig><fig id="F11" orientation="portrait" position="float"><label>Figure 11:</label><caption><p id="P102">The cytochrome P450-catalyzed transformation of tienilic acid to a glutathione conjugate is inhibited by 1-ABT.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0011.jpg"/></fig><fig id="F12" orientation="portrait" position="float"><label>Figure 12:</label><caption><p id="P103">The hepatic metabolism of desloratadine elucidated with the help of 1-ABT.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0012.jpg"/></fig><fig id="F13" orientation="portrait" position="float"><label>Figure 13:</label><caption><p id="P104">Epoxidation of precocene.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0013.jpg"/></fig><fig id="F14" orientation="portrait" position="float"><label>Figure 14:</label><caption><p id="P105">Oxidation of 3-methylindole to a reactive methylene iminium product that alkylates proteins.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0014.jpg"/></fig><fig id="F15" orientation="portrait" position="float"><label>Figure 15:</label><caption><p id="P106">Oxidation of cinnamic acid by cinnamic acid 4-hydroxylase in the biosynthesis of phenylpropanoids in plants.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0015.jpg"/></fig><fig id="F16" orientation="portrait" position="float"><label>Figure 16:</label><caption><p id="P107">Structure of schisandrin B.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0016.jpg"/></fig><fig id="F17" orientation="portrait" position="float"><label>Figure 17:</label><caption><p id="P108">Formation of 9,12,13-trihydroxy-10(<italic toggle="yes">E</italic>)-octadecenoic acid in <italic toggle="yes">Solanum lypoersicum</italic> (tomato).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0017.jpg"/></fig><fig id="F18" orientation="portrait" position="float"><label>Figure 18:</label><caption><p id="P109">Pathways for the biosynthesis of h&#252;orhammericine from tabersonine in the biogenesis of vindoline.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0018.jpg"/></fig><fig id="F19" orientation="portrait" position="float"><label>Figure 19:</label><caption><p id="P110">Structures of some of the herbicide agents whose metabolism is shown by studies with 1-ABT to involve cytochrome P450 enzymes.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0019.jpg"/></fig><fig id="F20" orientation="portrait" position="float"><label>Figure 20:</label><caption><p id="P111">Two intermediates in the biosynthesis of enokipodin A, B, C, and D identified as a result of inhibition of P450 enzymes by 1-ABT. The two intermediates are shown in the boxes.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-f0020.jpg"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1:</label><caption><p id="P112">Some compounds for which the role of P450 versus FMO has been investigated using 1-ABT as a P450 inactivating agent.</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Substrates</th><th align="center" valign="middle" rowspan="1" colspan="1">Enzyme source</th><th align="center" valign="middle" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">2-Aryl-1,3-dithiolanes</td><td align="center" valign="middle" rowspan="1" colspan="1">Rabbit lung</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R62" ref-type="bibr">62</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Alkyl <italic toggle="yes">p</italic>-tolylsulfides</td><td align="center" valign="middle" rowspan="1" colspan="1">Rabbit lung/mini pig liver</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R63" ref-type="bibr">63</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Thiocarbamides</td><td align="center" valign="middle" rowspan="1" colspan="1">Rat liver</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R64" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Benzimidazoline-2-thiones</td><td align="center" valign="middle" rowspan="1" colspan="1">Rat liver</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R65" ref-type="bibr">65</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2-(Alkylthio)-1,3,4-thiadiazoles 2-(Alkylthio)-1,3-benzothiazoles</td><td align="center" valign="middle" rowspan="1" colspan="1">Human liver</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R66" ref-type="bibr">66</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Thiouracil derivative</td><td align="center" valign="middle" rowspan="1" colspan="1">Rat / dog liver</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R67" ref-type="bibr">67</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2:</label><caption><p id="P113">Analogues of 1-ABT shown to inactivate cytochrome P450 enzymes.</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Compound number</th><th align="center" valign="middle" rowspan="1" colspan="1">Analog</th><th align="center" valign="middle" rowspan="1" colspan="1">%P450 loss <italic toggle="yes">in vitro</italic></th><th align="center" valign="middle" rowspan="1" colspan="1">Porphyrin pigment <italic toggle="yes">in vivo</italic></th><th align="center" valign="middle" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>1</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT</td><td align="center" valign="middle" rowspan="1" colspan="1">86<sup><xref rid="TFN1" ref-type="table-fn">a</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">yes</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R20" ref-type="bibr">20</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>7</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0021.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">65<sup><xref rid="TFN1" ref-type="table-fn">a</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">yes</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R20" ref-type="bibr">20</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>8</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0022.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">32<sup><xref rid="TFN1" ref-type="table-fn">a</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">yes</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R20" ref-type="bibr">20</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>9</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0023.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">20<sup><xref rid="TFN1" ref-type="table-fn">a</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">yes</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R20" ref-type="bibr">20</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>10</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0024.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">10<sup><xref rid="TFN1" ref-type="table-fn">a</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">yes</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R20" ref-type="bibr">20</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>11</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0025.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">43<sup><xref rid="TFN1" ref-type="table-fn">a</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">yes</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R22" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>12</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0026.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">37<sup><xref rid="TFN2" ref-type="table-fn">b</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">nd<sup><xref rid="TFN4" ref-type="table-fn">d</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R22" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>13</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0027.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">25<sup><xref rid="TFN3" ref-type="table-fn">c</xref></sup><break/>30<sup><xref rid="TFN2" ref-type="table-fn">b</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">nd<sup><xref rid="TFN4" ref-type="table-fn">d</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R89" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>14</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0028.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">31<sup><xref rid="TFN3" ref-type="table-fn">c</xref></sup><break/>37<sup><xref rid="TFN2" ref-type="table-fn">b</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">nd<sup><xref rid="TFN4" ref-type="table-fn">d</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R89" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>15</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0029.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">2<sup><xref rid="TFN3" ref-type="table-fn">c</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">nd<sup><xref rid="TFN4" ref-type="table-fn">d</xref></sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R89" ref-type="bibr">89</xref>]</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>a</label><p id="P114">Loss of P450 content on incubation of phenobarbital-induced rat liver microsomes with 1 mM inhibitor for 30 min.</p></fn><fn id="TFN2"><label>b</label><p id="P115">Loss of P450 content on incubation of &#946;-naphthoflavone induced rabbit lung microsomes with 10 &#956;M inhibitor.</p></fn><fn id="TFN3"><label>c</label><p id="P116">Loss of P450 content on incubation of untreated guinea pig pulmonary microsomes with 10 &#956;M inhibitor for 45 min.</p></fn><fn id="TFN4"><label>d</label><p id="P117">nd=not determined</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float" orientation="portrait"><label>Table 3:</label><caption><p id="P118">Consequences of the inhibition of 1-ABT-mediated P450 metabolism of a range of compounds.</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" rowspan="1" colspan="1"/><th align="center" valign="middle" rowspan="1" colspan="1">Effect of 1-ABT</th><th align="center" valign="middle" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Flurazepam</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0030.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Raised flurazepam brain concentration, confirming the parent drug is the active species</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R123" ref-type="bibr">123</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Furfuryl mercaptan</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0031.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Inhibited oxidation by rat to thiofuran methyl sulfoxide</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R124" ref-type="bibr">124</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>2-Methyl-3-furanthiol</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0032.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Inhibited oxidation by rat to thiofuran methyl sulfoxide</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R124" ref-type="bibr">124</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Sulfamethoxazole</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0033.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Partially inhibited oxidation to hydroxylamine</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R125" ref-type="bibr">125</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>OZ439</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0034.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Partially inhibited clearance of drug in rats</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R126" ref-type="bibr">126</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>CDRI 99/411</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0035.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Showed two metabolites are cytochrome P450-dependent</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R127" ref-type="bibr">127</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>[6]-Shogaol</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0036.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Showed P450 involved in formation of desaturated metabolites</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R128" ref-type="bibr">128</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>GDC-0152</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0037.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Inhibited the formation of a novel metabolite</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R129" ref-type="bibr">129</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Rebisofugenin</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0038.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Implicated CYP3A4 in AB-ring hydroxylation</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R130" ref-type="bibr">130</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>ETX0914</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0039.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Inhibited <italic toggle="yes">in vivo</italic> formation of several metabolites</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R131" ref-type="bibr">131</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Decursinol angelate</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0040.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Inhibited metabolism of the drug by human liver microsomes</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R132" ref-type="bibr">132</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Droneradone</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0041.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Almost completely inhibited metabolic clearance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R133" ref-type="bibr">133</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Tolperisone</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0042.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Inhibited metabolite formation and intrinsic clearance by human liver <break/>microsomes</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R134" ref-type="bibr">134</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>DB289</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0043.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Inhibited metabolite formation</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R135" ref-type="bibr">135</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>N-(5-chloro-2-methylphenyl)-N&#8217;-(2-methylpropyl)-thiourea</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0044.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">In vivo</italic>, decreased GSH adduct formation by 95%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R136" ref-type="bibr">136</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Epacadostat</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0045.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Showed gut bacteria reduced the <break/>=N-OH to =NH, but liver P450s catalyzed N-dealkylation</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R137" ref-type="bibr">137</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>U-91502</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0046.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Showed parent drug is responsible for the cardiopulmonary toxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R138" ref-type="bibr">138</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Dipeptide VLA-4 antagonist</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0047.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Showed oxidative metabolism not rate limiting in excretion of this drug</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R139" ref-type="bibr">139</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Triadimefon</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0048.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Established keto reduction to triadimenol is not by a P450 enzyme</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R140" ref-type="bibr">140</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Pan JNK inhibitors</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0049.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Brain exposure required for therapy achieved when 1-ABT coadministered</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R141" ref-type="bibr">141</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>ML375</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0050.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">Increased plasma exposure of the drug when administered with 1-ABT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R142" ref-type="bibr">142</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>TXY541</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-965876-t0051.jpg"/></td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT increased t<sub>1/2</sub> and reduced the dose required for efficacy</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R143" ref-type="bibr">143</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="T4" position="float" orientation="portrait"><label>Table 4:</label><caption><p id="P119">Effect of 1-ABT on arachidonic acid pathways.</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Effector</th><th align="center" valign="middle" rowspan="1" colspan="1">System</th><th align="center" valign="middle" rowspan="1" colspan="1">Finding</th><th align="center" valign="middle" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Endothelin-1</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Foetal lambs, guinea pigs</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT inhibits contraction of ductus arteriosus by oxygen, implicating a P450based mechanism</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R153" ref-type="bibr">153</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Acetylcholine</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Isolated rat hearts</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT inhibits cardiodepression by acetylcholine, implying a role for P450 and <break/>EETs</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R154" ref-type="bibr">154</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Acetylcholine leveromakalim</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rat mesenteric artery</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT, unlike miconazole, did not influence endothelium-dependent hyperpolarization</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R155" ref-type="bibr">155</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Endothelium-derived hyperpolarizing factor (EDHF)</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rat mesenteric artery</td><td align="center" valign="middle" rowspan="1" colspan="1">As 1-ABT did not counteract the effect, EDHF released by acetylcholine is not a <break/>P450-derived arachidonic acid metabolite</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R156" ref-type="bibr">156</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>High salt diet, acetylcholine</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT abolished the blood pressure increase due to intrarenal acetylcholine; implicates 20-HETE but not EETs in the process</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R157" ref-type="bibr">157</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Bradykinin</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Isolated rat hearts</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT abolished cardiodepression by bradykinin, implying a role for P450 and 14,15-EET</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R158" ref-type="bibr">158</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Bradykinin</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Perfused rat kidney</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT does not inhibit bradykinin increases in perfusion of the medulla mediated by the NO system and K(Ca) channels</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R159" ref-type="bibr">159</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Bradykinin</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Isolated rat heart</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT prevented the decrease in left ventricular pressure caused by bradykinin</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R160" ref-type="bibr">160</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Cyclosporin A, NO</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT inhibited cyclosporin A mediated increases of 20-HETE, systolic blood pressure, and renal damage</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R161" ref-type="bibr">161</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>NO</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT blocked the renal vasodilatory response to NO and reduced its diuretic and natriuretic effects</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R162" ref-type="bibr">162</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>ATP, NO</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT and NO synthase inhibitors blunted ATP mediated increases in renal arterial blood flow</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R163" ref-type="bibr">163</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Endotoxin hypotension, NO</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT diminished CYP4A activity but did not prevent the NO mediated decrease in mean arterial pressure (MAP)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R164" ref-type="bibr">164</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>NO</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats, pregnant</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT prevented the increases in systolic blood pressure caused by an NO donor, suggesting a role for 20-HETE</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R165" ref-type="bibr">165</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>NO, Na</bold><sup><bold>+</bold></sup><bold>-K</bold><sup><bold>+</bold></sup><bold>&#8722;2Cl</bold><sup><bold>-</bold></sup>
<bold>cotransport</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">MMDD1 cells</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT reversed inhibition of Na<sup>+</sup>-K<sup>+</sup>&#8722;2Cl<sup>-</sup> cotransport caused by NO, implying a role for a P450-enzyme</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R166" ref-type="bibr">166</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>NO interaction</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats, hypertensive</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT attenuated elevation of blood pressure caused by <italic toggle="yes">L</italic>-NAME and lowered organ damage</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R167" ref-type="bibr">167</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>O</bold><sub><bold>2</bold></sub>
<bold>sensing, K</bold><sup><bold>+</bold></sup>
<bold>channel</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rat carotid body type I cells</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT inhibited hypoxic depression of K<sup>+</sup> currents, suggesting a P450 enzyme is involved</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R168" ref-type="bibr">168</xref>,<xref rid="R169" ref-type="bibr">169</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Arachidonic acid, K</bold><sup><bold>+</bold></sup><bold>/Ca</bold><sup><bold>2+</bold></sup>
<bold>channels</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rat carotid body type I cells</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT did not alter the effects of arachidonic acid on K<sup>+</sup> currents, suggesting they are not mediated by a P450 enzyme</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R170" ref-type="bibr">170</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>EDHF</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rat aorta smooth muscle cells</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT, unlike miconazole, does not interfere with K<sup>+</sup> channel activation, negating a general P450 effect</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R171" ref-type="bibr">171</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>K</bold><sup><bold>+</bold></sup>
<bold>channels</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rabbit portal vein myocytes</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT, unlike ketoconazole, had no effect on native KDR or RPV Kv1.5 current, implying P450 inhibition not critical for ketoconazole effect</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R172" ref-type="bibr">172</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>K</bold><sup><bold>+</bold></sup>
<bold>channels</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Pulmonary arterial myocytes</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT reversibly inhibited steady-state K<sup>+</sup><sub>v</sub> channel currents and membrane potential, but interpretation unclear</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R173" ref-type="bibr">173</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Angiotensin</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT inhibited the doubling of mean arterial blood pressure mediated by angiotensin</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R174" ref-type="bibr">174</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Angiotensin</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats</td><td align="center" valign="middle" rowspan="1" colspan="1">Chronic blockade of EETs and 20-HETE with 1-ABT attenuated the ANG IIinduced rise in MAP by 40%</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R175" ref-type="bibr">175</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Angiotensin</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats, hypertensive</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT, angiotensin II, and endothelin individually reduced blood pressure to similar levels, and more in combination</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R176" ref-type="bibr">176</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Diabetes</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats, diabetic</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT attenuated vasoconstrictor responses to norepinephrine, endothelin-1, and angiotensin II</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R177" ref-type="bibr">177</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Postmenopause</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats, hypertensive</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT decreased blood pressure in postmenopausal, but not young, spontaneously hypertensive rats, implicating a 20-HETE contribution to postmenopausal hypertension</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R178" ref-type="bibr">178</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Pregnancy</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats, pregnant</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT decreased systolic blood pressure, urinary sodium, urinary 20-HETE, renal <break/>20-HETE</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R179" ref-type="bibr">179</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Pregnancy</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats, pregnant</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT decreased MAP in rats with reduced uterine perfusion pressure and lowered both 20-HETE formation and CYP4A expression</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R180" ref-type="bibr">180</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Diabetes, endothelin streptozotocin</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats, diabetic</td><td align="center" valign="middle" rowspan="1" colspan="1">Blockade of CaMKII, Ras-GTPase or the production of 20-HETE by 1-ABT normalized the altered vascular reactivity to ET-1 and carbachol in the carotid artery of streptozotocin-induced diabetic rats</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R181" ref-type="bibr">181</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Insulin resistance</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats</td><td align="center" valign="middle" rowspan="1" colspan="1">In the presence of testosterone, the 1-ABT inhibitable Cyp4A/20-HETE system plays a key role in elevating blood pressure secondary to insulin resistance</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R182" ref-type="bibr">182</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Natriuresis, Pressure response</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT decreased the pressure-natriuretic response by 50% and renal formation of 20-HETE and ETAs by 90% and 50%, respectively</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R183" ref-type="bibr">183</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Natriuresis, dopamine</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT reduced the natriuretic response to dopamine by 65% and markedly reduced urine flow and sodium excretion</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R184" ref-type="bibr">184</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Deoxycorticosterone (DOCA)- salt</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT reduced hypertension in a DOCA-salt model but did not prevent organ hypertrophy and proteinuria</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R185" ref-type="bibr">185</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>20-HETE vs EETs</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rats</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT decreased renal artery flow without altering medullary perfusion, whereas medullary NO increased</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R186" ref-type="bibr">186</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Renin Hypertension</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Ren-2 transgenic rats</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT in Ren-2 transgenic rats decreased blood pressure and cardiac hypertrophy, but not glomerulosclerosis, implicating P450 metabolites</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R187" ref-type="bibr">187</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Pressure response</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Perfused dog renal arcuate arteries</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT partially inhibited the myogenic response to elevated perfusion pressure; suggested a role for 20-HETE in the myogenic response</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R188" ref-type="bibr">188</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Balloon injury</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rat carotid arteries</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT prevents the increase in 20-HETE levels caused by balloon injury and attenuated vascular smooth muscle cell remodeling,</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R189" ref-type="bibr">189</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>VEGF</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rat muscle</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT blocked the increase in 20-HETE and angiogenesis caused by electrical stimulation</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R190" ref-type="bibr">190</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Type II Phospholipase A2 (sPLA2-II)</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Guinea pig alveolar macrophages</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT prevented the inhibition of sPLA2-II expression caused by low (5 &#956;M) but not high (30 &#956;M) concentrations of arachidonic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R191" ref-type="bibr">191</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>GABA receptor</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">HEK 293 cells</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT did not block the inhibitory effect of arachidonic acid on currents due to the &#945;1&#946;2&#947;2 GABA(A) receptor</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R192" ref-type="bibr">192</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Fetal bovine serum (FBS)</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Murine 3T6 fibroblasts</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT decreased 12(<italic toggle="yes">S</italic>)-HETE levels, 3T6 fibroblast growth, and DNA synthesis induced by FBS</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R193" ref-type="bibr">193</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Cholecystokinin octapeptide (CCK)</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rat pancreatic acinar cells</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT, unlike ketoconazole, did not alter baseline [Ca<sup>2+</sup>] or CCK-evoked oscillations</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R9" ref-type="bibr">9</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Pulmonary vasodilation</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Isolated perfused rat lung</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT partially inhibited immediate arachidonic acid-induced pulmonary vasodilation, suggesting a role for P450 enzymes</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R194" ref-type="bibr">194</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Pulmonary vasodilation</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Rat lung</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT inhibited vasoconstriction caused by hypoxia and angiotensin II, but not when 1-ABT was washed out first-conclude 1-ABT does not act through a P450 <break/>mechanism</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R195" ref-type="bibr">195</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Pulmonary vasoconstriction</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Isolated perfused rabbit lung</td><td align="center" valign="middle" rowspan="1" colspan="1">Hypoxia-induced vasoconstriction was inhibited by 1-ABT, but similar inhibition was observed under normoxia with a thromboxane analogue.</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R196" ref-type="bibr">196</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Ozone hyper-responsiveness</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Mouse lung</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT greatly attenuated airway sensitivity and the increases in 20-HETE caused by ozone</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R197" ref-type="bibr">197</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="T5" position="float" orientation="portrait"><label>Table 5:</label><caption><p id="P120">Effect of 1-ABT on estradiol-dependent pathways.</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="middle" rowspan="1" colspan="1">Cardiac fibroblasts</td><td align="center" valign="middle" rowspan="1" colspan="1">Inhibition by 1-ABT suggests estradiol inhibits cardiac fibroblast growth via an estrogen receptor-independent pathway involving metabolism of estradiol to methoxyestradiols</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R198" ref-type="bibr">198</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="middle" rowspan="1" colspan="1">Human glomerular mesangial cells</td><td align="center" valign="middle" rowspan="1" colspan="1">Estradiol inhibited, serum-induced, proliferation of glomerular mesangial cells was enhanced by P450 inducers and diminished by 1-ABT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R199" ref-type="bibr">199</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="middle" rowspan="1" colspan="1">Aortic vascular smooth muscle cells</td><td align="center" valign="middle" rowspan="1" colspan="1">Estradiol inhibited, serum-induced, proliferation of vascular smooth muscle cells was enhanced by P450 inducers and diminished by 1-ABT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R200" ref-type="bibr">200</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="middle" rowspan="1" colspan="1">Human coronary artery smooth muscle cells</td><td align="center" valign="middle" rowspan="1" colspan="1">Estradiol inhibited, serum-induced, proliferation of smooth muscle cells was enhanced by P450 inducers and diminished by 1-ABT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R201" ref-type="bibr">201</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Growth inhibition</td><td align="center" valign="middle" rowspan="1" colspan="1">Human cardiac fibroblasts</td><td align="center" valign="middle" rowspan="1" colspan="1">Estradiol inhibited, serum-induced, proliferation of human cardiac fibroblasts was enhanced by P450 inducers and diminished by 1-ABT</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R202" ref-type="bibr">202</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cell proliferation</td><td align="center" valign="middle" rowspan="1" colspan="1">Cultured rat vascular smooth muscle cells</td><td align="center" valign="middle" rowspan="1" colspan="1">1-ABT increased the growth promoting effect of 17&#946;-estradiol by inhibiting formation of 2- and 4-hydroxyestradiol and reactive oxygen species</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R203" ref-type="bibr">203</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Smooth muscle contraction</td><td align="center" valign="middle" rowspan="1" colspan="1">Rat aortic smooth muscle</td><td align="center" valign="middle" rowspan="1" colspan="1">17&#946;-estradiol inhibition of phenylephrine-induced contraction was not prevented by <break/>1-ABT, suggesting a P450-independent mechanism</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R204" ref-type="bibr">204</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="T6" position="float" orientation="portrait"><label>Table 6:</label><caption><p id="P121">Some toxicological processes in which cytochrome P450 enzymes were implicated though inhibition by 1-ABT.</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Xenobiotic</th><th align="center" valign="middle" rowspan="1" colspan="1">End point inhibited</th><th align="center" valign="middle" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Acebutolol</td><td align="center" valign="middle" rowspan="1" colspan="1">Antinuclear antibody production</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R266" ref-type="bibr">266</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Amodiaquine</td><td align="center" valign="middle" rowspan="1" colspan="1">Toxicity of amodiaquine</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R267" ref-type="bibr">267</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Carbamazepine</td><td align="center" valign="middle" rowspan="1" colspan="1">Protein-reactive metabolite formation</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R268" ref-type="bibr">268</xref>,<xref rid="R269" ref-type="bibr">269</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Clopidogrel</td><td align="center" valign="middle" rowspan="1" colspan="1">Hepatic injury</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R270" ref-type="bibr">270</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Efavirenz</td><td align="center" valign="middle" rowspan="1" colspan="1">Inhibition of 8-hydroxy-efavirenz formation and hepatic cell death</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R271" ref-type="bibr">271</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Leflunomide</td><td align="center" valign="middle" rowspan="1" colspan="1">Cytotoxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R272" ref-type="bibr">272</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Leflunomide</td><td align="center" valign="middle" rowspan="1" colspan="1">Hepatotoxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R273" ref-type="bibr">273</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Methapyrilene</td><td align="center" valign="middle" rowspan="1" colspan="1">Formation of reactive metabolite and genotoxic potential</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R274" ref-type="bibr">274</xref>,<xref rid="R275" ref-type="bibr">275</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ticlopidine</td><td align="center" valign="middle" rowspan="1" colspan="1">Protein covalent binding and hepatotoxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R276" ref-type="bibr">276</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Aflatoxin B1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cytotoxicity to 3T3 cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R277" ref-type="bibr">277</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">Toxification due to CYP2C19</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R278" ref-type="bibr">278</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Capsaicin</td><td align="center" valign="middle" rowspan="1" colspan="1">Formation of toxic metabolite</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R279" ref-type="bibr">279</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#946;-Carotene / &#946;-apo-8&#8217;-carotenal</td><td align="center" valign="middle" rowspan="1" colspan="1">Formation of DNA strand breaks</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R280" ref-type="bibr">280</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">White snake root constituents</td><td align="center" valign="middle" rowspan="1" colspan="1">Cytotoxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R281" ref-type="bibr">281</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Aromatic and heterocyclic amines</td><td align="center" valign="middle" rowspan="1" colspan="1">Genotoxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R282" ref-type="bibr">282</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Benzene</td><td align="center" valign="middle" rowspan="1" colspan="1">Induction of micronuclei</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R283" ref-type="bibr">283</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Butylated hydroxytoluene</td><td align="center" valign="middle" rowspan="1" colspan="1">Quinone methide formation</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R284" ref-type="bibr">284</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Tetrahydrofuran</td><td align="center" valign="middle" rowspan="1" colspan="1">Hepatocellular proliferation</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R285" ref-type="bibr">285</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Dimethylbenz[a]anthracene</td><td align="center" valign="middle" rowspan="1" colspan="1">Pre-B lymphocyte apoptosis</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R286" ref-type="bibr">286</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mono- and di-chlorobiphenyls</td><td align="center" valign="middle" rowspan="1" colspan="1">Mutagenicity assays in Chinese hamster V79 cells expressing CYP2E1 and SULT 1A1</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R287" ref-type="bibr">287</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">N-(3,5-Dichlorophenyl)-succinimide</td><td align="center" valign="middle" rowspan="1" colspan="1">Nephrotoxic metabolite formation and renal damage</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R288" ref-type="bibr">288</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">N-(3,5-Dichlorophenyl)-succinimide</td><td align="center" valign="middle" rowspan="1" colspan="1">Protein covalent binding and nephrotoxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R289" ref-type="bibr">289</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3-(3,5-Dichlorophenyl)-2,4-thiazolidinedione</td><td align="center" valign="middle" rowspan="1" colspan="1">Hepatotoxicity</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R290" ref-type="bibr">290</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2-Nitropropane</td><td align="center" valign="middle" rowspan="1" colspan="1">Micronucleus and multinuclei formation</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R291" ref-type="bibr">291</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">N-Nitrosodimethylamine</td><td align="center" valign="middle" rowspan="1" colspan="1">Micronucleus and multinuclei formation</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R291" ref-type="bibr">291</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">NNK (4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone)</td><td align="center" valign="middle" rowspan="1" colspan="1">DNA strand breaks</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R292" ref-type="bibr">292</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5-Nitrobenzo[b]naptho[2,1-d]thiophenes.</td><td align="center" valign="middle" rowspan="1" colspan="1">DNA adduct formation</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R293" ref-type="bibr">293</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">(<italic toggle="yes">N</italic>-(4-((1<italic toggle="yes">H</italic>-pyrrolo[2,3-b]pyridin-4-yl)oxy)-3-fluorophenyl)-1-(4-fluorophenyl) 2-oxo-1,2-dihydropyridine-3-carboxamide)</td><td align="center" valign="middle" rowspan="1" colspan="1">Vacuolar degeneration and necrosis of adrenal cortex</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R294" ref-type="bibr">294</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2,3,7,8-tetrachlorodibenzo-<italic toggle="yes">p</italic>-dioxin</td><td align="center" valign="middle" rowspan="1" colspan="1">Decreased biliary excretion of the compound in rats</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R295" ref-type="bibr">295</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="T7" position="float" orientation="portrait"><label>Table 7:</label><caption><p id="P122">Some toxicological processes not inhibited by 1-ABT and therefore unlikely to involve cytochrome P450 enzymes as active participants.</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Xenobiotic</th><th align="center" valign="middle" rowspan="1" colspan="1">End point not inhibited</th><th align="center" valign="middle" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Dapsone</td><td align="center" valign="middle" rowspan="1" colspan="1">Formation of protein adducts in normal human epidermal keratinocytes</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R296" ref-type="bibr">296</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">MRL-A</td><td align="center" valign="middle" rowspan="1" colspan="1">Formation of protein adduct</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R297" ref-type="bibr">297</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nimesulide</td><td align="center" valign="middle" rowspan="1" colspan="1">Toxicity to human and rat primary hepatocytes</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R298" ref-type="bibr">298</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Aminophenol</td><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Aminophenol mediated changes in renal proximal tubules</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R299" ref-type="bibr">299</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Carbaryl, Quinalphos, Benomyl Carbendazim</td><td align="center" valign="middle" rowspan="1" colspan="1">Cytotoxicity to Fa32 and human Hep G2 cells</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="R300" ref-type="bibr">300</xref>]</td></tr></tbody></table></table-wrap></floats-group></article></pmc-articleset>